P1 - Poster Session 1

Event Time:	Sunday May 5, 2019 11:30 am to 6:30 pm
Topic(s):	Research Methodology, Education, and History, Aging, Dementia, Cognitive, and Behavioral Neurology, Autoimmune Neurology, Cerebrovascular Disease and Interventional Neurology, Child Neurology and Developmental Neurology, Epilepsy/Clinical Neurophysiology (EEG), General Neurology, Headache, Movement Disorders, MS and CNS Inflammatory Disease, Neuro-oncology, Neuro-ophthalmology/Neuro-otology
Director(s):
Description:
Completion Message:
CME Credits:	0
Core Competencies:

Program Speakers - Tentative
Start/End Time	Title	Faculty
Currently there are no events in the timeline.

Disclosures
Speaker	Disclosure

Abstract Presenters
Neuro-Ophthalmology/Neuro-Otology
Start Time	Pub.	Title	Presenter
11:30 AM	001	Development of Portable Pupillometer for Assessment of Neurological Disease	Disclosure: Dr. Moss has received personal compensation for consulting, serving on a scientific advisory board, speaking, or other activities with legal firms.
Headache Clinical Trials I
Start Time	Pub.	Title	Presenter
11:30 AM	001	Galcanezumab Significantly Reduced Health Care Resource Utilization and Acute Medication Use in Patients with Chronic Migraine: Findings from a Phase 3, Randomized, Double-Blind, Placebo-Controlled and Open-Label Extension	Disclosure: Dr. Joshi has received personal compensation for consulting, serving on a scientific advisory board, speaking, or other activities with Amgen, Lilly, Teva, Supernus, Depomed, Promeus.
Aging and Dementia: Animal and Cell Models
Start Time	Pub.	Title	Presenter
11:30 AM	001	Pathological Changes To the Visual System in Alzheimer’s Disease	Disclosure: Dr. Mistry has nothing to disclose.
Autoimmune (AQP4/MOG) Gliopathies and NMOSDs
Start Time	Pub.	Title	Presenter
11:30 AM	001	Cerebellar Atrophies in Neuromyelitis Optica Spectrum Disease (NMOSD) patients	Disclosure: Dr. Souza has nothing to disclose.
Antithrombotic Treatment in Ischemic Stroke
Start Time	Pub.	Title	Presenter
11:30 AM	001	A Stroke of Bad Luck : Breakthrough Ischaemic Strokes on DOAC Therapy	Disclosure: Dr. Chan has nothing to disclose.
Amyotrophic Lateral Sclerosis
Start Time	Pub.	Title	Presenter
11:30 AM	001	Investigating Directionality of Neurodegeneration in vivo in ALS using Multimodal MRI	Disclosure: Dr. Toh has nothing to disclose.
Epilepsy: Comorbidities and SUDEP
Start Time	Pub.	Title	Presenter
11:30 AM	001	Factors Contributing to Quality Of Life in Patients With Epilepsy.	Disclosure: Dr. Doyle has nothing to disclose.
Clinical Advances in CNS Cancer Care
Start Time	Pub.	Title	Presenter
11:30 AM	001	Tumors in the cauda equina: a SEER analysis of tumor types and predictors of outcome	Disclosure: Dr. Das has nothing to disclose.
Autoimmune Neurology/MS and CNS Inflammatory Disease ePoster Session
Start Time	Pub.	Title	Presenter
11:30 AM	001	Optic Nerve Pathology and Visual Functioning in Pediatric Patients with anti-MOG Antibodies	Disclosure: Dr. Greenberg has received personal compensation for consulting, serving on a scientific advisory board, speaking, or other activities with Novartis, Alexion, Celgene, and EMD Serono. Dr. Greenberg has received grants from Chugai, Medimmune, Genentech, MedDay, PCORI, NIH, NMSS and Guthy Jackson Charitable Foundation for NMO.
Ataxia
Start Time	Pub.	Title	Presenter
11:30 AM	001	Results from the Long-Term Open Label Extension Phase Analyses of BHV4157-201: A Phase IIb/III, Randomized, Double-blind, Placebo-controlled Trial of the Safety and Efficacy of Troriluzole in Adult Subjects with Spinocerebellar Ataxia	Disclosure: Dr. Beiner has received personal compensation for consulting, serving on a scientific advisory board, speaking, or other activities with Biohaven Pharmaceuticals. Dr. Beiner holds stock and/or stock options in Biohaven Pharmaceuticals which sponsored research in which Dr. Beiner was involved as an investigator. Dr. Beiner holds stock and/or stock options in Biohaven Pharmaceuticals.
Neuro-Ophthalmology/Neuro-Otology
Start Time	Pub.	Title	Presenter
11:30 AM	002	Macular Pigment In Multiple Sclerosis	Disclosure: Dr. Xhepa has nothing to disclose.
Headache Clinical Trials I
Start Time	Pub.	Title	Presenter
11:30 AM	002	Assessment of the Efficacy of Erenumab During the Open-Label Treatment (13–24 Weeks) of Subjects with Episodic Migraine Who Failed 2–4 Prior Preventive Treatments: Results of the LIBERTY Study	Disclosure: Dr. Reuter has received personal compensation for consulting, serving on a scientific advisory board, speaking, or other activities with consulting fee, speaking/teaching fee, from Allergan, Amgen, Autonomic Technologies, CoLucid, ElectroCore, EliLilly, Medscape, Novartis, StreamMedUp, TEVA Pharmaceuticals. Dr. Reuter has received research support from research grants from Allergan, Amgen, Autonomic Technologies, CoLucid, ElectroCore, EliLilly, Medscape, Novartis, StreamMedUp, TEVA Pharmaceuticals.
Aging and Dementia: Animal and Cell Models
Start Time	Pub.	Title	Presenter
11:30 AM	002	iPSC Model of CHRFAM7A Effect on a7 Nicotinic Acetylcholine Receptor Function in the Human Context	Disclosure: Dr. Ihnatovych has nothing to disclose.
Autoimmune (AQP4/MOG) Gliopathies and NMOSDs
Start Time	Pub.	Title	Presenter
11:30 AM	002	Degree of Retinal Nerve Fiber Layer Thinning in Pediatric MOG-associated Optic Neuritis Appears Similar to Pediatric NMO	Disclosure: Dr. Shukla has nothing to disclose.
Antithrombotic Treatment in Ischemic Stroke
Start Time	Pub.	Title	Presenter
11:30 AM	002	Triglycerides, Creatinine and Body Mass Index are Independent Predictors of Occurrence of Stroke in Patients Adherent with Direct Oral Anticoagulant	Disclosure: Dr. Zhang has nothing to disclose.
Amyotrophic Lateral Sclerosis
Start Time	Pub.	Title	Presenter
11:30 AM	002	The Vitamin D Activator, CYP27B1, is a Novel Muscle Biomarker of ALS Disease Progression	Disclosure: Dr. Si has nothing to disclose.
Epilepsy: Comorbidities and SUDEP
Start Time	Pub.	Title	Presenter
11:30 AM	002	Characterizing Peri-Ictal Mood Changes in Patients with Epilepsy	Disclosure: Dr. Pahlavan has nothing to disclose.
Clinical Advances in CNS Cancer Care
Start Time	Pub.	Title	Presenter
11:30 AM	002	A Meta-Analysis Determining the Prevalence of Treatment-Associated Neurotoxicity in Cancer-Directed Immunotherapy with Antibodies	Disclosure: Dr. Horta has nothing to disclose.
Autoimmune Neurology/MS and CNS Inflammatory Disease ePoster Session
Start Time	Pub.	Title	Presenter
11:30 AM	002	Neuronal Autoantibodies and Clinical Significance in Stiff-Person Spectrum Disorder	Disclosure: Dr. Kaneko has nothing to disclose.
Ataxia
Start Time	Pub.	Title	Presenter
11:30 AM	002	The impact of ethnicity on the phenotype of a monogenetic disorder: spinocerebellar ataxias type 3	Disclosure: Dr. Gan has nothing to disclose.
Neuro-Ophthalmology/Neuro-Otology
Start Time	Pub.	Title	Presenter
11:30 AM	003	Anti-glutamic acid decarboxylase associated neurologic disorders referred from Neuro-ophthalmology and Neurotology: A case series with characterization of vestibulo-ocular function	Disclosure: Dr. Wang has nothing to disclose.
Headache Clinical Trials I
Start Time	Pub.	Title	Presenter
11:30 AM	003	Patient Gains in Daily Functioning and Reductions in Disability with Galcanezumab among Patients with Episodic and Chronic Migraine	Disclosure: Dr. Ruff has received personal compensation for consulting, serving on a scientific advisory board, speaking, or other activities with Eli Lilly and Company. Dr. Ruff holds stock and/or stock options in Eli Lilly and Company.
Aging and Dementia: Animal and Cell Models
Start Time	Pub.	Title	Presenter
11:30 AM	003	Neuroprotection of HP-beta-CD in the adult transgenic mice of Alzheimer disease	Disclosure: Dr. Yao has nothing to disclose.
Autoimmune (AQP4/MOG) Gliopathies and NMOSDs
Start Time	Pub.	Title	Presenter
11:30 AM	003	Systematic Review Investigating Relationship Between Neuromyelitis Optica Spectrum Disorder (NMOSD) and Vaccination	Disclosure: Dr. Vanood has nothing to disclose.
Antithrombotic Treatment in Ischemic Stroke
Start Time	Pub.	Title	Presenter
11:30 AM	003	Timing of Anti-Coagulation after Acute Ischemic Stroke and its relationship to risk of Intracranial Hemorrhage	Disclosure: Dr. Shehzad has nothing to disclose.
Amyotrophic Lateral Sclerosis
Start Time	Pub.	Title	Presenter
11:30 AM	003	Deconstructing progression of amyotrophic lateral sclerosis in stages: a Markov modeling approach.	Disclosure: Dr. Thakore has received research support from Novartis Pharmaceuticals Corporation.
Epilepsy: Comorbidities and SUDEP
Start Time	Pub.	Title	Presenter
11:30 AM	003	Cross-sensitivity of Psychiatric and Behavioral Side Effects with Antiepileptic Drug Use	Disclosure: Dr. Chen has nothing to disclose.
Clinical Advances in CNS Cancer Care
Start Time	Pub.	Title	Presenter
11:30 AM	003	MRI changes in patients with newly diagnosed glioblastoma treated as part of a Phase II trial with bavituximab, radiation, and temozolomide	Disclosure: Dr. Ly has nothing to disclose.
Autoimmune Neurology/MS and CNS Inflammatory Disease ePoster Session
Start Time	Pub.	Title	Presenter
11:30 AM	003	Improving Patient Experience, Clinical Practice, and Provider Knowledge and Competence of Chronic Inflammatory Demyelinating Polyneuropathy with Online Continuing Medical Education	Disclosure: Dr. Roc has nothing to disclose.
Ataxia
Start Time	Pub.	Title	Presenter
11:30 AM	003	Comparative Profiling of Peripheral Blood Mononuclear Cells Proteome in Patients With Friedreich's Ataxia	Disclosure: Dr. Pathak has nothing to disclose.
Neuro-Ophthalmology/Neuro-Otology
Start Time	Pub.	Title	Presenter
11:30 AM	004	The Effects of Alcohol Consumption on Cognitive Performance Using the King-Devick Rapid Number Naming Test and the Mobile Universal Lexicon Evaluation System	Disclosure: Dr. Tejani has nothing to disclose.
Headache Clinical Trials I
Start Time	Pub.	Title	Presenter
11:30 AM	004	Impact of Fremanezumab on Response Rates, Migraine Days, and Acute Medication Use in Patients with Chronic Migraine Who Have Failed at Least One Prior Migraine Preventive Medication	Disclosure: Dr. Silberstein has received personal compensation for consulting, serving on a scientific advisory board, speaking, or other activities with Stephen D. Silberstein, MD, is a consultant and/or advisory panel member for and has received honoraria from Alder Biopharmaceuticals, Allergan, Amgen, Avanir, eNeura, ElectroCore Medical, Labrys Biologics, Medscape, Medtronic, Neuralieve, NINDS, Pfizer, and Teva.. Dr. Silberstein has received research support from His employer receives research support from Allergan, Amgen, Cumberland Pharmaceuticals, ElectroCore Medical, Labrys Biologics, Eli Lilly, Merz, and Troy Healthcare..
Aging and Dementia: Animal and Cell Models
Start Time	Pub.	Title	Presenter
11:30 AM	004	Inflammasome-derived cytokine IL18 suppresses amyloid-induced seizures in Alzheimer’s prone mice	Disclosure: Dr. Cheung has nothing to disclose.
Autoimmune (AQP4/MOG) Gliopathies and NMOSDs
Start Time	Pub.	Title	Presenter
11:30 AM	004	Neuromyelitis Optica Spectrum Disorders- Comparison as per Serostatus and Application of International Consensus Criteria	Disclosure: Dr. Bali has nothing to disclose.
Antithrombotic Treatment in Ischemic Stroke
Start Time	Pub.	Title	Presenter
11:30 AM	004	Treatment of floating thrombus with apixaban: report of a case.	Disclosure: Dr. Soto-Rincon has nothing to disclose.
Amyotrophic Lateral Sclerosis
Start Time	Pub.	Title	Presenter
11:30 AM	004	The anatomical substrate of bulbar impairment in ALS: insights from multiparametric brainstem imaging, corticobulbar connectivity and somatotopic motor cortex measures	Disclosure: Dr. Bede has nothing to disclose.
Epilepsy: Comorbidities and SUDEP
Start Time	Pub.	Title	Presenter
11:30 AM	004	Psychiatric Effects of Ketogenic Diet Therapies on Adults with Chronic Epilepsy	Disclosure: Dr. Shegelman has nothing to disclose.
Clinical Advances in CNS Cancer Care
Start Time	Pub.	Title	Presenter
11:30 AM	004	EEG Findings in Chimeric Antigen Receptor T-Cell (CAR-T) Related Encephalopathy Syndrome	Disclosure: Dr. Satyanarayan has nothing to disclose.
Autoimmune Neurology/MS and CNS Inflammatory Disease ePoster Session
Start Time	Pub.	Title	Presenter
11:30 AM	004	Severe Cerebellar Syndrome Improved with Plasma Exchanges in Patient with Lung Adenocarcinoma Treated with Durvalumab	Disclosure: Dr. Tang has nothing to disclose.
Ataxia
Start Time	Pub.	Title	Presenter
11:30 AM	004	Overwhelming genetic heterogeneity and exhausting molecular diagnostic process in chronic and progressive ataxias: Facing up with an algorithm, a gene, a panel at the same time.	Disclosure: Dr. Zavala has nothing to disclose.
Neuro-Ophthalmology/Neuro-Otology
Start Time	Pub.	Title	Presenter
11:30 AM	005	Investigating the Structure and Function of the Retinohypothalamic Tract in Neuromyelitis Optica by Optical Coherence Tomography (OCT) and Pupillometry	Disclosure: Dr. Meltzer has nothing to disclose.
Headache Clinical Trials I
Start Time	Pub.	Title	Presenter
11:30 AM	005	Long-Term Impact of Fremanezumab on Response Rates, Acute Headache Medication Use, and Disability in Patients With Episodic Migraine: Results of a 1-Year Study	Disclosure: Dr. Brandes has received personal compensation for consulting, serving on a scientific advisory board, speaking, or other activities with Amgen, Eli Lilly and Company, Depomed, Avanir Pharmaceuticals, Promius Pharma, and Supernus Pharmaceuticals. Dr. Brandes has received research support from Amgen, Eli Lilly and Company, CoLucid Pharmaceuticals, Teva Pharmaceuticals, Zosano, Allergan, and Biohaven Pharma.
Aging and Dementia: Animal and Cell Models
Start Time	Pub.	Title	Presenter
11:30 AM	005	Procognitive and neuroprotective effect of 5-HT7 agonist in an animal model by ICV amyloid-b injection	Disclosure: Dr. Quintero Villegas has nothing to disclose.
Autoimmune (AQP4/MOG) Gliopathies and NMOSDs
Start Time	Pub.	Title	Presenter
11:30 AM	005	The Efficacy and Tolerability of Azathioprine for Patients with Neuromyelitis Optica Spectrum Disorder: A Systematic Review	Disclosure: Dr. Espiritu has nothing to disclose.
Antithrombotic Treatment in Ischemic Stroke
Start Time	Pub.	Title	Presenter
11:30 AM	005	Newer Anticoagulants in Patients with Atrial Fibrillation and Ischemic Stroke - a Two Year Experience	Disclosure: Dr. Bhattacharya has nothing to disclose.
Amyotrophic Lateral Sclerosis
Start Time	Pub.	Title	Presenter
11:30 AM	005	Neurophysiological Correlates of Excitability in ALS: Pretreatment Findings from the Retigabine and Mexiletine-2 Studies	Disclosure: Dr. Weiss has received research support from ALS Association and ALS Finding a Cure.
Epilepsy: Comorbidities and SUDEP
Start Time	Pub.	Title	Presenter
11:30 AM	005	Anxiety in Patients Admitted for Epilepsy Monitoring	Disclosure: Dr. Panda has nothing to disclose.
Clinical Advances in CNS Cancer Care
Start Time	Pub.	Title	Presenter
11:30 AM	005	Gliomatosis cerebri: Management and survival in the United States	Disclosure: Dr. Garcia has nothing to disclose.
Autoimmune Neurology/MS and CNS Inflammatory Disease ePoster Session
Start Time	Pub.	Title	Presenter
11:30 AM	005	Progressive Neurodegeneration in X-Linked Agammaglobulinaemia	Disclosure: Dr. Gall has nothing to disclose.
Ataxia
Start Time	Pub.	Title	Presenter
11:30 AM	005	Preclinical Assessment of TAK-831, a Selective D-Amino Acid Oxidase Inhibitor, in a Genetic Model of Friedreich’s Ataxia (YG8sR)	Disclosure: Dr. Fradley has nothing to disclose.
Neuro-Ophthalmology/Neuro-Otology
Start Time	Pub.	Title	Presenter
11:30 AM	006	Angio-OCT micro vascular markers and central auditory disorder as indipendent predictors of cognitive impairment in the Great Age Study population	Disclosure: Dr. Sardone has nothing to disclose.
Headache Clinical Trials I
Start Time	Pub.	Title	Presenter
11:30 AM	006	The Impact of Fremanezumab on Migraine-Specific Health-Related Quality of Life in Chronic Migraine Patients Who Previously Used Topiramate	Disclosure: Dr. Gandhi has received personal compensation for consulting, serving on a scientific advisory board, speaking, or other activities with Teva Pharmaceuticals..
Aging and Dementia: Animal and Cell Models
Start Time	Pub.	Title	Presenter
11:30 AM	006	Structure and Pro-toxic Mechanism of the Human Hsp90/PPIase/Tau Complex	Disclosure: Dr. Oroz has nothing to disclose.
Autoimmune (AQP4/MOG) Gliopathies and NMOSDs
Start Time	Pub.	Title	Presenter
11:30 AM	006	Autonomic Dysfunction in People with Neuromyelitis Optica Spectrum Disorders	Disclosure: Dr. Crnosija has received personal compensation for consulting, serving on a scientific advisory board, speaking, or other activities with Merck Serono.
Antithrombotic Treatment in Ischemic Stroke
Start Time	Pub.	Title	Presenter
11:30 AM	006	Aspirin Resistance And Ischemic Stroke: A Prospective Study In Indian Population.	Disclosure: Dr. Sisodia has nothing to disclose.
Amyotrophic Lateral Sclerosis
Start Time	Pub.	Title	Presenter
11:30 AM	006	Neuroelectric Biomarkers of Network Dysfunction in Amyotrophic Lateral Sclerosis	Disclosure: Dr. Nasseroleslami has nothing to disclose.
Epilepsy: Comorbidities and SUDEP
Start Time	Pub.	Title	Presenter
11:30 AM	006	A severe bone loss in pharmacoresistant epilepsy associates with enzyme-inducing antiepileptic drug	Disclosure: Dr. Rigotti has nothing to disclose.
Clinical Advances in CNS Cancer Care
Start Time	Pub.	Title	Presenter
11:30 AM	006	Incidence of Distant Recurrence in Adult Gliomas	Disclosure: Dr. Pan has nothing to disclose.
Autoimmune Neurology/MS and CNS Inflammatory Disease ePoster Session
Start Time	Pub.	Title	Presenter
11:30 AM	006	Safety of Checkpoint Inhibitors for Cancer Treatment in Patients with Multiple Sclerosis: A Case Report	Disclosure: Dr. Isitan has nothing to disclose.
Ataxia
Start Time	Pub.	Title	Presenter
11:30 AM	006	Ultrastructural Changes in Brain Stem Pathways in a Patient with Ataxia Associated with SPG7 Mutations	Disclosure: Dr. Ringman has received personal compensation for consulting, serving on a scientific advisory board, speaking, or other activities with InnoSense, LLC, RENEW. Dr. Ringman has received research support from Avid Pharmaceuticals.
Neuro-Ophthalmology/Neuro-Otology
Start Time	Pub.	Title	Presenter
11:30 AM	007	Non-chiasmal bitemporal pseudo-hemianopia: case series	Disclosure: Dr. Bingeliene has nothing to disclose.
Headache Clinical Trials I
Start Time	Pub.	Title	Presenter
11:30 AM	007	Randomized, Double-Blind, Pilot Study Comparing 3 Mg Subcutaneous Sumatriptan With 6 Mg Subcutaneous Sumatriptan Using DFN-11 Autoinjector for the Acute Treatment Of Rapidly-Escalating Migraine Attacks	Disclosure: Dr. Cady has received personal compensation for consulting, serving on a scientific advisory board, speaking, or other activities with Full time employee at Alder BioPharmaceuticals, Inc..
Aging and Dementia: Animal and Cell Models
Start Time	Pub.	Title	Presenter
11:30 AM	007	Reciprocal regulation of filamin A and amyloid precursor protein expression in astrocytes	Disclosure: Dr. Ekuta has nothing to disclose.
Autoimmune (AQP4/MOG) Gliopathies and NMOSDs
Start Time	Pub.	Title	Presenter
11:30 AM	007	The Effect of Pain on Quality of Life and Co-occurring Symptoms in Patients with Neuromyelitis Optica Spectrum Disorder	Disclosure: Dr. Mealy has received personal compensation for consulting, serving on a scientific advisory board, speaking, or other activities with Viela Bio.
Antithrombotic Treatment in Ischemic Stroke
Start Time	Pub.	Title	Presenter
11:30 AM	007	Smoking and Clopidogrel resistance in ischemic stroke	Disclosure: Dr. Kang has nothing to disclose.
Amyotrophic Lateral Sclerosis
Start Time	Pub.	Title	Presenter
11:30 AM	007	Do Sleep Scales Correlate with Pulmonary Function in ALS? Results From the ALS Nutrition/NIPPV Study Group	Disclosure: Dr. Khazaal has nothing to disclose.
Epilepsy: Comorbidities and SUDEP
Start Time	Pub.	Title	Presenter
11:30 AM	007	Anxiety and Depression Symptoms in the Epilepsy Clinic: Examining Psychiatric Treatment Characteristics in a Learning Health System Model	Disclosure: Dr. Jones has nothing to disclose.
Clinical Advances in CNS Cancer Care
Start Time	Pub.	Title	Presenter
11:30 AM	007	CAR-T-cell-Related Encephalopathy Syndrome: High Rates of Neurotoxicity in Clinical Practice	Disclosure: Dr. Yuen has nothing to disclose.
Autoimmune Neurology/MS and CNS Inflammatory Disease ePoster Session
Start Time	Pub.	Title	Presenter
11:30 AM	007	Progressive Parkinsonism and Cognitive Changes: A Rare Presentation of Chronic Lymphocytic Inflammation with Pontine Perivascular Enhancement Responsive to Steroids (CLIPPERS)	Disclosure: Dr. Khayatkhoei has nothing to disclose.
Ataxia
Start Time	Pub.	Title	Presenter
11:30 AM	007	Updates to the National Institute of Neurological Disorders and Stroke (NINDS) Friedreich’s Ataxia (FA) Common Data Element (CDE) Recommendations: 2018 FA Working Group Review	Disclosure: Dr. Gay has nothing to disclose.
Neuro-Ophthalmology/Neuro-Otology
Start Time	Pub.	Title	Presenter
11:30 AM	008	Prognostic Factors of Poor Outcome in Idiopathic Intracranial Hypertension	Disclosure: Dr. Farhat has nothing to disclose.
Headache Clinical Trials I
Start Time	Pub.	Title	Presenter
11:30 AM	008	Long-Term Efficacy of Fremanezumab in Patients With Chronic Migraine With Concomitant Preventive Medication Use	Disclosure: Dr. Yeung has received personal compensation for consulting, serving on a scientific advisory board, speaking, or other activities with Teva Pharmaceuticals.
Aging and Dementia: Animal and Cell Models
Start Time	Pub.	Title	Presenter
11:30 AM	008	Impaired Brain Cells Response in Obesity	Disclosure: Dr. Latif has nothing to disclose.
Autoimmune (AQP4/MOG) Gliopathies and NMOSDs
Start Time	Pub.	Title	Presenter
11:30 AM	008	Development of Resistance to B-Cell Depletion Following Ten Years of Effective Rituximab Treatment in a Patient with Neuromyelitis Optica	Disclosure: Dr. Harel has nothing to disclose.
Antithrombotic Treatment in Ischemic Stroke
Start Time	Pub.	Title	Presenter
11:30 AM	008	The Effect of New P2Y12 Receptor Antagonist, Ticagrelor, On Platelet Reactivity in Patients With Clopidogrel Resistance Undergoing Neuroendovascular Procedures.	Disclosure: Dr. Jahngir has nothing to disclose.
Amyotrophic Lateral Sclerosis
Start Time	Pub.	Title	Presenter
11:30 AM	008	Validation of the revised classification of cognitive and behavioral impairment in ALS	Disclosure: Dr. Vasta has nothing to disclose.
Epilepsy: Comorbidities and SUDEP
Start Time	Pub.	Title	Presenter
11:30 AM	008	A survey of neurologists screening and management of depression in patients with epilepsy	Disclosure: Dr. Riotto has nothing to disclose.
Clinical Advances in CNS Cancer Care
Start Time	Pub.	Title	Presenter
11:30 AM	008	A case series of metastatic glioblastoma at Memorial Sloan Kettering Cancer Center	Disclosure: Dr. Noch has nothing to disclose.
Autoimmune Neurology/MS and CNS Inflammatory Disease ePoster Session
Start Time	Pub.	Title	Presenter
11:30 AM	008	The potential of Teriflunomide for regional and global brain volume protection in single subject MS patients	Disclosure: Dr. Raji has received personal compensation for consulting, serving on a scientific advisory board, speaking, or other activities with Merck Serono, Genzyme, Novartis. Dr. Raji has received research support from Genzyme.
Ataxia
Start Time	Pub.	Title	Presenter
11:30 AM	008	Frataxin deficiency causes excessive mitochondrial fragmentation associated with mitochondrial fission core components	Disclosure: Dr. Johnson has nothing to disclose.
Neuro-Ophthalmology/Neuro-Otology
Start Time	Pub.	Title	Presenter
11:30 AM	009	The standard swinging flashlight test: reliable or not	Disclosure: Dr. Boucher has nothing to disclose.
Headache Clinical Trials I
Start Time	Pub.	Title	Presenter
11:30 AM	009	Safety Findings from the Phase 3 Studies (SAMURAI, SPARTAN) of Lasmiditan for Acute Treatment of Migraine	Disclosure: Dr. Krege has received compensation for employment at Eli Lilly and Company Dr. Krege holds stock and/or stock options in Eli Lilly.
Aging and Dementia: Animal and Cell Models
Start Time	Pub.	Title	Presenter
11:30 AM	009	Novel Insights into Intersectin1 Mechanistic Contributions to Brain Disorders	Jessica Wilson Disclosure: Dr. Wilson has nothing to disclose.
Autoimmune (AQP4/MOG) Gliopathies and NMOSDs
Start Time	Pub.	Title	Presenter
11:30 AM	009	A Case of Autoimmune Glial Fibrillary Acidic Protein Astrocytopathy(GFAP) Meningoencephalomyelitis Responsive to Infliximab	Disclosure: Dr. Rodriguez has nothing to disclose.
Antithrombotic Treatment in Ischemic Stroke
Start Time	Pub.	Title	Presenter
11:30 AM	009	Retrospective Comparison of Medication Therapy Management and Stroke/TIA Outcomes in Patients Who Have Undergone Testing for Antiplatelet Responsiveness and Pharmacist Intervention and versus Those Who Have Not	Disclosure: Dr. Westphal has received research support from ASHP, Acadia, Dent Family Foundation.
Amyotrophic Lateral Sclerosis
Start Time	Pub.	Title	Presenter
11:30 AM	009	Genetic Testing Has a High Diagnostic Yield for Individuals with ALS regardless of Family History	Disclosure: Dr. Yang has received personal compensation for consulting, serving on a scientific advisory board, speaking, or other activities with GeneDx.
Epilepsy: Comorbidities and SUDEP
Start Time	Pub.	Title	Presenter
11:30 AM	009	Symptoms and Impacts in Epilepsy: Findings from Qualitative Patient Interviews	Disclosure: Dr French did not receive personal income, but received NYU salary support from the Epilepsy Foundation and for consulting work and/or attending Scientific Advisory Boards on behalf of the Epilepsy Study Consortium for Acadia, Adamas, Addex, Aeonian, Alexza, Anavex, Axcella Health, Axovant, Biogen, Biomotiv/Koutif, Blackfynn, Bloom Science, Bridge Valley Ventures, Cavion, Cerebral Therapeutics, Cerevel, Clinilabs, Concert Pharmaceuticals, Covance, Crossject, CuroNZ, Eisai, Empatica, Engage Therapeutics, Epitel, GW Pharma, Idorsia, Impax, Ionis, J&J Pharmaceuticals, Marinus, MonosolRx, Neurelis, Novartis, Otsuka Pharmaceutical Development, Ovid Therapeutics Inc., Pfizer, Pfizer-Neusentis, Praxis, Redpin, Sage, Sancillio, Shire, SK Life Sciences, Springworks, Stoke, Sunovion, Supernus, Takeda, UCB Inc., Ultragenyx, Upsher Smith, Vyera, West Therapeutic Development, Xenon, Xeris, Zogenix, Zynerba. Dr. French received research grants from Biogen, Cavion, Engage, Neurelis, Ovid, SK Life Sciences, UCB, and Zogenix.
Clinical Advances in CNS Cancer Care
Start Time	Pub.	Title	Presenter
11:30 AM	009	Primary brain tumors admitted to the neurological intensive care unit: a single institution observational study	Disclosure: Dr. Kang has nothing to disclose.
Autoimmune Neurology/MS and CNS Inflammatory Disease ePoster Session
Start Time	Pub.	Title	Presenter
11:30 AM	009	Acute disseminated encephalomyelitis following Mycoplasma pneumoniae infection in a young adult collegiate athlete	Disclosure: Dr. Kyrtsos has nothing to disclose.
Ataxia
Start Time	Pub.	Title	Presenter
11:30 AM	009	Structural Magnetic Resonance Imaging Correlates of Neurodegeneration in a Spinocerebellar Ataxia Type 7 Cohort	Disclosure: Dr. Parker has nothing to disclose.
Neuro-Ophthalmology/Neuro-Otology
Start Time	Pub.	Title	Presenter
11:30 AM	010	Acute Optic Neuritis: looking for an accurate and early assessment	Disclosure: Dr. Fernandez has nothing to disclose.
Headache Clinical Trials I
Start Time	Pub.	Title	Presenter
11:30 AM	010	Evaluation of Cardiovascular Risks in Adult Patients with Episodic or Chronic Migraine Treated With Galcanezumab: Data From Three Phase 3, Randomized, Double-Blind, Placebo-Controlled Studies	Disclosure: Employment: Eli Lilly and Company Employee and minor stockholder of Eli Lilly and Company
Aging and Dementia: Genetics and Neuropathology
Start Time	Pub.	Title	Presenter
11:30 AM	010	Age of onset in genetic prion disease and the design of preventive clinical trials	Disclosure: Dr. Minikel has nothing to disclose.
Autoimmune (AQP4/MOG) Gliopathies and NMOSDs
Start Time	Pub.	Title	Presenter
11:30 AM	010	Neuromyelitis Optica Spectrum Disorder in a Tertiary Hospital in the Philippines: A Case Series	Disclosure: Dr. Espiritu has nothing to disclose.
Antithrombotic Treatment in Ischemic Stroke
Start Time	Pub.	Title	Presenter
11:30 AM	010	Fourteen-day Delay of Cerebral Ischemia due to Vasospasm after Traumatic Subarachnoid Hemorrhage in Mild Head Injury	Disclosure: Dr. Maran has nothing to disclose.
Amyotrophic Lateral Sclerosis
Start Time	Pub.	Title	Presenter
11:30 AM	010	The Canadian ALS Neuroimaging Consortium (CALSNIC)	Disclosure: Dr. Kalra has nothing to disclose.
Epilepsy: Comorbidities and SUDEP
Start Time	Pub.	Title	Presenter
11:30 AM	010	Impact of Autism Spectrum Disorder Diagnosis on Epilepsy in Patients with Tuberous Sclerosis Complex	Disclosure: Dr. Drogin has nothing to disclose.
Clinical Advances in CNS Cancer Care
Start Time	Pub.	Title	Presenter
11:30 AM	010	Patterns of Death and Palliative Care in Glioma Patients	Disclosure: Dr. Barbaro has nothing to disclose.
Autoimmune Neurology/MS and CNS Inflammatory Disease ePoster Session
Start Time	Pub.	Title	Presenter
11:30 AM	010	Acute and Lasting Benefits of a Virtual Reality in Multiple Sclerosis	Disclosure: Dr. Shaw has nothing to disclose.
Ataxia
Start Time	Pub.	Title	Presenter
11:30 AM	010	Inpatient Verses Outpatient Workup of Patients with Ataxia and Suspected Paraneoplastic Cerebellar Degeneration: Does Workup Location Matter?	Disclosure: Dr. Witek has nothing to disclose.
Neuro-Ophthalmology/Neuro-Otology
Start Time	Pub.	Title	Presenter
11:30 AM	011	Transcriptional control of optic nerve injury associated retinal ganglion cell death	Disclosure: Dr. Syc has nothing to disclose.
Headache Clinical Trials I
Start Time	Pub.	Title	Presenter
11:30 AM	011	Efficacy of Fremanezumab in Migraine Patients Who Have Failed at Least One Prior Migraine Preventive Medication	Disclosure: Dr. McAllister has received personal compensation for consulting, serving on a scientific advisory board, speaking, or other activities with Amgen Inc., Teva Neuroscience, Alder, Promius, Electrocore, and Allergen, Inc. Dr. McAllister has received personal compensation in an editorial capacity for Practical Neurology. Dr. McAllister has received research support from Alder, Amgen Inc., Teva Neuroscience, Sunovion, San-bio, Biohaven, Allergan, Inc., Novartis, ATI, Roche Diagnostics Corporation, Esai Inc., and Biogen Idec.
Aging and Dementia: Genetics and Neuropathology
Start Time	Pub.	Title	Presenter
11:30 AM	011	Tau and neurodegeneration mismatch is a signature of polypathology in AD continuum	Disclosure: Dr. Wolk has received personal compensation for consulting, serving on a scientific advisory board, speaking, or other activities with Merck, Jannsen, Eli Lilly and GE.
Autoimmune (AQP4/MOG) Gliopathies and NMOSDs
Start Time	Pub.	Title	Presenter
11:30 AM	011	Area Postrema syndrome: A Short Case Series Highlighting Diagnostic dilemmas, Clinical features and Outcome	Disclosure: Dr. Nadig has nothing to disclose.
Endovascular Therapy in Acute Ischemic Stroke
Start Time	Pub.	Title	Presenter
11:30 AM	011	The Role of Intravenous Thrombolysis in the Prediction of Functional Outcome in Patients who undergo Endovascular Thrombolysis with Newer Generation Stent Retrievers	Disclosure: Dr. aijb has nothing to disclose.
Amyotrophic Lateral Sclerosis
Start Time	Pub.	Title	Presenter
11:30 AM	011	Relationship between Forced Vital Capacity and Slow Vital Capacity in individuals with Amyotrophic Lateral Sclerosis Patients	Disclosure: Dr. Reynolds has nothing to disclose.
Epilepsy: Comorbidities and SUDEP
Start Time	Pub.	Title	Presenter
11:30 AM	011	Employment and socioeconomic status after epilepsy surgery: A study in a Mexican cohort.	Disclosure: Dr. Jorge De Sarachaga has nothing to disclose.
Clinical Advances in CNS Cancer Care
Start Time	Pub.	Title	Presenter
11:30 AM	011	Psychiatric Disturbance As a Presenting Symptom in Central Nervous System Lymphoma	Disclosure: Dr. Sharma has nothing to disclose.
Ataxia
Start Time	Pub.	Title	Presenter
11:30 AM	011	Cerebellar endoplasmic reticulum-mitochondria calcium signal pathways are impaired in the KIKO mouse model of Friedreich ataxia	Disclosure: Dr. Lin has received personal compensation for consulting, serving on a scientific advisory board, speaking, or other activities with Impel NeuroPharma. Dr. Lin has received research support from Impel NeuroPharma.
Neuro-Ophthalmology/Neuro-Otology
Start Time	Pub.	Title	Presenter
11:30 AM	012	Dwarf gecko as a model for studying retinal neurogenesis	Disclosure: Dr. Mendez has nothing to disclose.
Headache Clinical Trials I
Start Time	Pub.	Title	Presenter
11:30 AM	012	The Impact of Fremanezumab on Migraine-Specific Health-Related Quality of Life in Chronic Migraine Patients With Concomitant Preventive Medication Use	Disclosure: Dr. Gandhi has received personal compensation for consulting, serving on a scientific advisory board, speaking, or other activities with Teva Pharmaceuticals..
Aging and Dementia: Genetics and Neuropathology
Start Time	Pub.	Title	Presenter
11:30 AM	012	Interactions Between Brain Structures and Genetic Variants in Neurotransmitter Systems as Potential Biomarkers for Hallucinations and Delusions in Alzheimer’s Disease	Disclosure: Dr. Ahmed has nothing to disclose.
Autoimmune (AQP4/MOG) Gliopathies and NMOSDs
Start Time	Pub.	Title	Presenter
11:30 AM	012	An Atypical NMO Presentation with Locked-In Syndrome	Disclosure: Dr. Rehman has nothing to disclose.
Endovascular Therapy in Acute Ischemic Stroke
Start Time	Pub.	Title	Presenter
11:30 AM	012	Does Use of Adjunctive Therapy to Mechanical Thrombectomy Improve Outcomes Without Significant Risk in LVOs.	Disclosure: Dr. Singh has nothing to disclose.
Amyotrophic Lateral Sclerosis
Start Time	Pub.	Title	Presenter
11:30 AM	012	MRI Alterations in the Brachial Plexus of ALS Patients	Disclosure: Dr. Scamarcia has nothing to disclose.
Epilepsy: Comorbidities and SUDEP
Start Time	Pub.	Title	Presenter
11:30 AM	012	Quality Of Life And Disease Progress In Patients With Drug Resistant Epilepsy	Disclosure: Dr. Olivas has nothing to disclose.
Clinical Advances in CNS Cancer Care
Start Time	Pub.	Title	Presenter
11:30 AM	012	Characterization of Seizures (ILAE 1981 and 2017 Classifications) and their Response to Treatment in a Cohort of Patients with Glial Tumors.	Disclosure: Dr. Casas-Parera has nothing to disclose.
Ataxia
Start Time	Pub.	Title	Presenter
11:30 AM	012	Ataxia with Transglutaminase 6 Mutation (SCA35) Responding to Gluten-Free Diet: A Case Report	Disclosure: Dr. Lin has nothing to disclose.
Neuro-Ophthalmology/Neuro-Otology
Start Time	Pub.	Title	Presenter
11:30 AM	013	Inferior colliculus neurons that express the neuropeptide VIP project to auditory nuclei in the brainstem and thalamus.	Disclosure: Mr. Edelbrock has nothing to disclose.
Headache Clinical Trials I
Start Time	Pub.	Title	Presenter
11:30 AM	013	Improvement in Response Over Time With Fremanezumab in Patients Who Reverted From a Chronic to an Episodic Migraine Classification	Disclosure: Dr. Halker has received personal compensation for consulting, serving on a scientific advisory board, speaking, or other activities with Amgen, Biohaven, Allergan. Dr. Halker has received personal compensation in an editorial capacity for Current Neurology & Neuroscience Reports.
Aging and Dementia: Genetics and Neuropathology
Start Time	Pub.	Title	Presenter
11:30 AM	013	Longitudinal Decline in Lexical Retrieval is Related to AD Pathologic Burden in Middle Frontal, Superior and Temporal Regions in Progressive Aphasia	Disclosure: Dr. Bove has nothing to disclose.
Autoimmune (AQP4/MOG) Gliopathies and NMOSDs
Start Time	Pub.	Title	Presenter
11:30 AM	013	Clinical characteristics, diagnostic and outcome differences in patients with optic neuritis	Disclosure: Dr. Siegel has nothing to disclose.
Endovascular Therapy in Acute Ischemic Stroke
Start Time	Pub.	Title	Presenter
11:30 AM	013	Prior Intravenous Thrombolytics Administration is Associated with Increased Hospital Bills & Intracranial Hemorrhage Rates Without Improved Outcomes in Mechanical Thrombectomy Patients	Disclosure: Dr. Hassan has nothing to disclose.
Amyotrophic Lateral Sclerosis
Start Time	Pub.	Title	Presenter
11:30 AM	013	Intrathecal delivery of ALS cerebrospinal fluid induces motor deficits and motor neuron death in mice	Disclosure: Dr. Wong has nothing to disclose.
Epilepsy: Comorbidities and SUDEP
Start Time	Pub.	Title	Presenter
11:30 AM	013	Factors Associated with Quality of Life in a Low-income Population with Epilepsy.	Disclosure: Dr. Espinosa Jovel has nothing to disclose.
Clinical Advances in CNS Cancer Care
Start Time	Pub.	Title	Presenter
11:30 AM	013	Prognostic Factors and Survival in Primary CNS Lymphoma Patients at Yale	Disclosure: Dr. Prado has nothing to disclose.
Ataxia
Start Time	Pub.	Title	Presenter
11:30 AM	013	Diagnostic Value of Next Generation Sequencing Ataxia Panel as a Part of Multistep Investigation Approach in Sporadic and Autosomal Recessive Cerebellar Ataxias in Russia	Disclosure: Dr. Seliverstov has nothing to disclose.
Neuro-Ophthalmology/Neuro-Otology
Start Time	Pub.	Title	Presenter
11:30 AM	014	Delayed Development of a Dural AV Fistula and PTEN Hamartoma Syndrome in Pseudo-Idiopathic Intracranial Hypertension	Disclosure: Dr. Gold has nothing to disclose.
Headache Clinical Trials I
Start Time	Pub.	Title	Presenter
11:30 AM	014	Single and Multiple Doses of Ubrogepant Are Not Associated With a Clinically Significant Elevation of Alanine Aminotransferase in Healthy Adult Males	Disclosure: Dr. Bondiskey has received personal compensation for consulting, serving on a scientific advisory board, speaking, or other activities with Merck Sharp & Dohme Corp. Dr. Bondiskey holds stock and/or stock options in Merck Sharp & Dohme Corp., which sponsored research in which Dr. Bondiskey was involved as an investigator.
Aging and Dementia: Genetics and Neuropathology
Start Time	Pub.	Title	Presenter
11:30 AM	014	Hippocampal tau pathology burden in Lewy body disorders	Disclosure: Dr. Ittyerah has nothing to disclose.
Autoimmune (AQP4/MOG) Gliopathies and NMOSDs
Start Time	Pub.	Title	Presenter
11:30 AM	014	Spectral-Domain Optical Coherence Tomography in Autoimmune Disorders with Optic Neuropathy: A Retrospective Analysis of Distinctive Features.	Disclosure: Dr. Sriwastava has nothing to disclose.
Endovascular Therapy in Acute Ischemic Stroke
Start Time	Pub.	Title	Presenter
11:30 AM	014	Outcome of mechanical thrombectomy in patients with acute ischemic stroke on anticoagulation therapy	Disclosure: Dr. Karim has nothing to disclose.
Amyotrophic Lateral Sclerosis
Start Time	Pub.	Title	Presenter
11:30 AM	014	Radicava® (edaravone) for Amyotrophic Lateral Sclerosis: New Formulation and Its Development Plan	Disclosure: Dr. Takei has received personal compensation for consulting, serving on a scientific advisory board, speaking, or other activities with Mitsubishi Tanabe Pharma Corporation, Inc.. Dr. Takei holds stock and/or stock options in Mitsubishi Tanabe Pharma Corporation, Inc. which sponsored research in which Dr. Takei was involved as an investigator. .
Epilepsy: Comorbidities and SUDEP
Start Time	Pub.	Title	Presenter
11:30 AM	014	Effect of Seizure Auras on Mood in Epilepsy: the ESAME Survey	Disclosure: Dr. Bumsch has nothing to disclose.
Clinical Advances in CNS Cancer Care
Start Time	Pub.	Title	Presenter
11:30 AM	014	Feasibility of a Structured Tumor-related Epilepsy Education Intervention in Adult Gliomas	Disclosure: Dr. Wasilewski has nothing to disclose.
Ataxia
Start Time	Pub.	Title	Presenter
11:30 AM	014	Autosomal Recessive Spastic Ataxia of Charlovoix-Saguenay. A new pathogenic mutation.	Disclosure: Dr. Flanigan has nothing to disclose.
Neuro-Ophthalmology/Neuro-Otology
Start Time	Pub.	Title	Presenter
11:30 AM	015	Vancomycin Ototoxicity May Lead to Bilateral Vestibular Hypofunction	Disclosure: Dr. Zak has nothing to disclose.
Headache Clinical Trials I
Start Time	Pub.	Title	Presenter
11:30 AM	015	Long-Term Safety of Fremanezumab: Results of a 1-Year Study	Disclosure: Dr. Ning has nothing to disclose.
Aging and Dementia: Genetics and Neuropathology
Start Time	Pub.	Title	Presenter
11:30 AM	015	Neuropathological findings in Parkinson’s disease with mild cognitive impairment	Disclosure: Dr. Knox has nothing to disclose.
Autoimmune (AQP4/MOG) Gliopathies and NMOSDs
Start Time	Pub.	Title	Presenter
11:30 AM	015	Utilizing T-Cell Suppression In Recurrent GFAP Antibody Encephalitis	Disclosure: Dr. Nicholson has nothing to disclose.
Endovascular Therapy in Acute Ischemic Stroke
Start Time	Pub.	Title	Presenter
11:30 AM	015	Monitored anesthesia care by sedation-trained providers in acute stroke thrombectomy.	Disclosure: Dr. Slawski has nothing to disclose.
Amyotrophic Lateral Sclerosis
Start Time	Pub.	Title	Presenter
11:30 AM	015	BRIDGE: Dynamic Imagery and Art Therapy in ALS- A Clinical Study to Improve Patient Expression and Wellness	Disclosure: Dr. King has nothing to disclose.
Epilepsy: Comorbidities and SUDEP
Start Time	Pub.	Title	Presenter
11:30 AM	015	Self-Reported Depression and Anxiety Scores Similar in Patients with Temporal and Extra-Temporal Lobe Epilepsy	Disclosure: Dr. Abe has nothing to disclose.
Clinical Advances in CNS Cancer Care
Start Time	Pub.	Title	Presenter
11:30 AM	015	Primary CNS posttransplant lymphoproliferative disease (PCNS-PTLD): Diagnosis, minimal treatment toxicity, and surveillance in renal transplant patients	Disclosure: Dr. Summers has nothing to disclose.
Ataxia
Start Time	Pub.	Title	Presenter
11:30 AM	015	Opsoclonus Myoclonus Ataxia Related to West Nile Virus	Disclosure: Dr. Boucekkine has nothing to disclose.
Neuro-Ophthalmology/Neuro-Otology
Start Time	Pub.	Title	Presenter
11:30 AM	016	Observation of Angular Deformity of a Straight Line	Disclosure: Dr. Tishman has nothing to disclose.
Headache Clinical Trials I
Start Time	Pub.	Title	Presenter
11:30 AM	016	Assessment of the Long-Term Safety and Efficacy of Erenumab During Open-Label Treatment of Patients With Chronic Migraine	Disclosure: Dr. Tepper has received personal compensation for consulting, serving on a scientific advisory board, speaking, or other activities with Stewart J. Tepper, MD, has consulted for Acorda, Alder, Allergan, Amgen, ATI, Avanir, BioVision, Dr. Reddy’s, ElectroCore, Eli Lilly, eNeura, GLG, Guidepoint Global, Novartis, Pernix, Pfizer, Scion, Supernus, Teva, and Zosano. Dr. Tepper has received personal compensation in an editorial capacity for Headache Currents from AHS. Dr. Tepper has received royalty, license fees, or contractual rights payments from royalties for books published by Springer. Dr. Tepper has received research support from His employer, Dartmouth-Hitchcock Medical Center, American Headache Society (AHS), receives research grants from Adler, Allergan, Amgen, ATI, Dr. Reddy’s, Scion, Teva, and Zosano. .
Aging and Dementia: Genetics and Neuropathology
Start Time	Pub.	Title	Presenter
11:30 AM	016	RS4548513 (CTNNA3): A Genetic Risk Factor for Visual Construction Deficiency in Parkinson's disease	Disclosure: Dr. Murezzan has nothing to disclose.
Autoimmune (AQP4/MOG) Gliopathies and NMOSDs
Start Time	Pub.	Title	Presenter
11:30 AM	016	A Case of an Aggressive Demyelinating NMO Spectrum Disorder-like Event in a Rheumatoid Arthritis Patient Treated with Tofacitinib	Disclosure: Dr. Eckert has nothing to disclose.
Endovascular Therapy in Acute Ischemic Stroke
Start Time	Pub.	Title	Presenter
11:30 AM	016	General Anesthesia for Thrombectomy in Ischemic Stroke Leads to Poor Outcomes as Compared to Conscious Sedation	Disclosure: Dr. Bhan has nothing to disclose.
Amyotrophic Lateral Sclerosis
Start Time	Pub.	Title	Presenter
11:30 AM	016	Predicting benign brachial monomelic amyotrophy: factors at presentation that differentiate from amyotrophic lateral sclerosis	Disclosure: Dr. Mistry has nothing to disclose.
Epilepsy: Comorbidities and SUDEP
Start Time	Pub.	Title	Presenter
11:30 AM	016	Seizure-induced demargination predicts peri-ictal respiratory decompensation	Disclosure: Dr. Vega has nothing to disclose.
Clinical Advances in CNS Cancer Care
Start Time	Pub.	Title	Presenter
11:30 AM	016	Telehealth for Specialty Neurofibromatosis (NF) Care	Disclosure: Dr. Jordan has received personal compensation for consulting, serving on a scientific advisory board, speaking, or other activities with Consulting with SHEPHERD Foundation, NF Network, GLG, Guidepoint, and Clearview.
Parkinson's Disease Surgical, Stem Cell and Gene Therapies
Start Time	Pub.	Title	Presenter
11:30 AM	016	Results of an Open Label, Dose Escalating, Phase 1 Clinical Trial Evaluating the Safety of a Human Neural Stem Cell Based Therapy in Parkinson’s Disease	Disclosure: Dr. Kern has received personal compensation for consulting, serving on a scientific advisory board, speaking, or other activities with International Stem Cell Corporation. Dr. Kern has received compensation for serving on the Board of Directors of International Stem Cell Corporation. Dr. Kern holds stock and/or stock options in International Stem Cell Corporation which sponsored research in which Dr. Kern was involved as an investigator. . Dr. Kern holds stock and/or stock options in International Stem Cell Corporation. Dr. Kern has received research support from International Stem Cell Corporation.
Neuro-Ophthalmology/Neuro-Otology
Start Time	Pub.	Title	Presenter
11:30 AM	017	Herpes Simplex Virus (HSV)-2 Meningoencephalitis-associated Bilateral Optic Neuritis Successfully Treated with Steroids and Intravenous Immunoglobulin	Disclosure: Dr. El Ammar has nothing to disclose.
Headache Clinical Trials I
Start Time	Pub.	Title	Presenter
11:30 AM	017	Immunogenicity Assessment from Phase 3 Galcanezumab Trials in Patients with Episodic or Chronic Migraine	Disclosure: I am full-time employee and a stock shareholder of Eli Lilly and Company.
Aging and Dementia: Genetics and Neuropathology
Start Time	Pub.	Title	Presenter
11:30 AM	017	Genetic Polymorphisms Associate with Frontotemporal Cortical Thickness in Sporadic Amyotrophic Lateral Sclerosis	Disclosure: Dr. Placek has nothing to disclose.
Autoimmune (AQP4/MOG) Gliopathies and NMOSDs
Start Time	Pub.	Title	Presenter
11:30 AM	017	Anti-APQ4-negative NMO Spectrum Disorders with and without anti-MOG: A Retrospective Case Series	Disclosure: Dr. Mirzoev has nothing to disclose.
Endovascular Therapy in Acute Ischemic Stroke
Start Time	Pub.	Title	Presenter
11:30 AM	017	The first objective predictor of the hemorrhagic events after endovascular treatment of acute ischemic stroke using 2D parametric parenchymal blood flow	Disclosure: Dr. Elsaid has nothing to disclose.
Epilepsy: Comorbidities and SUDEP
Start Time	Pub.	Title	Presenter
11:30 AM	017	Quantitative Pupil Measurements In Epileptic Seizures And Non-Epileptic Events – A Step Towards SUDEP Pathophysiologic Mechanisms.	Disclosure: Dr. Yerram has nothing to disclose.
Clinical Advances in CNS Cancer Care
Start Time	Pub.	Title	Presenter
11:30 AM	017	Pineal parenchymal tumors of intermediate differentiation treated with ventricular radiation and temozolomide	Disclosure: Dr. Low has nothing to disclose.
Parkinson's Disease Surgical, Stem Cell and Gene Therapies
Start Time	Pub.	Title	Presenter
11:30 AM	017	PD-1102: A Phase 1 study of VY-AADC01 Administered Using a Posterior Approach in Patients with Parkinson’s Disease and Motor Fluctuations	Disclosure: Dr. Van Laar has received research support from Biogen.
Neuro-Ophthalmology/Neuro-Otology
Start Time	Pub.	Title	Presenter
11:30 AM	018	A Chronic Progressive Optic Neuropathy in a Patient with Anti-Myelin-Oligodendrocyte Glycoprotein (MOG) Antibodies	Disclosure: Dr. Gold has nothing to disclose.
Headache Clinical Trials I
Start Time	Pub.	Title	Presenter
11:30 AM	018	Absence of Clinically Significant Drug Interactions With Coadministration of Ubrogepant and an Ethinyl Estradiol/Norgestimate Oral Contraceptive in Healthy Female Subjects: A Phase 1 Pharmacokinetic Analysis	Disclosure: Dr. Li has received personal compensation for consulting, serving on a scientific advisory board, speaking, or other activities with Merck & Co, Inc.
Aging and Dementia: Genetics and Neuropathology
Start Time	Pub.	Title	Presenter
11:30 AM	018	Exome sequencing in carriers of the C9orf72 repeat mutation to identify pathogenic variants in other neurodegenerative genes	Disclosure: Dr. Tran has nothing to disclose.
Autoimmune (AQP4/MOG) Gliopathies and NMOSDs
Start Time	Pub.	Title	Presenter
11:30 AM	018	Paraneoplastic Neuromyelitis Optica Spectrum Disorder in a Patient with Endometrial Adenocarcinoma	Disclosure: Dr. Granger has nothing to disclose.
Endovascular Therapy in Acute Ischemic Stroke
Start Time	Pub.	Title	Presenter
11:30 AM	018	The Processing Time for Recanalization and Size of Ischemic Lesions on DWI Is Related with Complete Reperfusion After Mechanical Thrombectomy	Disclosure: Dr. Shin has nothing to disclose.
Amyotrophic Lateral Sclerosis
Start Time	Pub.	Title	Presenter
11:30 AM	018	An Update of Study of ALS Reversals: LifeTime Exposures (StARLiTE)	Disclosure: Dr. Crayle has nothing to disclose.
Epilepsy: Antiseizure Medications I
Start Time	Pub.	Title	Presenter
11:30 AM	018	Utilizing Optical Coherence Tomography to Assess the Effect of Phenytoin on Retinal Structures in Epilepsy Patients	Disclosure: Dr. Gilroy has nothing to disclose.
Clinical Advances in CNS Cancer Care
Start Time	Pub.	Title	Presenter
11:30 AM	018	A Feasibility Trial of the Modified Atkins Diet and Bevacizumab for Recurrent Glioblastoma	Disclosure: Dr. Rogers has nothing to disclose.
Parkinson's Disease Surgical, Stem Cell and Gene Therapies
Start Time	Pub.	Title	Presenter
11:30 AM	018	“Dual Frequency” Deep Brain Stimulation Programming Paradigm for Gait and Balance Impairment in Parkinson’s Disease	Disclosure: Dr. Karl has nothing to disclose.
Neuro-Ophthalmology/Neuro-Otology
Start Time	Pub.	Title	Presenter
11:30 AM	019	Saturday Night Retinopathy – A Rare Case of Acute Onset Vision Loss and Ophthalmoplegia	Disclosure: Dr. Dorotan has nothing to disclose.
Headache Clinical Trials I
Start Time	Pub.	Title	Presenter
11:30 AM	019	Absence of Clinically Significant Drug Interactions With Coadministration of Atogepant and an Ethinyl Estradiol/Levonorgestrel Oral Contraceptive in Healthy Female Subjects: A Phase 1 Pharmacokinetic Analysis	Disclosure: Dr. Ankrom has received personal compensation for consulting, serving on a scientific advisory board, speaking, or other activities with Merck & Co, Inc.. Dr. Ankrom holds stock and/or stock options in Merck & Co, Inc., which sponsored research in which Dr. Ankrom was involved as an investigator.
Aging and Dementia: Genetics and Neuropathology
Start Time	Pub.	Title	Presenter
11:30 AM	019	TDP-43 cytoplasmic inclusion formation in C9orf72-associated FTLD/ALS	Disclosure: Dr. Lee has nothing to disclose.
Autoimmune (AQP4/MOG) Gliopathies and NMOSDs
Start Time	Pub.	Title	Presenter
11:30 AM	019	The Essence and Boundaries of anti-Myelin Oligodendrocyte Glycoprotein Syndromes	Disclosure: Dr. Liu has nothing to disclose.
Endovascular Therapy in Acute Ischemic Stroke
Start Time	Pub.	Title	Presenter
11:30 AM	019	Inter-facility transfer workflow for thrombectomy in a rural stroke network: Longer Door-In-Door-Out (DIDO) time delays thrombectomy	Disclosure: Dr. Abdelhak has nothing to disclose.
Amyotrophic Lateral Sclerosis
Start Time	Pub.	Title	Presenter
11:30 AM	019	Health utility declines with advancing Fine'til 9 stage of ALS	Disclosure: Dr. Thakore has received research support from Novartis Pharmaceuticals Corporation.
Epilepsy: Antiseizure Medications I
Start Time	Pub.	Title	Presenter
11:30 AM	019	Safety of Cenobamate (YKP3089) as Adjunctive Treatment for Uncontrolled Focal Seizures in a Large, Multicenter, Open-Label Study	Disclosure: Yes: all funds paid to Thomas Jefferson University with research support from Medtronic, SK Life Science, Takeda, UCB Pharma, Neurelis, Eisai, Engage, Cavion
Clinical Advances in CNS Cancer Care
Start Time	Pub.	Title	Presenter
11:30 AM	019	Impact of Delay of Chemoradiation (CRT) in Newly Diagnosed Glioblastoma (GBM) Treated With Stupp Protocol	Disclosure: Dr. Ali has nothing to disclose.
Parkinson's Disease Surgical, Stem Cell and Gene Therapies
Start Time	Pub.	Title	Presenter
11:30 AM	019	National Trends in Utilization of Deep Brain Stimulation In Primary Movement Disorders: National Inpatient Sample Study 2006-2014	Disclosure: Dr. Vellipuram has nothing to disclose.
Neuro-Ophthalmology/Neuro-Otology
Start Time	Pub.	Title	Presenter
11:30 AM	020	A Case of Heidenhain Variant Creutzfeldt-Jakob Disease Presenting with Isolated Homonymous Quadrantanopia and Corresponding Nuclear Imaging Findings	Disclosure: Dr. Bhadola has nothing to disclose.
Headache Clinical Trials I
Start Time	Pub.	Title	Presenter
11:30 AM	020	Long-term Efficacy of Erenumab in Patients With Episodic Migraine Who Have Failed Prior Preventive Migraine Therapies	Disclosure: Dr. Reuter has received personal compensation for consulting, serving on a scientific advisory board, speaking, or other activities with consulting fee, speaking/teaching fee, from Allergan, Amgen, Autonomic Technologies, CoLucid, ElectroCore, EliLilly, Medscape, Novartis, StreamMedUp, TEVA Pharmaceuticals. Dr. Reuter has received research support from research grants from Allergan, Amgen, Autonomic Technologies, CoLucid, ElectroCore, EliLilly, Medscape, Novartis, StreamMedUp, TEVA Pharmaceuticals.
Aging and Dementia: Genetics and Neuropathology
Start Time	Pub.	Title	Presenter
11:30 AM	020	Small Vessel Characteristics of Autopsied Patients with CADASIL and Those Heterozygous for HTRA1 Mutations: 3D Analysis Using the CUBIC Tissue Clearing Technique	Disclosure: Dr. Saito has nothing to disclose.
Autoimmune (AQP4/MOG) Gliopathies and NMOSDs
Start Time	Pub.	Title	Presenter
11:30 AM	020	A Phase 1/2a Open-Label Study to Investigate the Safety of the Transplantation (by Injection) of Human Glial Restricted Progenitor Cells (hGRPs; Q-Cells®) into Subjects with Transverse Myelitis (TM)	Disclosure: Ms. Cameron Watts has received research support from Myeletis Organization.
Endovascular Therapy in Acute Ischemic Stroke
Start Time	Pub.	Title	Presenter
11:30 AM	020	RAPIDTM Based Treatment Algorithms Lead to Faster Activation of Neurointervention Team and Reduce Recanalization Times	Disclosure: Dr. Mehta has nothing to disclose.
Amyotrophic Lateral Sclerosis
Start Time	Pub.	Title	Presenter
11:30 AM	020	Biomarker Supervised G-CSF (Filgrastim) Response in ALS Patients	Disclosure: Dr. Johannesen has nothing to disclose.
Epilepsy: Antiseizure Medications I
Start Time	Pub.	Title	Presenter
11:30 AM	020	Analysis of Psychiatric Adverse Events and Suicidality in Clinical Trials of Adjunctive Eslicarbazepine Acetate in Children (Aged 4–17 Years) with Focal Seizures	Disclosure: Dr. Salpekar has received personal compensation for consulting, serving on a scientific advisory board, speaking, or other activities with Sunovion Pharmaceuticals Inc. (consulting only). Dr. Salpekar has received research support from Lundbeck (institution only).
Clinical Advances in CNS Cancer Care
Start Time	Pub.	Title	Presenter
11:30 AM	020	Neurological Adverse Effects Due to Programmed Death (PD-1) Inhibitors	Disclosure: Dr. Shi has nothing to disclose.
Parkinson's Disease Surgical, Stem Cell and Gene Therapies
Start Time	Pub.	Title	Presenter
11:30 AM	020	Correlation of Electrode Location and Outcomes of Gait and Axial Function in Parkinson’s Disease Patients managed with Subthalamic Deep Brain Stimulation	Disclosure: Dr. Huang has nothing to disclose.
Neuro-Ophthalmology/Neuro-Otology
Start Time	Pub.	Title	Presenter
11:30 AM	021	Posterior Ischemic Optic Neuropathy, a previously unknown complication of lung transplantation	Disclosure: Dr. Keller has nothing to disclose.
Behavioral and Cognitive Neurology: Other
Start Time	Pub.	Title	Presenter
11:30 AM	021	The Use of Standing Desks to Address Self-Regulating Behavior in Elementary Students	Disclosure: Dr. Wachob has nothing to disclose.
Headache Clinical Trials I
Start Time	Pub.	Title	Presenter
11:30 AM	021	Long-term Safety and Efficacy of Lasmiditan for Acute Treatment of Migraine Over a One-Year Period: Interim Results of an Open-Label Phase 3 Study (GLADIATOR)	Disclosure: Dr. Brandes has received personal compensation for consulting, serving on a scientific advisory board, speaking, or other activities with Amgen, Eli Lilly and Company, Depomed, Avanir Pharmaceuticals, Promius Pharma, and Supernus Pharmaceuticals. Dr. Brandes has received research support from Amgen, Eli Lilly and Company, CoLucid Pharmaceuticals, Teva Pharmaceuticals, Zosano, Allergan, and Biohaven Pharma.
Inflammatory Neurological Complications of Systemic Disease
Start Time	Pub.	Title	Presenter
11:30 AM	021	The Structural Basis of Susac's Syndrome	Disclosure: Dr. Munoz has received personal compensation for consulting, serving on a scientific advisory board, speaking, or other activities with Cortexyme.
Endovascular Therapy in Acute Ischemic Stroke
Start Time	Pub.	Title	Presenter
11:30 AM	021	To Stay or To Go? Utilization of a Mobile Interventional Stroke Team Shortens Time to Treatment in Large Vessel Occlusion	Disclosure: Dr. Velickovic Ostojic has nothing to disclose.
Amyotrophic Lateral Sclerosis
Start Time	Pub.	Title	Presenter
11:30 AM	021	Increasing the Efficiency of ALS Clinical Trials Using Machine Learning	Disclosure: Dr. Ennist has received personal compensation for consulting, serving on a scientific advisory board, speaking, or other activities with Origent Data Sciences.
Epilepsy: Antiseizure Medications I
Start Time	Pub.	Title	Presenter
11:30 AM	021	Safety and Efficacy of Adjunctive Perampanel in Younger (aged 4 to <7 years) and Older (7 to <12 years) Pediatric Patients with Partial-Onset Seizures (POS) or Primary Generalized Tonic-Clonic Seizures (PGTCS): Final Results from the 311 Core Study	Disclosure: Dr. Fogarasi has received personal compensation for consulting, serving on a scientific advisory board, speaking, or other activities with UCB and Novartis.
Clinical Advances in CNS Cancer Care
Start Time	Pub.	Title	Presenter
11:30 AM	021	The Financial Burden of Central Nervous System Cancers in the United States	Disclosure: Dr. Pena has nothing to disclose.
Parkinson's Disease Surgical, Stem Cell and Gene Therapies
Start Time	Pub.	Title	Presenter
11:30 AM	021	The Use of Omni vs. Directional Programming in Parkinson Disease and Essential Tremor DBS Patients	Disclosure: Dr. Sharma has nothing to disclose.
Neuro-Ophthalmology/Neuro-Otology
Start Time	Pub.	Title	Presenter
11:30 AM	022	Wernicke Encephalopathy Mimicking Idiopathic Intracranial Hypertension	Disclosure: Dr. Leon has nothing to disclose.
Behavioral and Cognitive Neurology: Other
Start Time	Pub.	Title	Presenter
11:30 AM	022	Model-Based Truncation of Cognitive Test Batteries to Minimize Assessment Time and Information Loss	Disclosure: Dr. Vermeent has received personal compensation for consulting, serving on a scientific advisory board, speaking, or other activities with Philips.
Headache Clinical Trials I
Start Time	Pub.	Title	Presenter
11:30 AM	022	Long-Term Impact of Fremanezumab on Headache-Related Disability and Quality of Life in Patients Who Reverted From a Chronic to an Episodic Migraine Classification	Disclosure: Dr. Ailani has received personal compensation for consulting, serving on a scientific advisory board, speaking, or other activities with Alder, Amgen, Allergan, Electrocore, Eli, Lilly and Company, Promius, Teva, Impel, Satsuma, Miller, Communications, Avent, Alpha, Sites Consulting. Dr. Ailani has received personal compensation in an editorial capacity for Current Pain and Headache Reports and Unusual Headache Syndromes. Dr. Ailani has received research support from American Migraine Foundation ARMR, Biohaven, Allergan.
Inflammatory Neurological Complications of Systemic Disease
Start Time	Pub.	Title	Presenter
11:30 AM	022	Progressive Brain Atrophy and Leptomeningeal Enhancement in Susac Syndrome	Disclosure: Dr. Malik has nothing to disclose.
Endovascular Therapy in Acute Ischemic Stroke
Start Time	Pub.	Title	Presenter
11:30 AM	022	Initial symptoms and delay in treatment of patients with posterior circulation strokes undergoing endovascular therapy	Disclosure: Dr. Gomez has nothing to disclose.
Amyotrophic Lateral Sclerosis
Start Time	Pub.	Title	Presenter
11:30 AM	022	How the National Amyotrophic Lateral Sclerosis (ALS) Registry Can Help with Your Research	Disclosure: Dr. Kaye has received personal compensation for consulting, serving on a scientific advisory board, speaking, or other activities with McKing Consulting Corp.
Epilepsy: Antiseizure Medications I
Start Time	Pub.	Title	Presenter
11:30 AM	022	Analysis of Allergic Reactions in Clinical Trials of Eslicarbazepine Acetate in Children (Aged 4–17 Years) with Focal Seizures	Disclosure: Dr. Resnick has received personal compensation for consulting, serving on a scientific advisory board, speaking, or other activities with Eisai, Sunovion Pharmaceuticals Inc., Supernus, Mallinckrodt.
Clinical Advances in CNS Cancer Care
Start Time	Pub.	Title	Presenter
11:30 AM	022	Facial palsy induced by cancer immunotherapy: a single center retrospective study	Disclosure: Dr. Yuen has nothing to disclose.
Parkinson's Disease Surgical, Stem Cell and Gene Therapies
Start Time	Pub.	Title	Presenter
11:30 AM	022	APOE E4 Carrier Status Modulates Cognitive Outcome after Deep Brain Stimulation in Parkinson’s Disease Patients	Disclosure: Dr. Yoon has nothing to disclose.
Neuro-Ophthalmology/Neuro-Otology
Start Time	Pub.	Title	Presenter
11:30 AM	023	Acute Bilateral Ophthalmoparesis due to Bacterial Meningitis in the Setting of Sphenoid Sinusitis	Disclosure: Dr. Pereira has nothing to disclose.
Behavioral and Cognitive Neurology: Other
Start Time	Pub.	Title	Presenter
11:30 AM	023	Impact of Educational Inequality on the Incidence of Post-stroke Vascular Mild Cognitive Impairment - Application of the Previous Study on Stratified Education-adjusted MoCA Assessment	Disclosure: Dr. Pisanuwongrak has nothing to disclose.
Headache Clinical Trials I
Start Time	Pub.	Title	Presenter
11:30 AM	023	Eptinezumab Reduces Migraine Frequency Within the First Month After Treatment in Patients with Episodic or Chronic Migraine	Disclosure: Dr. Winner has received personal compensation for consulting, serving on a scientific advisory board, speaking, or other activities with Allergan, Amgen, Supernus, Teva, Novartis, Avanir, and Promius.
Inflammatory Neurological Complications of Systemic Disease
Start Time	Pub.	Title	Presenter
11:30 AM	023	Pachymeningitis in Rheumatic Disease	Disclosure: Dr. Kneeland has nothing to disclose.
Endovascular Therapy in Acute Ischemic Stroke
Start Time	Pub.	Title	Presenter
11:30 AM	023	Posterior Circulation Large Vessel Occlusions are Associated with Longer Door-?to-Groin Time	Disclosure: Dr. Almallouhi has nothing to disclose.
Amyotrophic Lateral Sclerosis
Start Time	Pub.	Title	Presenter
11:30 AM	023	Characteristics of respiratory dysfunction in amyotrophic lateral sclerosis: a retrospective cohort study in 236 cases	Disclosure: Dr. Fu has nothing to disclose.
Epilepsy: Antiseizure Medications I
Start Time	Pub.	Title	Presenter
11:30 AM	023	A Two-Part, Double-Blind, Placebo-Controlled, Inpatient, Dose-Ranging Efficacy Study of Staccato Alprazolam (STAP-001) in Patients with Epilepsy with a Predictable Seizure Pattern: Results from the Initial Open-Label Feasibility Part	Disclosure: Dr French did not receive personal income, but received NYU salary support from the Epilepsy Foundation and for consulting work and/or attending Scientific Advisory Boards on behalf of the Epilepsy Study Consortium for Acadia, Adamas, Addex, Aeonian, Alexza, Anavex, Axcella Health, Axovant, Biogen, Biomotiv/Koutif, Blackfynn, Bloom Science, Bridge Valley Ventures, Cavion, Cerebral Therapeutics, Cerevel, Clinilabs, Concert Pharmaceuticals, Covance, Crossject, CuroNZ, Eisai, Empatica, Engage Therapeutics, Epitel, GW Pharma, Idorsia, Impax, Ionis, J&J Pharmaceuticals, Marinus, MonosolRx, Neurelis, Novartis, Otsuka Pharmaceutical Development, Ovid Therapeutics Inc., Pfizer, Pfizer-Neusentis, Praxis, Redpin, Sage, Sancillio, Shire, SK Life Sciences, Springworks, Stoke, Sunovion, Supernus, Takeda, UCB Inc., Ultragenyx, Upsher Smith, Vyera, West Therapeutic Development, Xenon, Xeris, Zogenix, Zynerba. Dr. French received research grants from Biogen, Cavion, Engage, Neurelis, Ovid, SK Life Sciences, UCB, and Zogenix.
Clinical Advances in CNS Cancer Care
Start Time	Pub.	Title	Presenter
11:30 AM	023	Planning a Glioma Partial Resection with DTI Tractography and Virtual Reality	Disclosure: Dr. Sanicola has nothing to disclose.
Parkinson's Disease Surgical, Stem Cell and Gene Therapies
Start Time	Pub.	Title	Presenter
11:30 AM	023	Using a quality improvement framework to examine deep brain stimulation in Parkinson’s disease: the RAD-PD initiative	Disclosure: Dr. Jimenez Shahed has received personal compensation for consulting, serving on a scientific advisory board, speaking, or other activities with St. Jude Medical/Abbott, Medtronic, Teva, Bracket, Nuvelution, Sunovion,. Dr. Jimenez Shahed has received research support from Biotie/Accorda, Medtronic, St. Jude Medical/Abbott, Eli Lilly & Company, Wilsons Therapeutics.
Neuro-Ophthalmology/Neuro-Otology
Start Time	Pub.	Title	Presenter
11:30 AM	024	Optic Neuritis and Intracranial Hypertension Caused by Chronic Lymphocytic Leukemia, Case Report	Disclosure: Dr. Madani has nothing to disclose.
Behavioral and Cognitive Neurology: Other
Start Time	Pub.	Title	Presenter
11:30 AM	024	Using the Montreal Cognitive Assessment (MoCA): to Predict Three Month Recovery Following a Stroke	Disclosure: Dr. Julayanont has nothing to disclose.
Headache Clinical Trials I
Start Time	Pub.	Title	Presenter
11:30 AM	024	Long-Term Efficacy of Fremanezumab in Patients With Chronic Migraine and Comorbid Moderate to Severe Depression	Disclosure: Dr. Lipton has received personal compensation for consulting, serving on a scientific advisory board, speaking, or other activities with American Academy of Neurology, Alder, Allergan, American Headache Society, Amgen, Autonomic Technologies, Avanir, Biohaven, Biovision, Boston Scientific, Dr. Reddy’s, Electrocore, Eli Lilly, eNeura Therapeutics, GlaxoSmithKline, Merck, Pernix, Pfizer, Supernus, Teva, Trigemina, Vector, and Vedanta. Dr. Lipton has received compensation for serving on the Board of Directors of eNeura and Biohaven. Dr. Lipton holds stock and/or stock options in Biohaven, which sponsored research in which Dr. Lipton was involved as an investigator. Dr. Lipton holds stock and/or stock options in Biohaven. Dr. Lipton has received research support from Migraine Research Foundation, the National Headache Foundation, and Amgen.
Inflammatory Neurological Complications of Systemic Disease
Start Time	Pub.	Title	Presenter
11:30 AM	024	Clinical spectrum of patients with Primary central nervous system vasculitis	Disclosure: Dr. Dash has nothing to disclose.
Endovascular Therapy in Acute Ischemic Stroke
Start Time	Pub.	Title	Presenter
11:30 AM	024	First Pass Rates Differ Between Anterior Circulation And Vertebrobasilar Occlusions During Mechanical Thrombectomy For Emergent Large Vessel Occlusions	Disclosure: Dr. Daniel has nothing to disclose.
Amyotrophic Lateral Sclerosis
Start Time	Pub.	Title	Presenter
11:30 AM	024	McGill University Single Item Quality-of-Life ( QoL ) Scale Compared with ALS Health-Related Quality-of-Life Likert Scales Including Breathing QoL Measurement	Disclosure: Dr. Brooks has received personal compensation for consulting, serving on a scientific advisory board, speaking, or other activities with Mitsubishi Tanabe Pharma USA, Biohaven, Cytokinetics, ITF Pharma. Dr. Brooks has received personal compensation in an editorial capacity for American Journal of Managed Care. Dr. Brooks has received research support from Medicinova, Neuraltus, Cytokinetics,Santhera, Biogen, ITF Pharma, Acceleron, Center for Disease Control, Orion, Biohaven.
Epilepsy: Antiseizure Medications I
Start Time	Pub.	Title	Presenter
11:30 AM	024	A Post-Marketing Observational Study to Evaluate the Safety and Tolerability of Perampanel as Add-On Therapy in Patients with Epilepsy Aged =12 Years	Disclosure: Dr. Maguire has nothing to disclose.
Clinical Advances in CNS Cancer Care
Start Time	Pub.	Title	Presenter
11:30 AM	024	iPROMPT: Integrated Predictive Radiographic biOMarkers of Progressed high grade astrocytic Tumors	Disclosure: Dr. Gatson has received personal compensation for consulting, serving on a scientific advisory board, speaking, or other activities with Novocure (Optune).
Parkinson's Disease Surgical, Stem Cell and Gene Therapies
Start Time	Pub.	Title	Presenter
11:30 AM	024	CLOVER-DBS: A Prospective, Multicenter Clinical Study with Blinding to Evaluate a Closed Loop Programming Algorithm for Directional Leads Based on External Feedback	Disclosure: Dr. Wenzel has nothing to disclose.
Neuro-Ophthalmology/Neuro-Otology
Start Time	Pub.	Title	Presenter
11:30 AM	025	Binasal Visual Field Defects in a Child with Acute Necrotizing Encephalopathy	Disclosure: Dr. Liu has nothing to disclose.
Behavioral and Cognitive Neurology: Other
Start Time	Pub.	Title	Presenter
11:30 AM	025	Concordance Between Structural and Functional Connectivity Reflects Available Cognitive Reserve in Multiple Sclerosis During Cognitive Rehabilitation	Disclosure: Dr. Fuchs has nothing to disclose.
Headache Clinical Trials I
Start Time	Pub.	Title	Presenter
11:30 AM	025	Early Impact of Eptinezumab on the Health-Related Quality of Life (HRQoL) of Patients with Episodic or Chronic Migraine: SF-36 Analysis Across the Spectrum of Migraine	Disclosure: Dr. Diamond has received personal compensation for consulting, serving on a scientific advisory board, speaking, or other activities with Alder BioPharmaceuticals, Amgen Inc., Avanir Pharmaceuticals, Depomed Inc., Eli Lilly and Co., Promius Pharma, Supernus Pharmaceuticals, Teva Pharmaceuticals, and Upsher-Smith Laboratories.
Inflammatory Neurological Complications of Systemic Disease
Start Time	Pub.	Title	Presenter
11:30 AM	025	Case of hypertrophic pachymeningitis with positive MPO-ANCA antibodies	Disclosure: Dr. Castrodad- Molina has nothing to disclose.
Endovascular Therapy in Acute Ischemic Stroke
Start Time	Pub.	Title	Presenter
11:30 AM	025	No Association Between Number of Stent Retriever Passes and Hemorrhagic Transformation for Mechanical Thrombectomy Patients.	Disclosure: Dr. Hassan has nothing to disclose.
Amyotrophic Lateral Sclerosis
Start Time	Pub.	Title	Presenter
11:30 AM	025	Safety and Efficacy of Edaravone in Delaying Functional Decline in Amyotrophic Lateral Sclerosis: A Meta-Analysis	Disclosure: Dr. Bagnas has nothing to disclose.
Epilepsy: Antiseizure Medications I
Start Time	Pub.	Title	Presenter
11:30 AM	025	Analysis of Hepatic and Hypothyroidism-related Events in Clinical Trials of Adjunctive Eslicarbazepine Acetate in Children (Aged 4–17 years) with Focal Seizures	Disclosure: Dr. Wheless has received personal compensation for consulting, serving on a scientific advisory board, speaking, or other activities with Lundbeck, Mallinckrodt, LivaNova, Eisai, Supernus, GW Pharma, NeuroPace, UCB, Actua, and Aquestive. Dr. Wheless has received research support from NIH, Shainberg Foundation, Mallinckrodt, LivaNova, Eisai, GW Pharma, INSYS Inc, Neuralis, Zogenix, NeuroPace, UCB, Actua, and Aquestive.
Clinical Advances in CNS Cancer Care
Start Time	Pub.	Title	Presenter
11:30 AM	025	NeMeRe, a Multi-Institutional Retrospective and Prospective Registry of Neoplastic Meningitis in Adults	Disclosure: Dr. Ghatnekar has nothing to disclose.
Parkinson's Disease Surgical, Stem Cell and Gene Therapies
Start Time	Pub.	Title	Presenter
11:30 AM	025	Monitoring Safety and Effectiveness of Deep Brain Stimulation Systems in a Real-World Population: The Product Surveillance Registry	Disclosure: Dr. Pagan has received personal compensation for consulting, serving on a scientific advisory board, speaking, or other activities with Sunovion, Teva, Acadia, Adamas, AbbVie, Medtronic, US Word Meds, Merz.
Behavioral and Cognitive Neurology: Other
Start Time	Pub.	Title	Presenter
11:30 AM	026	Perceptions of Treatment, Care After Hospital Discharge, and Recovery Following Autoimmune and Infectious Encephalitis	Disclosure: Dr. Nyamu has nothing to disclose.
Headache Clinical Trials I
Start Time	Pub.	Title	Presenter
11:30 AM	026	The Impact of Fremanezumab on Medication Overuse in Patients With Chronic Migraine	Disclosure: Dr. Silberstein has received personal compensation for consulting, serving on a scientific advisory board, speaking, or other activities with Stephen D. Silberstein, MD, is a consultant and/or advisory panel member for and has received honoraria from Alder Biopharmaceuticals, Allergan, Amgen, Avanir, eNeura, ElectroCore Medical, Labrys Biologics, Medscape, Medtronic, Neuralieve, NINDS, Pfizer, and Teva.. Dr. Silberstein has received research support from His employer receives research support from Allergan, Amgen, Cumberland Pharmaceuticals, ElectroCore Medical, Labrys Biologics, Eli Lilly, Merz, and Troy Healthcare..
Inflammatory Neurological Complications of Systemic Disease
Start Time	Pub.	Title	Presenter
11:30 AM	026	Wet, Wacky, and Wobbly Without Hydrocephalus	Disclosure: Dr. Hung has nothing to disclose.
Endovascular Therapy in Acute Ischemic Stroke
Start Time	Pub.	Title	Presenter
11:30 AM	026	Did Evolution of Evidence Based Stroke Thrombectomy Treatment Change Efficiency Across Stroke Systems of Care?	Disclosure: Dr. Kulhari has nothing to disclose.
Amyotrophic Lateral Sclerosis
Start Time	Pub.	Title	Presenter
11:30 AM	026	Pitfalls in the Diagnosis of Amyotrophic Lateral Sclerosis in a Hispanic Cohort	Disclosure: Dr. Trikamji has nothing to disclose.
Epilepsy: Antiseizure Medications I
Start Time	Pub.	Title	Presenter
11:30 AM	026	Selective T-type Calcium Channel Modulator CX-8998 Fully Suppresses Seizures in the GAERS Genetic Model of Epilepsy at Human Achievable Concentrations	Disclosure: Dr. Lee has received personal compensation for consulting, serving on a scientific advisory board, speaking, or other activities with Cavion Inc., Karyopharm Therapeutics, and Evelo Biosciences.
Clinical Advances in CNS Cancer Care
Start Time	Pub.	Title	Presenter
11:30 AM	026	Neurological Complications in an ALS Patient with Metastatic Melanoma after Immunotherapy	Disclosure: Dr. Jaffer has nothing to disclose.
Parkinson's Disease Surgical, Stem Cell and Gene Therapies
Start Time	Pub.	Title	Presenter
11:30 AM	026	Two Year Outcomes: A Prospective, Double Blinded, Multicenter Randomized Controlled Trial Evaluating Deep Brain Stimulation with a New Multiple Source, Constant Current Rechargeable System in Parkinson's Disease (INTREPID)	Disclosure: Dr. Vitek has received personal compensation for consulting, serving on a scientific advisory board, speaking, or other activities with Boston Scientific, Abbott, Medtronic. Dr. Vitek has received research support from Boston Scientific, Abbott, Medtronic.
General Neurology: Research Advances in Diagnosis, Pathogenesis, and Biomarkers
Start Time	Pub.	Title	Presenter
11:30 AM	026	A Common Data Language for Clinical Research Studies: Overview and Update on the National Institute of Neurological Disorders and Stroke (NINDS) Common Data Element (CDE) Recommendations	Disclosure: Dr. Sheikh has nothing to disclose.
Behavioral and Cognitive Neurology: Other
Start Time	Pub.	Title	Presenter
11:30 AM	027	The Contribution of Cognitive Impairment to Perceived Motor Disability in Amyotrophic Lateral Sclerosis	Disclosure: Dr. Ahmadi Jazi has nothing to disclose.
Inflammatory Neurological Complications of Systemic Disease
Start Time	Pub.	Title	Presenter
11:30 AM	027	Adult acute hemorrhagic leukoencephalitis: role of susceptibility-weighted imaging in diagnosis and importance of aggressive early immunotherapy.	Disclosure: Dr. Sugar has nothing to disclose.
Endovascular Therapy in Acute Ischemic Stroke
Start Time	Pub.	Title	Presenter
11:30 AM	027	Evidence Improves Outcomes Beyond ‘Belief’: Comparison of Patient Outcomes in Pre- and Post- DAWN era.	Disclosure: Dr. Kulhari has nothing to disclose.
Amyotrophic Lateral Sclerosis
Start Time	Pub.	Title	Presenter
11:30 AM	027	Clinical and Electrophysiological Profile and Study of Plasma Levels of Neurotoxic Metals in Amyotrophic Lateral Sclerosis	Disclosure: Dr. Garuda has nothing to disclose.
Epilepsy: Antiseizure Medications I
Start Time	Pub.	Title	Presenter
11:30 AM	027	Cosyntropin is poorly effective in treatment of infantile spasms	Disclosure: Dr. Arya has nothing to disclose.
Clinical Advances in CNS Cancer Care
Start Time	Pub.	Title	Presenter
11:30 AM	027	Eye Movement Abnormalities in CNS Germ Cell Tumors	Disclosure: Dr. Sarangi has nothing to disclose.
Parkinson's Disease Surgical, Stem Cell and Gene Therapies
Start Time	Pub.	Title	Presenter
11:30 AM	027	The STN Sweet Spot for Tremor Control in Parkinson’s Disease.	Disclosure: Dr. Stiep has nothing to disclose.
General Neurology: Research Advances in Diagnosis, Pathogenesis, and Biomarkers
Start Time	Pub.	Title	Presenter
11:30 AM	027	Evaluation of microRNAs in patients with sporadic amyotrophic lateral sclerosis by liquid biopsy as a disease biomarker	Disclosure: Dr. Takahashi has nothing to disclose.
Behavioral and Cognitive Neurology: Other
Start Time	Pub.	Title	Presenter
11:30 AM	028	Identifying Neural Activity Related to Both How and Why Movements are Performed	Disclosure: Dr. Mazurek has nothing to disclose.
Inflammatory Neurological Complications of Systemic Disease
Start Time	Pub.	Title	Presenter
11:30 AM	028	Rheumatoid Meningitis with Elevated Cyclic Citrullinated Peptide Antibodies and No Evidence of Arthritic Disease	Disclosure: Dr. Rose has nothing to disclose.
Endovascular Therapy in Acute Ischemic Stroke
Start Time	Pub.	Title	Presenter
11:30 AM	028	Impact of Race on Mechanical Thrombectomy Safety Outcomes	Disclosure: Dr. Liaw has nothing to disclose.
Amyotrophic Lateral Sclerosis
Start Time	Pub.	Title	Presenter
11:30 AM	028	Lifetime Sport Practice and Brain Metabolism in Amyotrophic Lateral Sclerosis: a 18F-FDG-PET study	Disclosure: Dr. Moglia has nothing to disclose.
Epilepsy: Antiseizure Medications I
Start Time	Pub.	Title	Presenter
11:30 AM	028	A 12-month, open-label, repeat-dose safety study of Valtoco ™ (NRL-1, diazepam nasal spray) in patients with epilepsy: Interim report	Disclosure: Yes: all funds paid to Thomas Jefferson University with research support from Medtronic, SK Life Science, Takeda, UCB Pharma, Neurelis, Eisai, Engage, Cavion
Clinical Advances in CNS Cancer Care
Start Time	Pub.	Title	Presenter
11:30 AM	028	Standardized Intrathecal (IT) Treatment and Surveillance in Leptomeningeal Carcinomatosis (LMC) Improves Patient Outcomes: developing Ommaya IT chemotherapy clinics	Disclosure: Dr. Leese has nothing to disclose.
Parkinson's Disease Surgical, Stem Cell and Gene Therapies
Start Time	Pub.	Title	Presenter
11:30 AM	028	Characteristics of oscillatory activity in the globus pallidus internus in patients with Parkinson’s disease	Disclosure: Dr. Zhuang has nothing to disclose.
General Neurology: Research Advances in Diagnosis, Pathogenesis, and Biomarkers
Start Time	Pub.	Title	Presenter
11:30 AM	028	Molecular background of ALS based on whole exome sequencing analysis	Disclosure: Dr. Hama has nothing to disclose.
Behavioral and Cognitive Neurology: Other
Start Time	Pub.	Title	Presenter
11:30 AM	029	Polyphenolic compounds ameliorate stress–induced depression by preventing NLRP3 inflammasome priming	Disclosure: Dr. Frolinger has nothing to disclose.
Inflammatory Neurological Complications of Systemic Disease
Start Time	Pub.	Title	Presenter
11:30 AM	029	Progressive Multifocal Leukoencephalopathy in a Patient with Relapsed Multiple Myeloma: A Case Report and Literature Review	Disclosure: Dr. Woodson has nothing to disclose.
Endovascular Therapy in Acute Ischemic Stroke
Start Time	Pub.	Title	Presenter
11:30 AM	029	Patterns and Outcomes of Endovascular Therapy in Mild Stroke: A Florida-Puerto Rico Collaboration	Disclosure: Dr. Asdaghi has nothing to disclose.
Amyotrophic Lateral Sclerosis
Start Time	Pub.	Title	Presenter
11:30 AM	029	Case Report: Familial Amyotrophic Lateral Sclerosis SOD1 c.122A>G (p.Glu41Gly) Mutation with Slow Disease Progression	Disclosure: Dr. Nguyen has nothing to disclose.
Epilepsy: Antiseizure Medications I
Start Time	Pub.	Title	Presenter
11:30 AM	029	Pharmacokinetic (PK) Assessment of Perampanel Intravenous (IV) Formulation as a Bioequivalent Alternative to Oral Tablet Administration	Disclosure: LR is an employee of Eisai Inc.
Clinical Advances in CNS Cancer Care
Start Time	Pub.	Title	Presenter
11:30 AM	029	Treatment of Cerebral Cysts with Ommaya Reservoir – A Review of 4 Cases	Disclosure: Dr. Mayers has nothing to disclose.
Parkinson's Disease Surgical, Stem Cell and Gene Therapies
Start Time	Pub.	Title	Presenter
11:30 AM	029	Longitudinal outcomes of LRRK2 gene mutation parkinsonism undergoing either Subthalamic Nucleus (STN) or Globus Pallidus Internus (GPi) Deep-Brain stimulation (DBS): a multi-group comparison	Disclosure: Dr. Leaver has nothing to disclose.
General Neurology: Research Advances in Diagnosis, Pathogenesis, and Biomarkers
Start Time	Pub.	Title	Presenter
11:30 AM	029	Expanding the NeuroChip: A low-cost and efficient diagnostic tool to detect neurological disease-related mutations	Disclosure: Dr. Patankar has nothing to disclose.
Behavioral and Cognitive Neurology: Other
Start Time	Pub.	Title	Presenter
11:30 AM	030	Scopolamine Enhances Low Frequency Cortical Rhythms and Impairs Temporal Processing in the Medial Prefrontal Cortex during an Interval Timing Task	Disclosure: Dr. Zhang has nothing to disclose.
Inflammatory Neurological Complications of Systemic Disease
Start Time	Pub.	Title	Presenter
11:30 AM	030	Systemic Autoimmune Diseases and Idiopathic Epilepsy	Disclosure: Dr. Groshans has nothing to disclose.
Endovascular Therapy in Acute Ischemic Stroke
Start Time	Pub.	Title	Presenter
11:30 AM	030	Mechanical Thrombectomy in patients with low NIHSS: A retrospective chart review	Disclosure: Dr. Katyal has nothing to disclose.
Amyotrophic Lateral Sclerosis
Start Time	Pub.	Title	Presenter
11:30 AM	030	ALS/FTD-linked UBQLN2-P497H Increases K63-linked Polyubiquitinated Protein Levels	Disclosure: Dr. Esengul has nothing to disclose.
Epilepsy: Antiseizure Medications I
Start Time	Pub.	Title	Presenter
11:30 AM	030	Population Pharmacokinetics Of Lamotrigine In Adults Patients With Epilepsy.	Disclosure: Dr. Chavez has nothing to disclose.
Child Neurology: Neurogenetics
Start Time	Pub.	Title	Presenter
11:30 AM	030	A kinome-wide RNAi screen identifies ERK2 as a druggable regulator of Shank3 stability	Disclosure: Dr. Holder has nothing to disclose.
Parkinson's Disease Surgical, Stem Cell and Gene Therapies
Start Time	Pub.	Title	Presenter
11:30 AM	030	DIRECT-DBS: A Prospective, Multi-center Clinical Study of a Directional DBS Lead – Therapeutic Windows with Directional Stimulation	Disclosure: Dr. Steigerwald has received personal compensation for consulting, serving on a scientific advisory board, speaking, or other activities with Boston Scientific, Medtronic, and St. Jude Medical.
General Neurology: Research Advances in Diagnosis, Pathogenesis, and Biomarkers
Start Time	Pub.	Title	Presenter
11:30 AM	030	Validation of an Axonal Injury Model by Scanning Electron Microscopy Imaging	Disclosure: Dr. Wilson has nothing to disclose.
Behavioral and Cognitive Neurology: Other
Start Time	Pub.	Title	Presenter
11:30 AM	031	Opioid Withdrawal Shifts Amygdalar Transcriptome and is Correlated with Gut Dysbiosis	Disclosure: Dr. O'Sullivan has nothing to disclose.
Inflammatory Neurological Complications of Systemic Disease
Start Time	Pub.	Title	Presenter
11:30 AM	031	A Case of CNS Vasculitic Changes in DRESS Syndrome	Disclosure: Dr. Cagniart has nothing to disclose.
Endovascular Therapy in Acute Ischemic Stroke
Start Time	Pub.	Title	Presenter
11:30 AM	031	Experience with Endovascular Therapy in Acute Ischemic Stroke Patients Presenting with Low National Institute of Health Stroke Scale Scores	Disclosure: Dr. Osteraas has nothing to disclose.
Amyotrophic Lateral Sclerosis
Start Time	Pub.	Title	Presenter
11:30 AM	031	The Posttranscriptional Regulation of Ubiquilin2 by HuR in ALS Pathogenesis	Disclosure: Dr. Lu has nothing to disclose.
Epilepsy: Antiseizure Medications I
Start Time	Pub.	Title	Presenter
11:30 AM	031	Clobazam Retention Rate in Pediatric Epilepsy	Disclosure: Dr. Gonzalez-Giraldo has nothing to disclose.
Child Neurology: Neurogenetics
Start Time	Pub.	Title	Presenter
11:30 AM	031	Classification of Mutations in TUBB4A: A New Spectrum of Disease	Disclosure: Dr. Charsar has nothing to disclose.
Parkinson's Disease Surgical, Stem Cell and Gene Therapies
Start Time	Pub.	Title	Presenter
11:30 AM	031	Deep Brain stimulation in Parkinson: Use of kinematics to study impact of DBS on gait	Disclosure: Dr. Tripathi has nothing to disclose.
General Neurology: Research Advances in Diagnosis, Pathogenesis, and Biomarkers
Start Time	Pub.	Title	Presenter
11:30 AM	031	Decreased PI3,5P2 and PI5P in Fibroblasts from Patients with FIG4 Deficiency	Disclosure: Dr. Shisheva has nothing to disclose.
Inflammatory Neurological Complications of Systemic Disease
Start Time	Pub.	Title	Presenter
11:30 AM	032	Brain mass dilemma- Rare presentation of ANCA negative Granulomatosis with polyangiitis	Disclosure: Dr. Ramirez-Salazar has nothing to disclose.
Endovascular Therapy in Acute Ischemic Stroke
Start Time	Pub.	Title	Presenter
11:30 AM	032	Less benefits of Mechanical Thrombectomy on Acute Large Vessel Occlusion Stroke Patients Who were Transferred to a Comprehensive Stroke Center	Disclosure: Dr. Elnazeir has nothing to disclose.
Neurophysiology in Neuromuscular Disorders I
Start Time	Pub.	Title	Presenter
11:30 AM	032	An improved methodology for eliciting the somatosensory evoked potential of the Saphenous Nerve during the intraoperative monitoring in spine surgery	Disclosure: Dr. Sanchez-Roldan has nothing to disclose.
Epilepsy: Antiseizure Medications I
Start Time	Pub.	Title	Presenter
11:30 AM	032	Time to Onset of Efficacy in Seizure Reduction With Cenobamate (YKP3089) in Patients With Uncontrolled Partial Seizures From 2 Randomized Clinical Trials	Disclosure: Dr. Kamin has received personal compensation for consulting, serving on a scientific advisory board, speaking, or other activities with SK Life Science, Inc.
Child Neurology: Neurogenetics
Start Time	Pub.	Title	Presenter
11:30 AM	032	Spherical Nucleic Acids Show Increased Distribution and Longer Persistence than Linear Oligonucleotides in Rat Brain Following Intrathecal Administration	Disclosure: Dr. Kandimalla has received personal compensation for consulting, serving on a scientific advisory board, speaking, or other activities with Exicure, Inc..
Parkinson's Disease Surgical, Stem Cell and Gene Therapies
Start Time	Pub.	Title	Presenter
11:30 AM	032	Effects of STN-DBS on axial and non-motor symptoms in patients with Parkinson’s disease: a prospective study	Disclosure: Dr. Miguel has nothing to disclose.
General Neurology: Research Advances in Diagnosis, Pathogenesis, and Biomarkers
Start Time	Pub.	Title	Presenter
11:30 AM	032	Neurofilament Light Chain (NfL) Levels in CSF, Serum, and Plasma of Healthy Donors Using the Quanterix NfL Advantage Kit™	Disclosure: Dr. Harp has received personal compensation for consulting, serving on a scientific advisory board, speaking, or other activities with Genentech.
Inflammatory Neurological Complications of Systemic Disease
Start Time	Pub.	Title	Presenter
11:30 AM	033	BDNF as a surrogate biomarker for systemic chronic damage in lupus.	Disclosure: Dr. Alessi has nothing to disclose.
Endovascular Therapy in Acute Ischemic Stroke
Start Time	Pub.	Title	Presenter
11:30 AM	033	Predictors of Poor Outcome after Mechanical Thrombectomy with Successful Recanalization	Disclosure: Dr. Anadani has nothing to disclose.
Neurophysiology in Neuromuscular Disorders I
Start Time	Pub.	Title	Presenter
11:30 AM	033	Carpal Tunnel Syndrome in Children from a Pediatric Neuromuscular Center	Disclosure: Dr. Irumudomon has nothing to disclose.
Epilepsy: Antiseizure Medications I
Start Time	Pub.	Title	Presenter
11:30 AM	033	Effects of Cenobamate on GABA-A Receptor Modulation	Disclosure: Dr. Sharma has nothing to disclose.
Child Neurology: Neurogenetics
Start Time	Pub.	Title	Presenter
11:30 AM	033	Phenotypic Characterization of Individuals with SYNGAP1 Pathogenic Variants Reveals Correlation Between Posterior Dominant Rhythm and Developmental Progression	Disclosure: Dr. Jimenez Gomez has nothing to disclose.
Parkinson's Disease Surgical, Stem Cell and Gene Therapies
Start Time	Pub.	Title	Presenter
11:30 AM	033	Long-term Effects of Bilateral Subthalamic Deep Brain Stimulation on Postural Instability and Gait Disturbance in Parkinson's Disease	Disclosure: Dr. Shin has nothing to disclose.
General Neurology: Research Advances in Diagnosis, Pathogenesis, and Biomarkers
Start Time	Pub.	Title	Presenter
11:30 AM	033	The Isoniazid Metabolites Pyridoxal Isonicotinoyl Hydrazone and Hydrazine Regulate Heme Biosynthesis	Disclosure: Dr. Brewer has nothing to disclose.
Inflammatory Neurological Complications of Systemic Disease
Start Time	Pub.	Title	Presenter
11:30 AM	034	Infliximab-induced Demyelinating Polyneuropathy in Neurosarcoidosis	Disclosure: Dr. Lineback has nothing to disclose.
Endovascular Therapy in Acute Ischemic Stroke
Start Time	Pub.	Title	Presenter
11:30 AM	034	Hemorrhagic transformation after Mechanical Thrombectomy Revascularization in Large Vessel Occlusion Ischemic Stroke	Disclosure: Dr. Saini has nothing to disclose.
Neurophysiology in Neuromuscular Disorders I
Start Time	Pub.	Title	Presenter
11:30 AM	034	Kinetics And Fiber Distribution Of The Three Muscle Heads Of Triceps For a Better C7 Myotomal EMG Study	Disclosure: Dr. Noto has nothing to disclose.
Epilepsy: Antiseizure Medications I
Start Time	Pub.	Title	Presenter
11:30 AM	034	The Pharmacokinetics of Cenobamate in Special Populations	Disclosure: Dr. Greene has received personal compensation for consulting, serving on a scientific advisory board, speaking, or other activities with SK Life Science, Inc..
Child Neurology: Neurogenetics
Start Time	Pub.	Title	Presenter
11:30 AM	034	Establishing Clinical Trial Readiness of the Rett Syndrome Hand Function Measure	Disclosure: Dr. Leonard has nothing to disclose.
Parkinson's Disease Surgical, Stem Cell and Gene Therapies
Start Time	Pub.	Title	Presenter
11:30 AM	034	Early Experiences with Multiple Independent Current Control DBS in Parkinson’s Disease	Disclosure: Dr. Lorido has nothing to disclose.
General Neurology: Research Advances in Diagnosis, Pathogenesis, and Biomarkers
Start Time	Pub.	Title	Presenter
11:30 AM	034	Evaluation of apolipoprotein E and a-synuclein as potential biomarkers in CSF to monitor pharmaco-therapeutic efficacy in dopamine dictated disease states of Parkinson's disease and schizophrenia	Disclosure: Dr. HARIPRASAD has nothing to disclose.
Inflammatory Neurological Complications of Systemic Disease
Start Time	Pub.	Title	Presenter
11:30 AM	035	Movement Disorders associated with Systemic Autoimmunity: A Case Series	Disclosure: Dr. McDonald has nothing to disclose.
Endovascular Therapy in Acute Ischemic Stroke
Start Time	Pub.	Title	Presenter
11:30 AM	035	Diabetes Mellitus Predicts Symptomatic Intracerebral Hemorrhage Following Thrombectomy in Acute Ischemic Stroke	Disclosure: Dr. Montalvo Perero has nothing to disclose.
Neurophysiology in Neuromuscular Disorders I
Start Time	Pub.	Title	Presenter
11:30 AM	035	Continuous Vagus Nerve Monitoring using the Laryngeal Adductor Reflex	Disclosure: Dr. Sanchez-Roldan has nothing to disclose.
Epilepsy: Antiseizure Medications I
Start Time	Pub.	Title	Presenter
11:30 AM	035	Efficacy and Tolerability of Clobazam in Adult Drug-Refractory Epilepsy	Disclosure: Dr. Levinson has nothing to disclose.
Child Neurology: Neurogenetics
Start Time	Pub.	Title	Presenter
11:30 AM	035	Resting-State EEG Abnormalities in Children with Rett Syndrome	Disclosure: Dr. Tomlinson has nothing to disclose.
Parkinson's Disease Surgical, Stem Cell and Gene Therapies
Start Time	Pub.	Title	Presenter
11:30 AM	035	Men Are More Likely to Have DBS for Tremor in Parkinson's Disease	Disclosure: Dr. Dalrymple has nothing to disclose.
General Neurology: Research Advances in Diagnosis, Pathogenesis, and Biomarkers
Start Time	Pub.	Title	Presenter
11:30 AM	035	Understand the disease emergence in hereditary transthyretin amyloidosis (hATTR): a longitudinal study of asymptomatic carriers to inaugural disease manifestations.	Disclosure: Dr. Plante-Bordeneuve has nothing to disclose.
Inflammatory Neurological Complications of Systemic Disease
Start Time	Pub.	Title	Presenter
11:30 AM	036	Skin, Gut and Nervous system – Think Degos Disease	Disclosure: Dr. Goswami has nothing to disclose.
Endovascular Therapy in Acute Ischemic Stroke
Start Time	Pub.	Title	Presenter
11:30 AM	036	Higher Baseline LDL levels and Increased Hemorrhagic Risk in Ischemic Stroke Patients Undergoing Mechanical Thrombectomy	Disclosure: Dr. Roman Casul has nothing to disclose.
Neurophysiology in Neuromuscular Disorders I
Start Time	Pub.	Title	Presenter
11:30 AM	036	Utility of Bumps Test in The Diagnosis of Carpal Tunnel Syndrome Compared to Nerve Conduction Study	Disclosure: Dr. Ghasemi has nothing to disclose.
Child Neurology: Neurogenetics
Start Time	Pub.	Title	Presenter
11:30 AM	036	JASPER Early Intervention in TSC (JETS): Methods to enhance study participation and scalability in rare disorders	Disclosure: Dr. Jeste has received personal compensation for consulting, serving on a scientific advisory board, speaking, or other activities with Hoffmann-La Roche Pharmaceuticals.
Parkinson's Disease Surgical, Stem Cell and Gene Therapies
Start Time	Pub.	Title	Presenter
11:30 AM	036	Refractory Gait Freezing Following GPi Stimulation for Parkinson's Disease	Disclosure: Dr. Sketchler has nothing to disclose.
General Neurology: Research Advances in Diagnosis, Pathogenesis, and Biomarkers
Start Time	Pub.	Title	Presenter
11:30 AM	036	Association between LDL-C/HDL-C ratio and Hemorrhagic Transformation in Acute Ischemic Stroke Patients	Disclosure: Dr. Wang has nothing to disclose.
Inflammatory Neurological Complications of Systemic Disease
Start Time	Pub.	Title	Presenter
11:30 AM	037	Post-Malaria Neurological Syndrome	Disclosure: Dr. Waseem has nothing to disclose.
Endovascular Therapy in Acute Ischemic Stroke
Start Time	Pub.	Title	Presenter
11:30 AM	037	Improved Outcomes after Mechanical Thrombectomy for In-hospital Strokes	Disclosure: Dr. Ehab has nothing to disclose.
Neurophysiology in Neuromuscular Disorders I
Start Time	Pub.	Title	Presenter
11:30 AM	037	Hematoma Risk After Needle Electromyography (EMG) In Patients on Newer Anticoagulants	Disclosure: Dr. Nagarajan has nothing to disclose.
Child Neurology: Neurogenetics
Start Time	Pub.	Title	Presenter
11:30 AM	037	Recurrent mosaic MTOR c.5930C>T (p.Thr1977Ile) Variant Causing Megalencephaly, Asymmetric Polymicrogyria, and Cutaneous Pigmentary Mosaicism	Disclosure: Dr. Handoko has nothing to disclose.
Parkinson's Disease Surgical, Stem Cell and Gene Therapies
Start Time	Pub.	Title	Presenter
11:30 AM	037	Dorsal GPi/GPe DBS Induced Dyskinesia	Disclosure: Dr. El Kouzi has nothing to disclose.
General Neurology: Rare and Unusual Presentations of Neurologic Disease
Start Time	Pub.	Title	Presenter
11:30 AM	037	Oromandibular dystonia in a patient with herpes simplex virus encephalitis (HSVE)	Disclosure: Dr. Josephy has nothing to disclose.
Inflammatory Neurological Complications of Systemic Disease
Start Time	Pub.	Title	Presenter
11:30 AM	038	Acute Disseminated Encephalomyelitis In An Adult Associated With Staphylococcus Aureus Bacteremia And Infective Endocarditis	Disclosure: Dr. Shujaat has nothing to disclose.
Endovascular Therapy in Acute Ischemic Stroke
Start Time	Pub.	Title	Presenter
11:30 AM	038	A Comparison of Outcomes Associated With Mechanical Thrombectomy in Acute Ischemic Stroke Patients Performed Within and Outside Clinical Trials In The United States	Disclosure: Dr. Qureshi has nothing to disclose.
Neurophysiology in Neuromuscular Disorders I
Start Time	Pub.	Title	Presenter
11:30 AM	038	Ratio of Distal to Proximal Epidermal Nerve Fiber Density as Predictor of Small Fiber Neuropathy	Disclosure: Dr. Farrenburg has nothing to disclose.
Child Neurology: Neurogenetics
Start Time	Pub.	Title	Presenter
11:30 AM	038	Iron deficiency and response to treatment with regard to sleep difficulties in Angelman Syndrome	Disclosure: Dr. Ryan has nothing to disclose.
Parkinson's Disease Surgical, Stem Cell and Gene Therapies
Start Time	Pub.	Title	Presenter
11:30 AM	038	Outcomes of Deep Brain Stimulation Surgery in Parkinson's Disease: Real Life Experience from a Tertiary Care Center	Disclosure: Dr. Brennan has received personal compensation for consulting, serving on a scientific advisory board, speaking, or other activities with Abbvie.
General Neurology: Rare and Unusual Presentations of Neurologic Disease
Start Time	Pub.	Title	Presenter
11:30 AM	038	Plateau waves of intracranial pressure mimicking seizure in a patient with fungal meningitis	Disclosure: Dr. Wu has nothing to disclose.
Inflammatory Neurological Complications of Systemic Disease
Start Time	Pub.	Title	Presenter
11:30 AM	039	Optic Neuritis and Spinal Nerve Root Masses- An Unusual Presentation of Neurosarcoidosis	Disclosure: Dr. Zafar has nothing to disclose.
Endovascular Therapy in Acute Ischemic Stroke
Start Time	Pub.	Title	Presenter
11:30 AM	039	The Impact of “July Phenomenon” on Door-to-Groin Time and Long-term ?Outcome of Stroke Patients Treated with Mechanical Thrombectomy	Disclosure: Dr. Almallouhi has nothing to disclose.
Neurophysiology in Neuromuscular Disorders I
Start Time	Pub.	Title	Presenter
11:30 AM	039	Neuromuscular ultrasound for the non-invasive assessment of breast cancer patients with peripheral neuropathy from taxanes	Disclosure: Dr. Strowd has received personal compensation for consulting, serving on a scientific advisory board, speaking, or other activities with Innocrin Pharmaceuticals and Monteris Medical. Dr. Strowd has received personal compensation in an editorial capacity for Neurology. Dr. Strowd has received research support from American Society of Clinical Oncology Conquer Cancer Foundation.
Child Neurology: Neurogenetics
Start Time	Pub.	Title	Presenter
11:30 AM	039	A Expanded Cohort Study of the X-linked HNRNPH2-related Neurodevelopmental Disorder	Disclosure: Dr. Bain has nothing to disclose.
Parkinson's Disease Surgical, Stem Cell and Gene Therapies
Start Time	Pub.	Title	Presenter
11:30 AM	039	Outcomes of a Prospective, Multicenter, International Registry of Deep Brain Stimulation for Parkinson's Disease	Disclosure: Dr. Deuschl has received personal compensation for consulting, serving on a scientific advisory board, speaking, or other activities with Boston Scientific. Dr. Deuschl has received personal compensation in an editorial capacity for European Academy of Neurology. Dr. Deuschl has received royalty, license fees, or contractual rights payments from Thieme publisher and has received research support from Medtronic and Boston Scientific.
General Neurology: Rare and Unusual Presentations of Neurologic Disease
Start Time	Pub.	Title	Presenter
11:30 AM	039	Case Report of Transient Acute Parkinsonism in the setting of West Nile Virus Encephalitis	Disclosure: Dr. Vanguru has nothing to disclose.
Inflammatory Neurological Complications of Systemic Disease
Start Time	Pub.	Title	Presenter
11:30 AM	040	An adolescent female with angiography-negative childhood primary angiitis of the central nervous system	Disclosure: Dr. Leung has nothing to disclose.
Endovascular Therapy in Acute Ischemic Stroke
Start Time	Pub.	Title	Presenter
11:30 AM	040	Mechanical Thrombectomy In Acute Ischemic Stroke: Etiology And Trends Of Readmissions In A National Population-based Cohort Study (2010-2014)	Disclosure: Dr. Li has nothing to disclose.
Child Neurology: Neurogenetics
Start Time	Pub.	Title	Presenter
11:30 AM	040	Case Series: Expansion of MT-ATP6 Pathogenic Variant Phenotype	Disclosure: Dr. Purohit has nothing to disclose.
Parkinson's Disease Surgical, Stem Cell and Gene Therapies
Start Time	Pub.	Title	Presenter
11:30 AM	040	Tradeoffs in current steering technologies for deep brain stimulation	Disclosure: Dr. Zhang has received personal compensation for consulting, serving on a scientific advisory board, speaking, or other activities with Abbott. Dr. Zhang has received research support from Abbott.
General Neurology: Rare and Unusual Presentations of Neurologic Disease
Start Time	Pub.	Title	Presenter
11:30 AM	040	A Rare Case of Peripheral Neurolymphomatosis in Cutaneous T-cell Lymphoma	Disclosure: Dr. Paul has nothing to disclose.
Inflammatory Neurological Complications of Systemic Disease
Start Time	Pub.	Title	Presenter
11:30 AM	041	Neurologic Involvement in Seronegative Sjögren’s Syndrome with Positive Lip Biopsy: A Single Center Experience	Disclosure: Dr. Wong has nothing to disclose.
Endovascular Therapy in Acute Ischemic Stroke
Start Time	Pub.	Title	Presenter
11:30 AM	041	Endovascular Thrombectomy in Acute-Onset Ischemic Stroke – Beyond the Standard Time Windows: A Case Report and a Review of the Literature	Disclosure: Dr. So has nothing to disclose.
Child Neurology: Neurogenetics
Start Time	Pub.	Title	Presenter
11:30 AM	041	Developmental and behavioral characteristics of children with Dup15q syndrome	Disclosure: Dr. Distefano has nothing to disclose.
Huntington's Disease and Other Choreas
Start Time	Pub.	Title	Presenter
11:30 AM	041	Salivary Biomarkers in Huntington’s Disease	Disclosure: Dr. Corey-Bloom has received personal compensation for consulting, serving on a scientific advisory board, speaking, or other activities with Genentech, Teva. Dr. Corey-Bloom has received research support from Vaccinex, Wave Life Sciences, CHDI.
General Neurology: Rare and Unusual Presentations of Neurologic Disease
Start Time	Pub.	Title	Presenter
11:30 AM	041	Neurological symptoms in a patient diagnosed with adrenal oncocytic cortical carcinoma.	Disclosure: Dr. Aguilar Tejedor has nothing to disclose.
Inflammatory Neurological Complications of Systemic Disease
Start Time	Pub.	Title	Presenter
11:30 AM	042	Recurrent Occipital Lobe Ischemic Strokes in COPA Syndrome	Disclosure: Dr. Morgan has nothing to disclose.
Endovascular Therapy in Acute Ischemic Stroke
Start Time	Pub.	Title	Presenter
11:30 AM	042	Role of CT Perfusion Parameters and Collateral Score in Predicting Outcomes in Large Vessel Occlusion Strokes Who Received Both Intravenous Alteplase and Endovascular Thrombectomy	Disclosure: Dr. Das has nothing to disclose.
Child Neurology: Neurogenetics
Start Time	Pub.	Title	Presenter
11:30 AM	042	Children with Neurogenetic Disorders Hospitalized with Community-acquired Pneumonia are at Increased Risk for Poor Outcomes	Disclosure: Dr. Kolikonda has nothing to disclose.
Huntington's Disease and Other Choreas
Start Time	Pub.	Title	Presenter
11:30 AM	042	Preliminary Reliability and Validity of a Novel Digital Biomarker Smartphone Application to Assess Cognitive and Motor Symptoms in Huntington’s Disease (HD)	Disclosure: Dr. Lipsmeier has received personal compensation for consulting, serving on a scientific advisory board, speaking, or other activities with F. Hoffmann-La Roche Ltd.. Dr. Lipsmeier has received royalty, license fees, or contractual rights payments from F. Hoffmann-La Roche Ltd..
General Neurology: Rare and Unusual Presentations of Neurologic Disease
Start Time	Pub.	Title	Presenter
11:30 AM	042	Apparent Germline IDH1 Mutation in a Patient with Ollier Disease and Glioblastomas: A Case Report	Disclosure: Dr. Kendroud has nothing to disclose.
Inflammatory Neurological Complications of Systemic Disease
Start Time	Pub.	Title	Presenter
11:30 AM	043	Optic Perineuritis and Central Nervous System Vasculitis Induced after Dengue Infection	Disclosure: Dr. Baratela has nothing to disclose.
Endovascular Therapy in Acute Ischemic Stroke
Start Time	Pub.	Title	Presenter
11:30 AM	043	Femoral Neuropathy Following Transfemoral Neuroendovascular Procedures. An Analysis of a Prospective Registry	Disclosure: Dr. Babar has nothing to disclose.
Child Neurology: Neurogenetics
Start Time	Pub.	Title	Presenter
11:30 AM	043	Neurobehavioral Issues in the Phenotypic Spectrum of Variations in OTX2	Disclosure: Dr. Patel has nothing to disclose.
Huntington's Disease and Other Choreas
Start Time	Pub.	Title	Presenter
11:30 AM	043	Defining Clinically Meaningful Change on the Composite Unified Huntington’s Disease Rating Scale (cUHDRS)	Disclosure: Dr. Trundell has received personal compensation for consulting, serving on a scientific advisory board, speaking, or other activities with Roche Products Ltd.
General Neurology: Rare and Unusual Presentations of Neurologic Disease
Start Time	Pub.	Title	Presenter
11:30 AM	043	A Rare Case of an Acute Confusional Migraine in an Adult	Disclosure: Dr. Zafar has nothing to disclose.
Inflammatory Neurological Complications of Systemic Disease
Start Time	Pub.	Title	Presenter
11:30 AM	044	Atypical Epilepsy in Common Variable Immunodeficiency: A Single Institution Case Series	Disclosure: Dr. Galli has nothing to disclose.
Endovascular Therapy in Acute Ischemic Stroke
Start Time	Pub.	Title	Presenter
11:30 AM	044	Hemorrhagic Transformation Following Mechanical Thrombectomy in Acute Ischemic Stroke and Risk of Seizures.	Disclosure: Dr. El Alayli has nothing to disclose.
Child Neurology: Neurogenetics
Start Time	Pub.	Title	Presenter
11:30 AM	044	Novel autosomal recessive variants in GEMIN5 gene lead to developmental delay motor dysfunction, and cerebellar atrophy.	Disclosure: Dr. Rajan has nothing to disclose.
Huntington's Disease and Other Choreas
Start Time	Pub.	Title	Presenter
11:30 AM	044	Decreased cerebral blood flow in the striatum is an early event in Huntington’s disease pathology	Disclosure: Dr. Furr-Stimming has received personal compensation for consulting, serving on a scientific advisory board, speaking, or other activities with Medscape and TNS. Dr. Furr-Stimming has received research support from CHDI, Vaccinex, HDSA, ADAMAS, McGraw Hill.
General Neurology: Rare and Unusual Presentations of Neurologic Disease
Start Time	Pub.	Title	Presenter
11:30 AM	044	Eyes make Brain go Crazy	Disclosure: Dr. Hwang has nothing to disclose.
Inflammatory Neurological Complications of Systemic Disease
Start Time	Pub.	Title	Presenter
11:30 AM	045	Symptomatic Cerebrovascular Manifestations as presenting symptom for Neurosarcoidosis	Disclosure: Dr. Abu has nothing to disclose.
Large Vessel Occlusions: Detection, Epidemiology, and Outcomes
Start Time	Pub.	Title	Presenter
11:30 AM	045	SALVO- Speedy Detection of Large Vessel Occlusion - Ischemic Stroke in Hyper Acute Setting	Disclosure: Dr. Philip has nothing to disclose.
Child Neurology: Neurogenetics
Start Time	Pub.	Title	Presenter
11:30 AM	045	FOXG1 syndrome: A rare disorder often misdiagnosed as cerebral palsy	Disclosure: Dr. Lia has nothing to disclose.
Huntington's Disease and Other Choreas
Start Time	Pub.	Title	Presenter
11:30 AM	045	Electroconvulsive Therapy (ECT) for the Treatment of Refractory Depression in Huntington’s Disease Patients: A Case Series	Disclosure: Dr. Smith has nothing to disclose.
General Neurology: Rare and Unusual Presentations of Neurologic Disease
Start Time	Pub.	Title	Presenter
11:30 AM	045	Transient global amnesia and takotsubo cardiomyopathy: report of two cases and literature review	Disclosure: Dr. Valencia Sanchez has nothing to disclose.
Inflammatory Neurological Complications of Systemic Disease
Start Time	Pub.	Title	Presenter
11:30 AM	046	Neurosarcoidosis: Longitudinal Experience in a Single-Center, Academic Health Care System	Disclosure: Dr. Lord has nothing to disclose.
Large Vessel Occlusions: Detection, Epidemiology, and Outcomes
Start Time	Pub.	Title	Presenter
11:30 AM	046	A Clinical Paradigm for Classifying Neurologic Symptoms to Screen for Emergent Large Vessel Occlusions	Disclosure: Dr. Pollard has nothing to disclose.
Child Neurology: Neurogenetics
Start Time	Pub.	Title	Presenter
11:30 AM	046	Diversity of Epilepsy and Movement Disorder Phenotypes in STXBP1 Mutations	Disclosure: Dr. Haffner has nothing to disclose.
Huntington's Disease and Other Choreas
Start Time	Pub.	Title	Presenter
11:30 AM	046	Feasibility of Using a Smartphone Application to Evaluate Huntington Disease	Disclosure: Dr. Adams has nothing to disclose.
General Neurology: Rare and Unusual Presentations of Neurologic Disease
Start Time	Pub.	Title	Presenter
11:30 AM	046	Deaf, Confused and Blind: A Rare Presentation of Wernicke Encephalopathy	Disclosure: Dr. Gilani has nothing to disclose.
Inflammatory Neurological Complications of Systemic Disease
Start Time	Pub.	Title	Presenter
11:30 AM	047	Acute Motor-Sensory Axonal Neuropathy Associated with Systemic Lupus Erythematosus: A Challenge in Treatment	Disclosure: Dr. Thakolwiboon has nothing to disclose.
Large Vessel Occlusions: Detection, Epidemiology, and Outcomes
Start Time	Pub.	Title	Presenter
11:30 AM	047	Gaze Deviation on Initial CT as Predictor of Large Vessel Occlusion	Disclosure: Dr. Kulacz has nothing to disclose.
Child Neurology: Neurogenetics
Start Time	Pub.	Title	Presenter
11:30 AM	047	"Peer-to-Peer": A program to Connect a Clinical Genomicist and the Treating Neurologist to Correlate Genotype with Phenotype	Disclosure: Dr. Mintz has received personal compensation for consulting, serving on a scientific advisory board, speaking, or other activities with Philips-Electrical Geodesics and The Center for Neurological and Neurodevelopmental Health (CNNH). Dr. Mintz has received research support from Aquestive Therapeutics, Curemark, Eisai Inc., Impax Laboratories, Neurim Pharmaceuticals, Nuvelution Pharma Inc., PhenoSolve, Sunovion, and Teva.
Huntington's Disease and Other Choreas
Start Time	Pub.	Title	Presenter
11:30 AM	047	Ancillary Service Utilization and Impact in Huntington’s Disease	Disclosure: Dr. Yomtoob has nothing to disclose.
General Neurology: Rare and Unusual Presentations of Neurologic Disease
Start Time	Pub.	Title	Presenter
11:30 AM	047	A Representative Case of Spinocerebellar Ataxia Type 7	Disclosure: Dr. Margolesky has nothing to disclose.
Inflammatory Neurological Complications of Systemic Disease
Start Time	Pub.	Title	Presenter
11:30 AM	048	Neurobehçet presenting with sympathetic ophthalmia and pseudotumoral brainstem lesion in afro-american patient.	Disclosure: Dr. Carneiro has nothing to disclose.
Large Vessel Occlusions: Detection, Epidemiology, and Outcomes
Start Time	Pub.	Title	Presenter
11:30 AM	048	Risk factors for acute ischemic stroke caused by anterior large vessel occlusion	Disclosure: Dr. Adams has nothing to disclose.
Child Neurology: Neurogenetics
Start Time	Pub.	Title	Presenter
11:30 AM	048	Periodic Paralysis in the Phenotypic Spectrum of CLCN1 Gene Mutation	Disclosure: Dr. Patel has nothing to disclose.
Huntington's Disease and Other Choreas
Start Time	Pub.	Title	Presenter
11:30 AM	048	MRI Volumetric Analysis of 20 Early Manifest Huntington Disease Patients to Determine the Safety of Delivering Gene Therapy to the Striatum	Disclosure: Dr. Gill has received personal compensation for consulting, serving on a scientific advisory board, speaking, or other activities with UniQure and Renishaw. Dr. Gill has received research support from UniQure and Renishaw.
General Neurology: Rare and Unusual Presentations of Neurologic Disease
Start Time	Pub.	Title	Presenter
11:30 AM	048	Extending The Clinical Spectrum of Dejerine Sottas Syndrome: A new Family With Cognitive Impairment And Hearing Loss Carrying Trembler Mutation	Disclosure: Dr. Bouchachi has nothing to disclose.
Inflammatory Neurological Complications of Systemic Disease
Start Time	Pub.	Title	Presenter
11:30 AM	049	Progressive Multifocal Leukoencephalopathy Mimicking Acute Ischemic Stroke In A Patient With Idiopathic CD4 Lymphocytopenia	Disclosure: Dr. Kolikonda has nothing to disclose.
Large Vessel Occlusions: Detection, Epidemiology, and Outcomes
Start Time	Pub.	Title	Presenter
11:30 AM	049	How Much Does Atrial Fibrillation Contribute to Large Vessel Occlusions?	Disclosure: Dr. Seachrist has nothing to disclose.
Child Neurology: Neurogenetics
Start Time	Pub.	Title	Presenter
11:30 AM	049	Neurodegeneration and muscular involvement in intermediate autosomal recessive CLCN7-related Osteopetrosis: an atypical presentation	Disclosure: Dr. Durães has nothing to disclose.
Huntington's Disease and Other Choreas
Start Time	Pub.	Title	Presenter
11:30 AM	049	The Visual System in Huntington’s Disease	Disclosure: Dr. Hamedani has nothing to disclose.
General Neurology: Rare and Unusual Presentations of Neurologic Disease
Start Time	Pub.	Title	Presenter
11:30 AM	049	Syringomyelia with Cystic Fibrosis: A Case Report and Literature Review	Disclosure: Dr. Zhong has nothing to disclose.
Inflammatory Neurological Complications of Systemic Disease
Start Time	Pub.	Title	Presenter
11:30 AM	050	A Case of Multiple Cocaine-Induced Toxicities: Rash, Neuroleptic Malignant Syndrome, and Levamisole-Induced Leukoencephalopathy	Disclosure: Dr. Hurtubise has nothing to disclose.
Large Vessel Occlusions: Detection, Epidemiology, and Outcomes
Start Time	Pub.	Title	Presenter
11:30 AM	050	A Case Series of Seven Patients with Recurrent Large-Vessel Strokes within 72 Hours of the Initial Event.	Disclosure: Dr. Stefanowski has nothing to disclose.
Child Neurology: Neurogenetics
Start Time	Pub.	Title	Presenter
11:30 AM	050	CEDNIK syndrome, a rare neuro-cutaneous disorder	Disclosure: Dr. Tiwana has nothing to disclose.
Huntington's Disease and Other Choreas
Start Time	Pub.	Title	Presenter
11:30 AM	050	White matter microstructural alterations in Huntington Disease: when neurodegeneration starts?	Disclosure: Dr. Azevedo has nothing to disclose.
General Neurology: Rare and Unusual Presentations of Neurologic Disease
Start Time	Pub.	Title	Presenter
11:30 AM	050	Creutzfeldt Jakob (CJD) Disease presenting with Opthalmoplegia and Peripheral Neuropathy	Disclosure: Dr. Allam has nothing to disclose.
Inflammatory Neurological Complications of Systemic Disease
Start Time	Pub.	Title	Presenter
11:30 AM	051	Unusual presentations for Lupus: From Occular Oddities to Cauda Equina Nerve Root Enhancement	Disclosure: Dr. Salim Khan has nothing to disclose.
Large Vessel Occlusions: Detection, Epidemiology, and Outcomes
Start Time	Pub.	Title	Presenter
11:30 AM	051	Hyperviscosity in Acute Ischemic Stroke with Large Vessel Steno-occlusive Lesion	Disclosure: Dr. Lee has nothing to disclose.
Child Neurology: Neuromuscular Disease Trials: DMD and SMA
Start Time	Pub.	Title	Presenter
11:30 AM	051	Symptoms and Complications Over Three Years among Later Childhood, Adolescent and Adult Spinal Muscular Atrophy Patients: A Natural History Study within U.S. Hospitals	Disclosure: Dr. Paradis has received personal compensation for consulting, serving on a scientific advisory board, speaking, or other activities with Biogen. Dr. Paradis holds stock and/or stock options in Biogen.
Huntington's Disease and Other Choreas
Start Time	Pub.	Title	Presenter
11:30 AM	051	Allele Selective Antisense Oligonucleotides for Reducing Mutant Huntingtin	Disclosure: Dr. Brown has received personal compensation for consulting, serving on a scientific advisory board, speaking, or other activities with Wave Life Sciences. Dr. Brown has received compensation for serving on the Board of Directors of Wave Life Sciences. Dr. Brown has received research support from Wave Life Sciences.
General Neurology: Rare and Unusual Presentations of Neurologic Disease
Start Time	Pub.	Title	Presenter
11:30 AM	051	A Case of a Cervical Pannus Without Rheumatoid Arthritis or Trauma	Disclosure: Dr. Beshai has nothing to disclose.
Inflammatory Neurological Complications of Systemic Disease
Start Time	Pub.	Title	Presenter
11:30 AM	052	Acute transverse myelitis revealing primary biliary cirrhosis	Disclosure: Dr. Chtourou has nothing to disclose.
Large Vessel Occlusions: Detection, Epidemiology, and Outcomes
Start Time	Pub.	Title	Presenter
11:30 AM	052	Time-Domain Near Infrared Spectroscopy in Acute Ischemic Stroke Patients with Different Sites of Large Vessel Occlusion.	Disclosure: Dr. Giacalone has nothing to disclose.
Child Neurology: Neuromuscular Disease Trials: DMD and SMA
Start Time	Pub.	Title	Presenter
11:30 AM	052	Treatment Algorithm for Infants Diagnosed with Spinal Muscular Atrophy Through Newborn Screening	Disclosure: Dr. Glascock has nothing to disclose.
Huntington's Disease and Other Choreas
Start Time	Pub.	Title	Presenter
11:30 AM	052	Generalized Chorea and JAK2V617F Mutation-Positive Myeloproliferative Disorders: A Case Report and Literature Review	Disclosure: Dr. Bette has received personal compensation for consulting, serving on a scientific advisory board, speaking, or other activities with Lundbeck.
General Neurology: Rare and Unusual Presentations of Neurologic Disease
Start Time	Pub.	Title	Presenter
11:30 AM	052	Cerebral Angiolipoma of the Parietal Region Presenting as Olfactory Hallucinations	Disclosure: Dr. Achari has nothing to disclose.
Inflammatory Neurological Complications of Systemic Disease
Start Time	Pub.	Title	Presenter
11:30 AM	053	Neurologic Involvement in Progressive Hemifacial Atrophy: A Case Report Focused Review	Disclosure: Dr. Owens has nothing to disclose.
Large Vessel Occlusions: Detection, Epidemiology, and Outcomes
Start Time	Pub.	Title	Presenter
11:30 AM	053	Frequency of Guideline-Ineligible Large Vessel Occlusion Strokes	Disclosure: Dr. Desai has nothing to disclose.
Child Neurology: Neuromuscular Disease Trials: DMD and SMA
Start Time	Pub.	Title	Presenter
11:30 AM	053	Motor Outcomes after Clinical Treatment with Nusinersen: A Single-center Experience	Disclosure: Dr. Kichula has received personal compensation for consulting, serving on a scientific advisory board, speaking, or other activities with PTC Therapeutics, Biogen, Stealth BioTherapeutics.
Huntington's Disease and Other Choreas
Start Time	Pub.	Title	Presenter
11:30 AM	053	Chorea after West Nile Virus Encephalitis: A Case Report	Disclosure: Dr. Kirby has nothing to disclose.
General Neurology: Rare and Unusual Presentations of Neurologic Disease
Start Time	Pub.	Title	Presenter
11:30 AM	053	Diabetic striatopathy; An uncommon cause of stroke-like symptoms	Disclosure: Dr. Hussaini has nothing to disclose.
Carotid Disease
Start Time	Pub.	Title	Presenter
11:30 AM	054	One Year Follow-Up after Elective Carotid Artery Stenting in 720 Patients: A Single Centre Experience	Disclosure: Dr. Pamidimukkala has nothing to disclose.
Inflammatory Neurological Complications of Systemic Disease
Start Time	Pub.	Title	Presenter
11:30 AM	054	Longitudinally Extensive Dorsal Column Lesion in a Patient with Longstanding Anti-Hu and Anti-Amphphysin Autoimmunity	Disclosure: Dr. Aljarallah has nothing to disclose.
Child Neurology: Neuromuscular Disease Trials: DMD and SMA
Start Time	Pub.	Title	Presenter
11:30 AM	054	The Economic Burden of Spinal Muscular Atrophy Patients in a Commercially-Insured Population in the United States	Disclosure: Dr. Goble has received personal compensation for consulting, serving on a scientific advisory board, speaking, or other activities with Janssen Scientific Affairs LLC.
General Neurology: Rare and Unusual Presentations of Neurologic Disease
Start Time	Pub.	Title	Presenter
11:30 AM	054	Paraplegia on vacation: Surfer’s myelopathy variant	Disclosure: Dr. Alzahrany has nothing to disclose.
Carotid Disease
Start Time	Pub.	Title	Presenter
11:30 AM	055	Difference in Outcomes in Patients with Carotid Stenting With and Without Balloon Angioplasty	Disclosure: Dr. Bodhit has nothing to disclose.
Neuroinflammatory Complications of Systemic Disease: Sarcoid, Behcet, & CLIPPERS
Start Time	Pub.	Title	Presenter
11:30 AM	055	MRI Analysis in 54 Cases of Sarcoidosis-associated Myelitis Identifies Characteristic Imaging Features and Clues to Pathogenesis	Disclosure: Dr. Murphy has nothing to disclose.
Child Neurology: Neuromuscular Disease Trials: DMD and SMA
Start Time	Pub.	Title	Presenter
11:30 AM	055	Effect of Aggressive Therapies on Spinal Muscular Atrophy Type 1 Patients Receiving Nusinersen	Disclosure: Dr. Tiongson has nothing to disclose.
General Neurology: Rare and Unusual Presentations of Neurologic Disease
Start Time	Pub.	Title	Presenter
11:30 AM	055	Myasthenia Gravis Presenting as Recurrent Falls in a Young Man	Disclosure: Dr. McHugh has nothing to disclose.
Carotid Disease
Start Time	Pub.	Title	Presenter
11:30 AM	056	Baseline Physical Activity Profiles in CREST-2 Trial Participants	Disclosure: Dr. Chaturvedi has received personal compensation in an editorial capacity for NEJM Journal Watch Neurology. Dr. Chaturvedi has received research support from Boehringer Ingelheim.
Neuroinflammatory Complications of Systemic Disease: Sarcoid, Behcet, & CLIPPERS
Start Time	Pub.	Title	Presenter
11:30 AM	056	Diagnosis and Management of Pachymeningitis	Disclosure: Dr. Wood has nothing to disclose.
Child Neurology: Neuromuscular Disease Trials: DMD and SMA
Start Time	Pub.	Title	Presenter
11:30 AM	056	Number Needed to Treat (NNT) in Spinal Muscular Atrophy Type 1 (SMA1) with AVXS-101 Relative to Nusinersen	Disclosure: Dr. Droege has received personal compensation for consulting, serving on a scientific advisory board, speaking, or other activities with AveXis, Inc.
General Neurology: Rare and Unusual Presentations of Neurologic Disease
Start Time	Pub.	Title	Presenter
11:30 AM	056	Sensory Neuropathy with Orthostatic Fainting: Transthyretin-related Amyloid Polyneuropathy	Disclosure: Dr. Heide has received personal compensation for consulting, serving on a scientific advisory board, speaking, or other activities with Dr. Willmar Schwabe GmbH, Karlsruhe, Germany.
Carotid Disease
Start Time	Pub.	Title	Presenter
11:30 AM	057	Carotid Plaque Characteristics Correlated to Baseline Vascular Risk Factors in a Large Randomized Trial: Results from CREST-2	Disclosure: Dr. Lal has nothing to disclose.
Neuroinflammatory Complications of Systemic Disease: Sarcoid, Behcet, & CLIPPERS
Start Time	Pub.	Title	Presenter
11:30 AM	057	Rare Case of Autoimmune GFAP Astrocytopathy-Associated LETM	Disclosure: Dr. Gadani has nothing to disclose.
Child Neurology: Neuromuscular Disease Trials: DMD and SMA
Start Time	Pub.	Title	Presenter
11:30 AM	057	AVXS-101 Gene-Replacement Therapy (GRT) in Presymptomatic Spinal Muscular Atrophy (SMA): Study Update	Disclosure: Dr. Schultz has received personal compensation for consulting, serving on a scientific advisory board, speaking, or other activities with AveXis, Inc. and Biogen. Dr. Schultz has received research support from AveXis, Inc.
General Neurology: Rare and Unusual Presentations of Neurologic Disease
Start Time	Pub.	Title	Presenter
11:30 AM	057	A Rare Case of Acute Inflammatory Demyelinating Polyradiculoneuropathy (AIDP) with Hyperreflexia in North America	Disclosure: Dr. Weng has nothing to disclose.
Carotid Disease
Start Time	Pub.	Title	Presenter
11:30 AM	058	Control of Blood Pressure Following Carotid Artery Stenting: Is it Baroreceptor Resetting?	Disclosure: Dr. Pamidimukkala has nothing to disclose.
Neuroinflammatory Complications of Systemic Disease: Sarcoid, Behcet, & CLIPPERS
Start Time	Pub.	Title	Presenter
11:30 AM	058	CSF Cytokine Profile In definite Neuro-behcet Disease	Disclosure: Dr. Kchaou has nothing to disclose.
Child Neurology: Neuromuscular Disease Trials: DMD and SMA
Start Time	Pub.	Title	Presenter
11:30 AM	058	AVXS-101 Gene-Replacement Therapy (GRT) for Spinal Muscular Atrophy Type 1 (SMA1): Pivotal Phase 3 Study (STR1VE) Update	Disclosure: Dr. Day has received personal compensation for consulting, serving on a scientific advisory board, speaking, or other activities with AMO, Audentes, AveXis, Biogen, Cytokinetics, Santhera, and Sarepta. Dr. Day has received research support from AveXis, Biogen, Cytokinetics, Genzyme, Ionis, Roche, Santhera, and Sarepta.
General Neurology: Rare and Unusual Presentations of Neurologic Disease
Start Time	Pub.	Title	Presenter
11:30 AM	058	A Case of Sporadic Erythromelalgia Presenting with Small Fiber Neuropathy	Disclosure: Dr. Patel has nothing to disclose.
Carotid Disease
Start Time	Pub.	Title	Presenter
11:30 AM	059	No Association Between Carotid Artery Atherosclerosis and Hyoid Proximity: Results from a Cross-sectional and Longitudinal Cohort Study	Disclosure: Dr. Siegler has nothing to disclose.
Neuroinflammatory Complications of Systemic Disease: Sarcoid, Behcet, & CLIPPERS
Start Time	Pub.	Title	Presenter
11:30 AM	059	Stroke Diagnosis and Treatment Patterns in Patients with Multiple Sclerosis	Disclosure: Dr. Melamed has nothing to disclose.
Child Neurology: Neuromuscular Disease Trials: DMD and SMA
Start Time	Pub.	Title	Presenter
11:30 AM	059	Phase 1 Study of Intrathecal Administration of AVXS-101 Gene-Replacement Therapy (GRT) for Spinal Muscular Atrophy Type 2 (SMA2) (STRONG)	Disclosure: Dr. Finkel has received personal compensation for consulting, serving on a scientific advisory board, speaking, or other activities with AveXis, Biogen, Capricor, Catabasis, Ionis, Neurogene, Novartis, ReveraGen, Roche, Sarepta. . Dr. Finkel has received personal compensation in an editorial capacity for Elsevier (Swaiman's Pediatric Neurology textbook).. Dr. Finkel has received royalty, license fees, or contractual rights payments from Children's Hospital of Philadelphia (CHOP INTEND licensing fees). Dr. Finkel has received research support from AveXis, Biogen, Catabasis, Capricor, Italfaramaco, Pfizer, ReveraGen, Roche, Summit.
General Neurology: Rare and Unusual Presentations of Neurologic Disease
Start Time	Pub.	Title	Presenter
11:30 AM	059	Unusual Respiratory Manifestation in a Patient with Stiff Person Syndrome (SPS)	Disclosure: Dr. Lin has nothing to disclose.
Carotid Disease
Start Time	Pub.	Title	Presenter
11:30 AM	060	Carotid Revascularization and Medical Management for Asymptomatic Carotid Stenosis: CREST-2 Update	Disclosure: Dr. Meschia has nothing to disclose.
Neuroinflammatory Complications of Systemic Disease: Sarcoid, Behcet, & CLIPPERS
Start Time	Pub.	Title	Presenter
11:30 AM	060	Differential Diagnosis in Late Onset Multiple Sclerosis	Disclosure: Dr. Yorio has nothing to disclose.
Child Neurology: Neuromuscular Disease Trials: DMD and SMA
Start Time	Pub.	Title	Presenter
11:30 AM	060	The Value of AVXS-101 Gene Replacement Therapy for Spinal Muscular Atrophy Type 1: Improved Survival, Pulmonary and Nutritional Support, and Motor Function with Decreased Hospitalization	Disclosure: Dr. Dabbous has received personal compensation for consulting, serving on a scientific advisory board, speaking, or other activities with AveXis, Inc.
General Neurology: Rare and Unusual Presentations of Neurologic Disease
Start Time	Pub.	Title	Presenter
11:30 AM	060	Intravascular Lymphoma: A Rare Cause of Rapidly Progressive Myelopathy	Disclosure: Dr. Krause has nothing to disclose.
Carotid Disease
Start Time	Pub.	Title	Presenter
11:30 AM	061	Cognitive Profile in Patients with Hemodynamic Failure due to Severe Carotid Stenosis	Disclosure: Dr. Palmer has nothing to disclose.
Neuroinflammatory Complications of Systemic Disease: Sarcoid, Behcet, & CLIPPERS
Start Time	Pub.	Title	Presenter
11:30 AM	061	When Occam’s Razor Fails: A McArdle Disease Diagnosis Following Idiopathic Transverse Myelitis	Disclosure: Dr. Chen has nothing to disclose.
Child Neurology: Neuromuscular Disease Trials: DMD and SMA
Start Time	Pub.	Title	Presenter
11:30 AM	061	Ambulation Status, Role Participation and Caregiver Assistance among Individuals with Spinal Muscular Atrophy Type III: Results from the 2018 Cure SMA Membership Survey	Disclosure: Dr. Belter has nothing to disclose.
General Neurology: Rare and Unusual Presentations of Neurologic Disease
Start Time	Pub.	Title	Presenter
11:30 AM	061	It's on the tip of my tongue! Prolonged paresthesia of the tongue after dental procedure	Disclosure: Dr. Salim Khan has nothing to disclose.
Carotid Disease
Start Time	Pub.	Title	Presenter
11:30 AM	062	Carotid Web in patients with Carotid Stenosis and Stroke of Undetermined Etiology	Disclosure: Dr. Sharma has nothing to disclose.
Neuroinflammatory Complications of Systemic Disease: Sarcoid, Behcet, & CLIPPERS
Start Time	Pub.	Title	Presenter
11:30 AM	062	Case Series of Sarcoid Myelitis Masquerading as Disc-Related Compression Myelopathy	Disclosure: Dr. Gluck has nothing to disclose.
Child Neurology: Neuromuscular Disease Trials: DMD and SMA
Start Time	Pub.	Title	Presenter
11:30 AM	062	A Phase 1b/2 Study of the Anti-Myostatin Adnectin RG6206 (BMS-986089) in Ambulatory Boys with Duchenne Muscular Dystrophy: A 72-Week Treatment Update	Disclosure: Dr. Wagner has received personal compensation for consulting, serving on a scientific advisory board, speaking, or other activities with Sarepta, Wave, Fibrogen, Dynacure, Lion, and PTC Therapeutics. Dr. Wagner has received research support from Pfizer, Roche, and Sarepta.
Research Methodology, Clinical Outcome and Quality Improvement
Start Time	Pub.	Title	Presenter
11:30 AM	062	Literature Bias in Alzheimer's Disease Research: An Exploration of Factors Influencing Treatment Outcomes	Disclosure: Dr. Spear has received personal compensation for consulting, serving on a scientific advisory board, speaking, or other activities with MedAware Systems, Inc. Dr. Spear holds stock and/or stock options in MedAware Systems, Inc. which sponsored research in which Dr. Spear was involved as an investigator. Dr. Spear has received research support from MedAware Systems, Inc..
Carotid Disease
Start Time	Pub.	Title	Presenter
11:30 AM	063	Platelet YES1, PIK3CB, and GNA14 Expression Correlates with Coated-Platelet Levels in Asymptomatic Internal Carotid Stenosis	Disclosure: Dr. Kirkpatrick has nothing to disclose.
Neuroinflammatory Complications of Systemic Disease: Sarcoid, Behcet, & CLIPPERS
Start Time	Pub.	Title	Presenter
11:30 AM	063	Hypertrophic Cervical Spine Pachymeningitis due to Sarcoidosis: A Case Report	Disclosure: Dr. Mehta has nothing to disclose.
Child Neurology: Neuromuscular Disease Trials: DMD and SMA
Start Time	Pub.	Title	Presenter
11:30 AM	063	Interim Report on the Safety and Efficacy of Longer-term Treatment With Nusinersen in Later-onset Spinal Muscular Atrophy (SMA): Results From the SHINE Study	Disclosure: Dr. Darras has received personal compensation for consulting, serving on a scientific advisory board, speaking, or other activities with AveXis, Biogen, Bristol-Myers Squibb, Cytokinetics, Marathon, PTC Therapeutics, Roche, Santhera, and Sarepta. Dr. Darras has received research support from the National Institutes of Health/National Institute of Neurological Disorders and Stroke, the Slaney Family Fund for SMA, Working on Walking Fund, the SMA Foundation, CureSMA, Ionis Pharmaceuticals, Inc., Biogen, AveXis, Cytokinetics, Fibrogen, PTC Therapeutics, Roche, Santhera, Sarepta, and Summit.
Research Methodology, Clinical Outcome and Quality Improvement
Start Time	Pub.	Title	Presenter
11:30 AM	063	Improving Hospital Discharge Time of Patients Admitted to Pediatric Neurology	Disclosure: Dr. Eksambe has nothing to disclose.
Carotid Disease
Start Time	Pub.	Title	Presenter
11:30 AM	064	Characterization and Validation of Somatosensory Evoked Potential Morphology during Carotid Endarterectomy to Detect Stroke	Disclosure: Dr. Jorge has nothing to disclose.
Neuroinflammatory Complications of Systemic Disease: Sarcoid, Behcet, & CLIPPERS
Start Time	Pub.	Title	Presenter
11:30 AM	064	Vanishing “Trident Sign” in Recurrent Sarcoid Myelitis Treated with Rituximab	Disclosure: Dr. Li has received personal compensation for consulting, serving on a scientific advisory board, speaking, or other activities with Bristol-Myers Squibb Company. Dr. Li holds stock and/or stock options in Bristol-Myers Squibb Company which sponsored research in which Dr. Li was involved as an investigator. .
Child Neurology: Neuromuscular Disease Trials: DMD and SMA
Start Time	Pub.	Title	Presenter
11:30 AM	064	Clinical and Electrophysiological outcomes of Spinal Muscular Atrophy type 1 patients treated with Nusinersen.	Disclosure: Dr. Kern-Smith has nothing to disclose.
Research Methodology, Clinical Outcome and Quality Improvement
Start Time	Pub.	Title	Presenter
11:30 AM	064	Precision Medicine of Subarachnoid Hemorrhage Management for Early-Hospital-Discharge: Safety, Feasibility, and Secondary Value-Based Health Economic Outcomes	Disclosure: Dr. Hasan has nothing to disclose.
Carotid Disease
Start Time	Pub.	Title	Presenter
11:30 AM	065	Slowly Progressive, Acquired Hemicerebral Atrophy Secondary to Chronic Internal Carotid Vascular Disease Mimicking Neurodegenerative Disease	Disclosure: Dr. Vitt has nothing to disclose.
Neuroinflammatory Complications of Systemic Disease: Sarcoid, Behcet, & CLIPPERS
Start Time	Pub.	Title	Presenter
11:30 AM	065	CLIPPERS Syndrome: Case Report in a patient from Southern Colombia.	Disclosure: Dr. Herrera-Céspedes has nothing to disclose.
Child Neurology: Neuromuscular Disease Trials: DMD and SMA
Start Time	Pub.	Title	Presenter
11:30 AM	065	Case Series: Spinal Muscular Atrophy Patients’ Response to Nusinersen in a Caribbean Cohort	Disclosure: Dr. Montalvo has nothing to disclose.
Research Methodology, Clinical Outcome and Quality Improvement
Start Time	Pub.	Title	Presenter
11:30 AM	065	Child Neurology Consult Service Quality Improvement Project at a large Children's Hospital	Disclosure: Dr. Kaul has nothing to disclose.
Carotid Disease
Start Time	Pub.	Title	Presenter
11:30 AM	066	‘On-treatment platelet reactivity' under both high and low shear stress conditions and relationship with cerebral micro-embolic signals in asymptomatic and symptomatic carotid stenosis: Results from the HaEmostasis In carotid STenosis(HEIST) study.	Disclosure: Dr. Murphy has nothing to disclose.
Neuroinflammatory Complications of Systemic Disease: Sarcoid, Behcet, & CLIPPERS
Start Time	Pub.	Title	Presenter
11:30 AM	066	A travelling salesman’s long journey toward a diagnosis of neurosarcoidosis	Disclosure: Dr. Osman has nothing to disclose.
Child Neurology: Neuromuscular Disease Trials: DMD and SMA
Start Time	Pub.	Title	Presenter
11:30 AM	066	Deflazacort or Prednisone Treatment for Duchenne Muscular Dystrophy: A Meta-Analysis of Disease Progression Rates in Recent Multicenter Clinical Trials	Disclosure: Dr. Signorovitch has received personal compensation for consulting, serving on a scientific advisory board, speaking, or other activities with Analysis Group Inc.
Research Methodology, Clinical Outcome and Quality Improvement
Start Time	Pub.	Title	Presenter
11:30 AM	066	Neurofilament light test results vary substantially across different assay platforms and assay reagents	Disclosure: Dr. Deisenhammer has received personal compensation for consulting, serving on a scientific advisory board, speaking, or other activities with Biogen, Celgene, Genzyme, Merck, Novartis, Roche. Dr. Deisenhammer has received research support from by Biogen and Genzyme-Sanofi..
Neuroinflammatory Complications of Systemic Disease: Sarcoid, Behcet, & CLIPPERS
Start Time	Pub.	Title	Presenter
11:30 AM	067	Adult-Onset Fulminant Necrotizing Encephalitis: A Rare Variant of Neurosarcoidosis	Disclosure: Dr. Thuringer has nothing to disclose.
Child Neurology: Neuromuscular Disease Trials: DMD and SMA
Start Time	Pub.	Title	Presenter
11:30 AM	067	Effect of Ataluren on Age at Loss of Ambulation in Nonsense Mutation Duchenne Muscular Dystrophy: Observational Data from the STRIDE Registry	Disclosure: Dr. Delage his a full-rime employee of PTC Therapeutics , Switzerland, GmBH Dr. Delage holds stock and/or stock options in PTC Therapeutics, Inc, which sponsored research in which Dr. Delage was involved as an investigator.
Research Methodology, Clinical Outcome and Quality Improvement
Start Time	Pub.	Title	Presenter
11:30 AM	067	Development of a Conceptual Model to Inform a Clinical Outcome Assessment Strategy in Adolescents and Young Adults with Fragile X Syndrome	Disclosure: Dr. Lee has received personal compensation for consulting serving on a scientific advisory board speaking or other activities with Ovid Therapeutics. Dr. Lee has received compensation for serving on the Board of Directors of Ovid Therapeutics. Dr. Lee holds stock and For stock options in Ovid Therapeutics which sponsored research in which Dr. Lee was involved as an investigator.
Neuroinflammatory Complications of Systemic Disease: Sarcoid, Behcet, & CLIPPERS
Start Time	Pub.	Title	Presenter
11:30 AM	068	Brucellosis Presenting as a Longitudinally Extensive Transverse Myelitis	Disclosure: Dr. Yamout has received personal compensation for consulting, serving on a scientific advisory board, speaking, or other activities with Bayer, Biogen, Genpharm, Genzyme, Merck-Serono, Novartis. Dr. Yamout has received research support from Bayer, Biogen, Merck-Serono, Novartis, Pfizer.
Child Neurology: Neuromuscular Disease Trials: DMD and SMA
Start Time	Pub.	Title	Presenter
11:30 AM	068	Early signs of gross motor delay in very young boys with Duchenne muscular dystrophy	Disclosure: Dr. Miller has nothing to disclose.
Research Methodology, Clinical Outcome and Quality Improvement
Start Time	Pub.	Title	Presenter
11:30 AM	068	mHealth Interventions: Lots on the Market but are they Studied? An Analysis of mHealth Interventions for Neuropsychiatric Conditions	Disclosure: Dr. Reichel has nothing to disclose.
Neuroinflammatory Complications of Systemic Disease: Sarcoid, Behcet, & CLIPPERS
Start Time	Pub.	Title	Presenter
11:30 AM	069	Co-ocurrence of Neurosarcoidosis and Intrathecal Reactivation of Epstein-Barr Virus	Disclosure: Dr. Salazar has nothing to disclose.
Child Neurology: Neuromuscular Disease Trials: DMD and SMA
Start Time	Pub.	Title	Presenter
11:30 AM	069	Developing Tools to Assess Changes Associated with Aerobic Exercise in Boys with Duchenne Muscular Dystrophy	Disclosure: Dr. Zelikovich has nothing to disclose.
Research Methodology, Clinical Outcome and Quality Improvement
Start Time	Pub.	Title	Presenter
11:30 AM	069	The Mayo Clinic Center for MS and Autoimmune Neurology Biorepository (CMSAN): Infrastructure Development	Disclosure: Dr. Sagen has nothing to disclose.
NMOSDs and Autoimmune (AQP4/MOG) Gliopathies
Start Time	Pub.	Title	Presenter
11:30 AM	070	Transverse myelitis presentation and outcomes at the Kansas University Health System	Disclosure: Dr. Siwoski has nothing to disclose.
Child Neurology: Neuromuscular Disease Trials: DMD and SMA
Start Time	Pub.	Title	Presenter
11:30 AM	070	Travel Burden of Spinal Muscular Atrophy Patients in the United States	Disclosure: Dr. Goble has received personal compensation for consulting, serving on a scientific advisory board, speaking, or other activities with Janssen Scientific Affairs LLC.
Research Methodology, Clinical Outcome and Quality Improvement
Start Time	Pub.	Title	Presenter
11:30 AM	070	Work Productivity Activity Impairment Results from the Cure SMA 2018 Community Update Survey	Disclosure: Dr. Belter has nothing to disclose.
NMOSDs and Autoimmune (AQP4/MOG) Gliopathies
Start Time	Pub.	Title	Presenter
11:30 AM	071	Spinal Cord Atrophy in Neuromyelitis Optica Is Associated to Spinal Cord Lesions and Clinical Disability	Disclosure: Dr. Cacciaguerra has nothing to disclose.
Research Methodology, Clinical Outcome and Quality Improvement
Start Time	Pub.	Title	Presenter
11:30 AM	071	The Successful Use of Internal Research Funding as a Catalyst to Achieve External Grant Support	Disclosure: Dr. Wang has nothing to disclose.
NMOSDs and Autoimmune (AQP4/MOG) Gliopathies
Start Time	Pub.	Title	Presenter
11:30 AM	072	Clinical determinants and therapeutic modifiers of relapse and disability outcomes in neuromyelitis optica spectrum disorder	Disclosure: Dr. Kunchok has received research support from Biogen for a previous research fellowship ending May 2018.
Research Methodology, Clinical Outcome and Quality Improvement
Start Time	Pub.	Title	Presenter
11:30 AM	072	Strategizing Clinical Trial Recruitment in the Digital Age	Disclosure: Dr. Agarwal has received personal compensation for consulting, serving on a scientific advisory board, speaking, or other activities with ADAMAS, Cerecor, US WorldMeds. Dr. Agarwal has received research support from Astellas, Merck.
NMOSDs and Autoimmune (AQP4/MOG) Gliopathies
Start Time	Pub.	Title	Presenter
11:30 AM	073	Global and Regional Hippocampal Volumes Are Preserved in Neuromyelitis Optica and Do not Seem to Be Related to Cognitive Impairment	Disclosure: Dr. Cacciaguerra has nothing to disclose.
Research Methodology, Clinical Outcome and Quality Improvement
Start Time	Pub.	Title	Presenter
11:30 AM	073	Methodology for Development of Indication-Specific Outcome Measures in Rare Disease Trials: An innovative research approach	Disclosure: Dr. Ventola has received personal compensation for consulting, serving on a scientific advisory board, speaking, or other activities with Takeda; Roche Pharmaceuticals. Dr. Ventola has received royalty, license fees, or contractual rights payments from Wiley Publishing.
NMOSDs and Autoimmune (AQP4/MOG) Gliopathies
Start Time	Pub.	Title	Presenter
11:30 AM	074	A Global Atlas of NMO Diagnosis and Treatment Practices	Disclosure: Dr. Holroyd has nothing to disclose.
Research Methodology and Education: Patient and Continuing Medical Education
Start Time	Pub.	Title	Presenter
11:30 AM	074	Cannabinoid-Based Therapeutics in Epilepsy: An Assessment of Knowledge and Attitudes of Neurologists, Pediatricians, and PCPs	Disclosure: Dr. Finnegan has nothing to disclose.
NMOSDs and Autoimmune (AQP4/MOG) Gliopathies
Start Time	Pub.	Title	Presenter
11:30 AM	075	Neuromyelitis optica spectrum disorders: The evaluation of 66 patients followed by Istanbul Bilim University, Department of Neurology	Disclosure: Dr. Altunrende has nothing to disclose.
Research Methodology and Education: Patient and Continuing Medical Education
Start Time	Pub.	Title	Presenter
11:30 AM	075	Neurophobia, a Worldwide Concern for Neurology Training: A Systematic Review.	Disclosure: Dr. Moreno-Zambrano has nothing to disclose.
NMOSDs and Autoimmune (AQP4/MOG) Gliopathies
Start Time	Pub.	Title	Presenter
11:30 AM	076	A Curious Case of Bilateral Optic Neuropathy!	Disclosure: Dr. Abdalla has nothing to disclose.
Research Methodology and Education: Patient and Continuing Medical Education
Start Time	Pub.	Title	Presenter
11:30 AM	076	CME-Certified Timed, Rapid Fire Debate of Hot Topics in MS Improves Awareness of Diagnostic and Therapeutic Data Among Neurologists and Primary Care Physicians	Disclosure: Dr. Finnegan has nothing to disclose.
11:30 AM	077	The development of an evidence- and consensus-based approach to the neurologic examination	Disclosure: Dr. Hillis has received research support from GE Healthcare.
NMOSDs and Autoimmune (AQP4/MOG) Gliopathies
Start Time	Pub.	Title	Presenter
11:30 AM	078	A case of primary CNS lymphoma associated with neuromyelitis optica spectrum disorder: Is there a paraneoplastic link?	Disclosure: Dr. Garrido Sanabria has nothing to disclose.
Research Methodology and Education: Patient and Continuing Medical Education
Start Time	Pub.	Title	Presenter
11:30 AM	078	Addressing Gaps in MS Patient Care Via Personalized Continuing Education	Disclosure: Dr. Robinson has received personal compensation for consulting, serving on a scientific advisory board, speaking, or other activities with Vindico Medical Education.
NMOSDs and Autoimmune (AQP4/MOG) Gliopathies
Start Time	Pub.	Title	Presenter
11:30 AM	079	Myelitis Associated with Systemic Lupus Erythematous: Is it Lupus Myelitis, Neuromyelitis Optica, or Multiple Sclerosis?	Disclosure: Dr. Proebstel has nothing to disclose.
Research Methodology and Education: Patient and Continuing Medical Education
Start Time	Pub.	Title	Presenter
11:30 AM	079	Bed Side to Web Side Neurological Care	Disclosure: Dr. Jens has nothing to disclose.
NMOSDs and Autoimmune (AQP4/MOG) Gliopathies
Start Time	Pub.	Title	Presenter
11:30 AM	080	Transverse Myelitis: Lyme Disease or MOG-Antibody Associated Demyelination?	Disclosure: Dr. Zarghami has nothing to disclose.
Research Methodology and Education: Patient and Continuing Medical Education
Start Time	Pub.	Title	Presenter
11:30 AM	080	Social Media’s Impact on Stroke Education	Disclosure: Dr. Goswami has nothing to disclose.
NMOSDs and Autoimmune (AQP4/MOG) Gliopathies
Start Time	Pub.	Title	Presenter
11:30 AM	081	Clinically Isolated Demyelinating Syndrome Associated with Anti-MOG Antibody	Disclosure: Dr. Schmalstieg has nothing to disclose.
Research Methodology and Education: Patient and Continuing Medical Education
Start Time	Pub.	Title	Presenter
11:30 AM	081	Neurological and neuroscience education: mitigating neurophobia to mentor health care providers	Disclosure: Dr. Sandrone has nothing to disclose.
Neuroscience Research Prize Recipients
Start Time	Pub.	Title	Presenter
	082	Quantitative Analysis of Mechanical Impact using a Cellular Vibrational Model of Differentiated Neuroblastoma Cells	Caleb Shi Disclosure: Dr. Shi has nothing to disclose.
NMOSDs and Autoimmune (AQP4/MOG) Gliopathies
Start Time	Pub.	Title	Presenter
11:30 AM	082	Neuromyelitis Optica Spectrum Disorder : is it different in Morocco ?	Disclosure: Dr. Bennis has nothing to disclose.
Neuroscience Research Prize Recipients
Start Time	Pub.	Title	Presenter
	083	Characterizing the source of microglia proliferation after ischemic preconditioning	Rachel Chernoff Disclosure:
NMOSDs and Autoimmune (AQP4/MOG) Gliopathies
Start Time	Pub.	Title	Presenter
11:30 AM	083	Epidemiology of NeuromyelitisOptica Spectrum DisordersPatients in Kuwait.	Disclosure: Dr. Ahmed has nothing to disclose.
Neuroscience Research Prize Recipients
Start Time	Pub.	Title	Presenter
	084	A Novel Mechanism by which 4-Nonylphenol Accelerates Alzheimer’s Pathogenesis and Induces both Tau-amyloid Mediated Toxicity and Neuroinflammation	Kevin Zhong Disclosure: Dr. Zhong has nothing to disclose.
NMOSDs and Autoimmune (AQP4/MOG) Gliopathies
Start Time	Pub.	Title	Presenter
11:30 AM	084	Beneficial Effects of High-dose Biotin (MD1003) in Models of X-linked adrenoleukodystrophy	Disclosure: Dr. Fourcade has nothing to disclose.
Neuroscience Research Prize Recipients
Start Time	Pub.	Title	Presenter
	085	Staying Ahead of the Hit: Can Therapeutic Hypothermia Diminish the Impact of Traumatic Brain Injury in Drosophila Melanogaster?	Shan Lateef Disclosure: Dr. Lateef has nothing to disclose.
NMOSDs and Autoimmune (AQP4/MOG) Gliopathies
Start Time	Pub.	Title	Presenter
11:30 AM	085	SARM1 Loss of Function in Chronic and Acute CNS Axonopathies	Disclosure: Dr. Krauss has received personal compensation for consulting, serving on a scientific advisory board, speaking, or other activities with Disarm Therapeutics. Dr. Krauss holds stock and/or stock options in Disarm Therapeutics which sponsored research in which Dr. Krauss was involved as an investigator. Dr. Krauss has received research support from Disarm Therapeutics.
11:30 AM	086	Thalamic subregions and visual function changes in NMOSD and RRMS patients using 7T MRI	Disclosure: Dr. Chien has nothing to disclose.
Autoimmune Neurology: Basic Science: New Directions
Start Time	Pub.	Title	Presenter
11:30 AM	087	Regulatory T cells in the CNS Impact Microglia Instead of Lymphocytes	Disclosure: Dr. Bittner has nothing to disclose.
11:30 AM	088	Novel approaches for the establishment of transgenic T-cell-receptor experimental autoimmune neuritis in mice	Disclosure: Dr. Sgodzai has nothing to disclose.
11:30 AM	089	Alpha-Tocopherol Ameliorates Experimental Autoimmune Neuritis	Disclosure: Dr. Kihara has nothing to disclose.
11:30 AM	090	Immunomodulatory Effects of Bortezomib in Experimental Autoimmune Neuritis in Lewis rats	Disclosure: Dr. Klimas has nothing to disclose.
11:30 AM	091	IL-4 Receptor Signaling is Relevant for Brain Homeostasis	Disclosure: Dr. Zipp has nothing to disclose.
11:30 AM	092	Oxidized Albumin in Acute Ischemic Stroke is Associated With Better Outcomes	Disclosure: Dr. Salottolo has nothing to disclose.
11:30 AM	093	In vitro Microglia Cell Line and Human Mesenchymal Stem Cells Viability IS Inhibited by Hydrogen Gas	Disclosure: Dr. Chen has nothing to disclose.
11:30 AM	094	May visual neglect hide an autoimmune process?	Disclosure: Dr. Poretto has nothing to disclose.
MS Clinical Practice and Decision Making
Start Time	Pub.	Title	Presenter
11:30 AM	095	Emotional Expressions associated with Therapeutic Inertia in Multiple Sclerosis care	Disclosure: Dr. Saposnik has received personal compensation for consulting, serving on a scientific advisory board, speaking, or other activities with Biogen, EMD Serono, Sanofi Genzyme, Novartis Pharmaceuticals,and Roche. Dr. Saposnik has received research support from Roche Boheringher.
11:30 AM	096	The Traffic Light System reduces Therapeutic Inertia in MS Care: results from a RCT	Disclosure: Dr. Saposnik has received personal compensation for consulting, serving on a scientific advisory board, speaking, or other activities with Biogen, EMD Serono, Sanofi Genzyme, Novartis Pharmaceuticals,and Roche. Dr. Saposnik has received research support from Roche Boheringher.
11:30 AM	097	A Descriptive Nation-wide Survey of Laboratory Monitoring Practices of Multiple Sclerosis Clinicians in Canada	Disclosure: Dr. Atwal has nothing to disclose.
11:30 AM	098	Influence of Live-Online Education on Multiple Sclerosis Disease Management: Trends in Medical Knowledge and Practice Behaviors from Novice to Expert Clinicians	Disclosure: Dr. Roc has nothing to disclose.
11:30 AM	099	Design and Implementation of a Pharmacist-Run Multiple Sclerosis Optimization Clinic	Disclosure: Dr. Hellerslia has nothing to disclose.
11:30 AM	100	Online Medical Education Improves Knowledge of Immune Mechanisms in the Treatment of MS Among Neurologists	Disclosure: Dr. Maeglin has nothing to disclose.
11:30 AM	101	Therapeutic Inertia Correlates with the Level of Agreement on the Landscape of MS Treatments	Disclosure: Dr. Oh has received personal compensation for consulting, serving on a scientific advisory board, speaking, or other activities with Biogen Idec, EMD Serono, Genzyme, Novartis, Roche. Dr. Oh has received research support from Biogen Idec, Genzyme, MS Society of Canada, Teva.
11:30 AM	102	Influence of Gender and Age in Use of Ocrelizumab for PPMS Patients Among US Neurologists	Disclosure: Dr. Naismith has received personal compensation for consulting, serving on a scientific advisory board, speaking, or other activities with Acorda, Alkermes, Biogen, Celgene, EMD Serono, Genentech, Genzyme, and Novartis. Dr. Naismith has received personal compensation in an editorial capacity as the Associate Editor NEJM Journal Watch. Dr. Naismith has received research support from Acorda, Alkermes, Biogen, Celgene, EMD Serono, Genentech, Genzyme, and Novartis.
11:30 AM	103	Trends for Healthcare Cost among Commercially Insured Individuals with Multiple Sclerosis	Disclosure: Dr. Kim has nothing to disclose.
11:30 AM	104	Facilitating Collaboration in MS Care through Point-of- care Tools and Innovation in CME	Disclosure: Dr. Hefele has nothing to disclose.
11:30 AM	105	Telemedicine in Multiple Sclerosis Care: A National Utilization Assessment and Systematic Review	Disclosure: Dr. Wallin has nothing to disclose.
11:30 AM	106	Cost effectiveness of Fingolimod Compared to Interferon-ß1a in the Management of Pediatric-Onset Multiple Sclerosis (POMS) in Canada	Disclosure: Dr. Nakhaipour has received personal compensation for consulting, serving on a scientific advisory board, speaking, or other activities with Novartis Pharmaceuticals Canada Inc..
11:30 AM	107	A multiple sclerosis nurse practitioner fellowship: meeting the comprehensive needs of the multiple sclerosis community	Disclosure: Dr. Lakin has nothing to disclose.

Ready to register for the 2019 AAN Annual Meeting?

Related Courses

Saturday, May 4, 2019
7:00 AM-9:00 AM
C1 - What Do I Do Now?: Assessment and Management of Neuropsychiatric Symptoms in Neurocognitive Disorders Daniel Kaufer MD, FAAN
C3 - Clinical EEG: Normal EEG, Normal Variants, and How to Avoid The Common Pitfall of Over-reading Selim Benbadis MD, FAAN
C4 - Pediatric Neuro-ophthalmology Update Christopher Glisson DO, FAAN
C5 - What Do I Do Now?: Neurologic Consultations in Cancer Patients I Jaishri Blakeley MD
C6 - Therapy of Movement Disorders: A Case-based Approach David Riley MD
C7 - Clinical Pearls in Autoimmune Neurology: Real World Cases Stacey Clardy MD, PhD
C8 - Cognitive Psychology of Neurologic Errors: Why Do Neurologists Make Errors? Louis Caplan MD, FAAN
7:00 AM-12:30 PM
C9 - Clerkship and Program Directors Conference: Let’s Build an Educational Scholarly Product Zachary London MD, FAAN
8:00 AM-8:30 AM
Are you My Mentor? How to Select a Good Mentor for Your Research Center Deborah Hall MD, PhD, FAAN
9:00 AM-9:30 AM
What Should Applicants Look for in a Program? Adam De Havenon MD
How to Successfully Publish Quality Improvement Projects Anup Patel MD, FAAN
Trainee Experience: Navigating the AAN and Your Career
9:30 AM-11:30 AM
C13 - Clinicopathological Correlation Session in Dementia David Irwin MD
C14 - Child Neurology: Headache Amy Gelfand MD
C15 - Clinical EEG: Focal, Diffuse, and Epileptiform Abnormalities in Adults Katherine Noe MD, PhD, FAAN
C16 - Cerebrovascular Disease I: Prevention Larry Goldstein MD, FAAN, FAHA
C17 - What Do I Do Now?: Neurologic Consultations in Cancer Patients II Patrick Wen MD, FAAN
C18 - Cerebellar and Afferent Ataxias: Diagnosis and Management Massimo Pandolfo MD, FAAN
C19 - Multiple Sclerosis Overview I: Clinical Pearls Mary Willis MD
C20 - Neurologic Complications of Medical Disease Sara Hocker MD, FAAN
10:00 AM-10:30 AM
Quality Improvement Research in Neurology Mona Bahouth MD
11:00 AM-11:30 AM
Your CV Is Talking About You Behind Your Back and Your LORs Are, Too! Na Tosha Gatson MD, PhD
11:00 AM-11:45 AM
Fellowship as a Springboard to Junior Faculty Kathryn Nevel MD
12:00 PM-12:30 PM
Navigating the Annual Meeting App Carlayne Jackson MD, FAAN
12:00 PM-3:30 PM
Futures in Neurological Research Boot Camp Deborah Hall MD, PhD, FAAN
12:00 PM-4:00 PM
C22 - Resident Basic Science I: Neuropathology J. Clay Goodman MD, FAAN
C23 - Skills Workshop: Neuro-ophthalmology and Neurovestibular Exam Lab (Registration Required) Matthew Thurtell MD
1:00 PM-1:30 PM
Statistics: Sample Size William Meurer MD
1:00 PM-1:45 PM
Tips and Tools for Successful Recruitment Peggy Nolty
What's Going On With E/M? Luana Ciccarelli , Bruce Cohen MD, FAAN
1:30 PM-3:30 PM
C26 - Clinical EEG: Neonatal and Pediatric Nicholas Abend MD
C27 - Cerebrovascular Disease II: Update on Guidance-Based Diagnosis and Management of Hemorrhagic Stroke Andrew Naidech MD, FAAN
C34 - Evaluating Tremor in the Office Andres Deik Acosta Madiedo MD
C29 - Multiple Sclerosis Overview II: Clinical Advances Scott Newsome DO, FAAN
C30 - Neurologic Complications of Medical and Surgical Therapies Sara Hocker MD, FAAN
C31 - Mitochondrial Disorders in Neurology Michio Hirano MD, FAAN
C32 - The Neurology of Social Behavior Bradford Dickerson MD, FAAN
C33 - Teleneurología (Teleneurology) Susana Bowling MD
1:30 PM-4:00 PM
C35 - Educators' Leadership Program (Registration Required) Rana Said MD, FAAN
1:45 PM-2:30 PM
The Experience of Music Therapy in the Interdisciplinary Treatment of TBI Renee Pazdan MD, FAAN, Rebecca Vaudreuil EdM, MT-BC
2:00 PM-2:45 PM
A Career in Neuroimaging Michael Hutchinson MD, PhD
2:30 PM-3:15 PM
Dancing with Parkinson's Diviya Kaul MD
2:45 PM-3:30 PM
Case Studies: Ethical Conundrums in Neurology Ariane Lewis MD, Justin Sattin MD, Daniel Larriviere MD, JD, FAAN, Salvador Cruz-Flores MD, FAAN, James Russell MD, MS, FRPC, FAAN, William Graf MD, FAAN, Winston Chiong MD
3:00 PM-3:45 PM
Using Technology to Get Real Answers from Your Patients Lidia Maria Moura MD, FAAN
Interventional Neurology: Training and Practice Adnan Qureshi MD
3:00 PM-4:00 PM
AAN Business Meeting
3:45 PM-4:45 PM
Women in Neurology Meeryo Choe MD, Jennifer Bickel MD, FAAN, Veronica Santini MD, Renee Pazdan MD, FAAN
4:15 PM-5:30 PM
Hot Topics Plenary Session Eric Klawiter MD, FAAN
5:00 PM-5:30 PM
Trainee Experience: Navigating the AAN and Your Career
5:00 PM-5:45 PM
Telestroke Across the Continuum Amy Guzik MD
5:45 PM-6:45 PM
Advancing Medicine: Inspiration and Innovation Featuring Hugh Herr, PhD Hugh Herr PhD

Sunday, May 5, 2019
7:00 AM-7:30 AM
Trainee Experience: Navigating the AAN and Your Career
7:00 AM-7:45 AM
Resident Evaluation of Faculty: A New Approach Deborah Fay
7:00 AM-9:00 AM
C46 - Actualización en dolor de cabeza y trastornos neuromusculares (Update: Headache and Neuromuscular Disorder) Jose Merino MD, MPhil, FAAN, Dario Beltran MD, FAAN
C37 - Chronic Traumatic Encephalopathy: Update Andrew Budson MD
C39 - How to Design Meaningful Clinical Trials Laurie Gutmann MD, FAAN
C40 - Child Neurology: Stroke Lori Billinghurst MD
C41 - Neuro-oncology in 2019: Navigating Current Trends Maciej Mrugala MD, PhD, MPH, FAAN
C42 - The Dystonias: Diagnosis, Treatment and Update on Etiologies Rachel Saunders-Pullman MD
C44 - Multiple Sclerosis Therapy: Symptom Management Andrew Solomon MD, FAAN
C45 - Status Epilepticus Stephan Schuele MD, FAAN
8:00 AM-8:30 AM
C260 - Accreditation Step by Step: From Self Study to Site Visit Crys Draconi
Neuroscience of Bias Jose Posas MD
Clerkship Director Conversation Rachel Marie Salas MD, FAAN
8:00 AM-8:45 AM
Coding for Residents Kavit Shah MD
8:30 AM-9:00 AM
C261 - How to Become An Advocate For Yourself and Your Program Sana Ghafoor MD
Neuroscience Course Director Conversation Peter Hannon MD, Madhu Soni MD, FAAN
9:00 AM-10:00 AM
C262 - Choosing, Training, Forging, and Mentoring Chief Residents: Program Coordinator Role Marla Scofield C-TAGME
9:15 AM-12:00 PM
Presidential Plenary Session Natalia Rost MD, MPH, FAAN, FAHA
11:30 AM-6:30 PM
12:00 PM-12:45 PM
Almuerzo con Colegas: Perlas clínicas/ solicitando una residencia o subespecialidad en neurología
12:00 PM-1:00 PM
Neurology Pictionary Bert Vargas MD, FAAN
1:00 PM-2:15 PM
S1 - Neuroepidemiology
1:00 PM-3:00 PM
C60 - Assessment of Rapidly Progressive Dementias I: Prion and Non-prion Neurodegenerative Diseases Michael Geschwind MD, PhD, FAAN
C49 - Neurology Update I: Multiple Sclerosis, Sleep, and Neuromuscular Disease Ralph Jozefowicz MD, FAAN, Adam Quick MD
C50 - Cerebrovascular Disease III: Update on Neuroimaging Modalities and Endovascular Therapies for Acute Ischemic Stroke Johanna Fifi MD
C51 - Balance and Gait Disorders Alfonso Fasano MD, PhD
C52 - Introduction to Integrative Neurology Sarah Mulukutla MD, MPH
C53 - Introduction to Primary Headache Disorders: Migraine and Other Primary Headaches Including Tension-Type, Hypnic, Primary Stabbing and Nummular Headache Syndromes, Epicrania Fugax and Retinal Migraine Deborah Friedman MD, MPH, FAAN
C54 - Neuro-otology: The Common Peripheral Vestibular Disorders Kevin Kerber MD
C56 - Multiple Sclerosis Therapy: Disease-modifying Treatment I Scott Newsome DO, FAAN
C57 - Drugs and Toxin-induced Neurologic Emergencies Sara Hocker MD, FAAN
S3 - Epilepsy/Clinical Neurophysiology (EEG) I
S4 - Clinical Trials in Movement Disorders
S6 - MS and CNS Inflammatory Disease: Clinical Considerations I
1:00 PM-5:00 PM
Consortium of Neurology Program Directors Business Meeting Zachary London MD, FAAN, Jaffar Khan MD, FAAN, Erica Schuyler MD
1:00 PM-5:30 PM
C64 - Skills Workshop: Neurophysiologic Intraoperative Monitoring (Registration Required) Aatif Husain MD
C63 - Resident Basic Science II: Neuropharmacology James Owens MD, PhD
1:30 PM-2:30 PM
AAN Leadership: Using Experiences to Answer the Tough Questions Ralph Sacco MD, MS, FAHA, FAAN, Sandra Olson MD, FAAN, Roger Rosenberg MD, FAAN, Stanley Fahn MD, FAAN, Stephen Sergay MB BCh, FAAN, Robert Griggs MD, FAAN, Terrence Cascino MD, FAAN, Francis Kittredge MD,FAAN
2:00 PM-2:30 PM
SIGN Faculty Advisor Conversation Yolanda Reyes-Iglesias MD
2:00 PM-2:45 PM
Teaching the Next Generation of Physician Advocates: Advocacy Curriculum for Neurology Residents Kara Stavros MD, Jonathan Cahill MD
Navigating a Career in Academics Joseph Safdieh MD, FAAN, Jennifer Molano MD, FAAN
3:00 PM-3:45 PM
Practice Innovation in Epilepsy Anup Patel MD, FAAN
Lost in Translation: Acknowledging and Respecting Cultural Differences With Your Patients Jose Merino MD, MPhil, FAAN, Joseph Sirven MD, FAAN
Education Research: The Secret Sauce to Career Advancement as Clinician Educator Andrew Southerland MD
3:30 PM-5:30 PM
C76 - Assessment of Rapidly Progressive Dementias II: Infections and Autoimmune Mediated Conditions Michael Geschwind MD, PhD, FAAN
C67 - Neurology Update II: Behavioral Neurology, Movement Disorders, and Neuro-ophthalmology Ralph Jozefowicz MD, FAAN, Adam Quick MD
C68 - Cerebrovascular Disease IV: Telestroke Eric Anderson MD, PhD
C69 - The Palliative Care Guide in Neurology: Best Practice in Communication, Advance Care Planning, and End-of-life Care of Patients with Brain Tumors and Other Life-limiting Neurological Disorders Tobias Walbert MD, PhD
C70 - Introduction to Primary Headache Disorders: Trigeminal Autonomic Cephalalgias and Other Primary Headaches Including New Daily Persistent Headache, Cough, Exercise, and Thunderclap Headaches Christopher Boes MD, FAAN
C71 - Neuro-otology: Diagnosis and Treatment of Nuanced Causes of Dizziness Kevin Kerber MD
C72 - Disordered Sleep in Common Neurologic Diseases: Traumatic Brain Injury, Stroke, and Parkinson’s Disease LynnMarie Trotti MD
C73 - Multiple Sclerosis Therapy: Disease-modifying Treatment II John Rose MD, FAAN
C74 - CNS Toxicities Neeraj Kumar MD
N1 - Neuroscience in the Clinic: Child Neurology: Emerging Understanding of the Epilepsy-Movement Disorder Spectrum Across the Lifespan Deborah Hall MD, PhD, FAAN, Erika Augustine MD, FAAN
S9 - Aging and Dementia: Clinical Trials and Novel Therapies
S10 - Biomarkers in Movement Disorders
S11 - Autoimmune CNS Inflammatory Disorders: Clinical Advances
4:00 PM-4:45 PM
Navigating Prior Authorizations Pearce Korb MD, FAAN
Living an Alpha Brain Wave Life: Work/Life Balance Tamika Burrus MD, FAAN
4:15 PM-5:00 PM
The Teenage Brain: Neuroscience You Can Use Frances Jensen MD, FAAN
4:45 PM-5:30 PM
Neuro-oncology Section Guided Poster Tour
5:00 PM-5:30 PM
Trainee Experience: Navigating the AAN and Your Career
5:00 PM-5:45 PM
How to Be a Teacher as a Resident Jeremy Cutsforth-Gregory MD
5:15 PM-6:15 PM
Standing on the Shoulders of Giants Cynthia Comella MD, FAAN

Monday, May 6, 2019
7:00 AM-7:30 AM
Tips to Sail Through the IRB Deborah Hall MD, PhD, FAAN
Trainee Experience: Navigating the AAN and Your Career
7:00 AM-8:45 AM
Clerkship Administrators Certification Program Celia Linton
7:00 AM-9:00 AM
C78 - Young Onset and Atypical Alzheimer's Dementia Jonathan Graff-Radford MD
C79 - Differential Diagnosis of Neurologic Infections Michael Wilson MD, FAAN
C80 - Epileptologists’ Secrets for the Busy General Neurologist: Localization, Imaging, and Fear of Surgery Carol Ulloa MD
C81 - Core Principles of Brain Tumors Nimish Mohile MD, FAAN
C82 - Stroke in Young Adults and Women Aneesh Singhal MD, FAAN
C83 - Diagnosis and Treatment of Functional Movement Disorders Mark Hallett MD, FAAN
C85 - Severe TBI: From ICU to Rehabilitation Susanne Muehlschlegel MD, MPH
C86 - Neuromyelitis Optica Spectrum Disorders Dean Wingerchuk MD, FAAN
C87 - Skills Workshop: Clinical Usefulness of Botulinum Toxin for Spasticity (Registration Required) Allison Brashear MD, MBA, FAAN
7:30 AM-9:00 AM
Student Interest Group in Neurology (SIGN) Meeting Madhu Soni MD, FAAN
8:00 AM-8:45 AM
Physical Exercise and Cognitive Training in Neurology-Application in Aging & Neurodegenerative Disease Ergun Uc MD
Personal Finances for Residents Brad Klein MD, MBA, FAAN
8:00 AM-9:00 AM
Updating the NIH BRAIN Initiative: A Dialogue with the AAN Walter Koroshetz MD, FAAN
8:30 AM-9:00 AM
Residency Program Director Conversation Rana Said MD, FAAN
9:15 AM-12:00 PM
Contemporary Clinical Issues Plenary Session Randolph Marshall MD, FAAN
11:30 AM-6:30 PM
P2 - Poster Session 2
11:45 AM-12:30 PM
Self-management in Neurologic Disease Lisa Shulman MD, FAAN, Barbara Jobst MD, FAAN
12:00 PM-12:45 PM
Training in Research for Academic Neurologists to Sustain Careers and Enhance the Numbers of Diverse Scholars (TRANSCENDS) Program Bruce Ovbiagele MD, MSc, FAAN
LGBTQ+ Health in Neurology - Why It's Important and What You Need to Know Nicole Rosendale MD
12:00 PM-1:00 PM
Would You Fly With This Pilot? Joseph Sirven MD, FAAN
1:00 PM-1:30 PM
Diversity Officer Roundtable Discussion Roy Hamilton MD, MS, FAAN
1:00 PM-1:45 PM
Controversies in Neuroimaging James Johnston MD, JD, James Burke MD
1:00 PM-2:00 PM
Advancing Medicine: Inspiration and Innovation Featuring Mona Hanna-Attisha, MD, MPH, FAAP Mona Hanna-Attisha MD, MPH, FAAP
1:00 PM-3:00 PM
C88 - Mild Cognitive Impairment: Implications for Clinicians Ronald Petersen PhD, MD, FAAN
C90 - Clinical Epilepsy I: Basics Tracey Milligan MD, FAAN
C91 - Neurology Update III: Headache, Neuro-otology, and Epilepsy Adam Quick MD, Ralph Jozefowicz MD, FAAN
C92 - Autism Spectrum Disorders What We Know and Where We Are Going Rujuta Wilson MD
C93 - Paroxysmal Movement Disorders Kailash Bhatia MD, FAAN
C94 - Now You See It, Now You Know It: Pathognomonic Neuro-ophthalmology Examination Findings Eric Eggenberger DO, FAAN
C97 - Neuroendocrine Update: Nuts and Bolts of What You Need to Know Alison Pack MD
C98 - Faculty Development: Enhancing Your Role in Student and Resident Training Vicki Shanker MD
C100 - Esclerosis Múltiple y Otras Enfermedades Inflamatorias Desmielinizantes y Autoinmunes del Sistema Nervioso Central (MS and Other Demyelinating Inflammatory and Autoimmune Central Nervous System Disorders) Lilyana Amezcua MD, FAAN
N2 - Neuroscience in the Clinic: Interpretations of Genetic Results Karen Marder MD, MPH, FAAN, Massimo Pandolfo MD, FAAN
S12 - Progressive Multiple Sclerosis
S13 - Behavioral and Cognitive Neurology: Behavioral Neurology, Aging, and Dementia
S14 - Translational and Clinical Advances in Neuro-oncology
S15 - Intracerebral Hemorrhage and SAH
S16 - Huntington's Disease: From Bench to Clinical Trials
S17 - Headache: Clinical Trials I
1:00 PM-5:30 PM
C103 - Resident Basic Science III: Neuroanatomy: All the Lesions Zachary London MD, FAAN
C105 - Skills Workshop: Clinical Uses of Botulinum Toxin for Dystonia (Registration Required) Diego Torres-Russotto MD, FAAN
C104 - Research Career Symposium Chad Hales MD, PhD, FAAN
1:30 PM-2:30 PM
Blind Spots: The Impact of Conscious and Unconscious Biases Jeffrey McClean MD, FAAN, Charles Flippen MD, FAAN, Laraine Kaminsky
2:00 PM-2:45 PM
Using EHR to Close Referral Loops Melissa Yu MD, FAAN, Allison Weathers MD, FAAN, Allan Wu MD
A Career in Clinical Practice Stephen Sergay MB BCh, FAAN
2:00 PM-3:00 PM
ABPN Continuing Certification Information Session J. Clay Goodman MD, FAAN, A. Gordon Smith MD, FAAN
2:30 PM-3:15 PM
The Role of Integrative Medicine in Epilepsy Ann Marie Collier MD
2:45 PM-3:30 PM
Self Reflected: Deeply Fusing Art and Science to Create the World's Most Complex Artistic Depiction of the Human Brain Greg Dunn PhD
3:00 PM-3:45 PM
Research Outputs from the Axon Registry Lyell Jones MD, FAAN
Child Neurology for Trainees Rana Said MD, FAAN
3:30 PM-4:00 PM
Residency Program Director Conversation Emily Pharr MD
3:30 PM-5:30 PM
C106 - Cognitive Impairment Due to Alzheimer's Disease: Using Old Skills and New Tools for Diagnosis and Treatment David Knopman MD, FAAN
C107 - Emergency Room Neuro-ophthalmology Heather Moss MD, PhD, FAAN
C108 - Clinical Epilepsy II: Considerations Across the Age Span: Pediatrics, Pregnancy, and Elderly Barbara Jobst MD, FAAN
C109 - Neurology Update IV: Stroke, Neuro-infectious Disease, and Autoimmune Encephalopathies Adam Quick MD, Ralph Jozefowicz MD, FAAN
C110 - Adult and Pediatric Neuro-Oncology for the Neurohospitalist Na Tosha Gatson MD, PhD
C115 - Emerging Approaches to Biosensing for the Diagnosis and Management of Neurological Disease John Hixson MD
C116 - LGBTQI Health in Neurology Holly Hinson MD, MCR, FAAN
C117 - Tourette Syndrome: Assessment and Management Tamara Pringsheim MD, FAAN
C119 - Actualización en lesión cerebral traumática e ictus isquémico (Update: TBI and Stroke) Dario Beltran MD, FAAN, Jose Merino MD, MPhil, FAAN
S19 - Child Neurology: Updates in Autism, Migraine, MS, and Stroke
S20 - Headache Imaging and Physiology and Episodic Syndromes Associated with Migraine
S21 - Autoimmune Neurology: Novel Diagnostic and Predictive Biomarkers and Immunopathologic Mechanisms of Disease
S22 - Stroke Genetics, Cellular Responses, and Animal Models
Presentation of the Potamkin Prize for Research in Pick's, Alzheimer's, and Related Diseases
3:45 PM-4:45 PM
Philadelphia: The City of Neurology Love Christopher Goetz MD, FAAN, Stephen Reich MD, FAAN, Frances Jensen MD, FAAN, Donald Silberberg MD,FAAN
4:00 PM-4:30 PM
Clerkship Director Conversation Holli Horak MD, FAAN
4:00 PM-4:45 PM
#MeanReviews: Flipping Imposter Syndrome on Its Head Rachel Marie Salas MD, FAAN
4:30 PM-5:00 PM
Everything You Wanted to Know About the Neurology® Resident & Fellow Section John Millichap MD, FAAN
5:00 PM-5:30 PM
Trainee Experience: Navigating the AAN and Your Career
Residency Program Director Conversation Erica Schuyler MD
5:00 PM-5:45 PM
Defining, Evaluating, and Promoting Healthy Cognitive Aging Kirk Daffner MD, FAAN
Careers in Movement Disorders Stanley Fahn MD, FAAN
5:00 PM-6:00 PM
Standing on the Shoulders of Giants Kenneth Heilman MD, FAAN

Tuesday, May 7, 2019
7:00 AM-7:30 AM
Diversifying Your Funding Sources with NIH and Other Sources Ana-Claire Meyer MD
Trainee Experience: Navigating the AAN and Your Career
7:00 AM-7:45 AM
Pursuing a Career in Industry Brandy Matthews MD, FAAN
7:00 AM-9:00 AM
C123 - Child Neurology: Genetic and Metabolic Testing in Pediatric Epilepsy James Riviello MD
C122 - Neurocognitive Assessment for Neurologists Mario Mendez MD, PhD, FAAN
C124 - Endovascular Treatment of Acute Stroke and Cerebrovascular Disease Dileep Yavagal MD, FAAN
C126 - Active Management of Professionalism Lapses: A New Way of Thinking Ann Poncelet MD, FAAN
C127 - Hyperkinetic Movement Disorders: Videodiagnosis and Treatment Steven Frucht MD
C129 - Critical Care Consultations for Neurohospitalists Vanja Douglas MD
C130 - Diagnostic Pearls in Myelitis: a Case-based Approach Eoin Flanagan MBBCh
7:30 AM-9:00 AM
C263 - Access: Strategies to Improve Access in Academic Medicine Jaya Trivedi MD, FAAN
8:00 AM-8:45 AM
Welcome to NIH Day/Overview of NIH Funding with NINDS Director and NIA Director, Division of Neuroscience Walter Koroshetz MD, FAAN
9:15 AM-11:30 AM
Clinical Trials Plenary Session Deborah Hall MD, PhD, FAAN, Holly Hinson MD, MCR, FAAN
11:30 AM-6:30 PM
P3 - Poster Session 3
11:45 AM-12:45 PM
Emerging Science Session
12:00 PM-12:30 PM
Learn About Opportunities to Work with the NIH Intramural Program Avindra Nath MD, MBBS, FAAN
12:00 PM-12:45 PM
Optimizing Communication in Difficult Patient Relationships Veronica Santini MD
12:00 PM-1:00 PM
Neuro Game Show: Localize the Lesion Luis Torres MD
12:30 PM-1:00 PM
NIH Grant Review Process Shanta Rajaram PhD
1:00 PM-1:45 PM
Women in Neurology: Thriving Through Challenges Kathrin LaFaver MD, FAAN, Divya Singhal MD
K Awards and Training Programs – Planning for a Career as an NIH Investigator Nina Schor MD, PhD, FAAN
1:00 PM-3:00 PM
C132 - Frontotemporal Dementias Elizabeth Finger MD, FAAN
C133 - Clinical Epilepsy III: Advanced (Status, Beyond AED, Video EEG) William Tatum DO, FAAN
C135 - Case Studies: Challenging Acute Ischemic Stroke Cases Vivien Lee MD, FAAN
C136 - Neuroimaging for the General Neurologist I: Brain Joshua Klein MD, PhD, FANA, FAAN, Ligia Onofrei MD
C137 - Deep Brain Stimulation I: Basic Principles and Programming in Movement Disorders Michael Pourfar MD
C138 - Hot Topics in Headaches and Related Disorders I: Unusual Headaches, Childhood Headaches, and Concussion Management Amy Gelfand MD
C139 - Eye Movement Disorders: A Systematic Approach to the Evaluation of Diplopia Janet Rucker MD
C142 - Autoimmune Neurology I Basics and Beyond: Autoimmune Encephalitis and Paraneoplastic Neurological Syndromes of the CNS and PNS Stacey Clardy MD, PhD
C143 - Education Research Methodology Course Andrew Southerland MD
N3 - Neuroscience in the Clinic: Stem Cells Antonio Omuro MD, Paul George MD, PhD, MSE
C144 - Actualización científica I (Scientific Update I - Spanish) Edgar Samaniego MD
S25 - Child Neurology: Spinal Muscular Atrophy: Treatments and Outcomes
S26 - MS and CNS Inflammatory Disease: Clinical Considerations II
S27 - General Neurology: Improving Neurologic Care and the Impact of Therapeutics
C264 - Division Chief's Round Table: Maximizing Effectiveness and Addressing Challenges Claire Henchcliffe MD, PhD, FAAN
1:30 PM-2:30 PM
Neuro Exam Tricks and Tips Nancy Newman MD, FAAN, Ludwig Gutmann MD, FAAN, Laurie Gutmann MD, FAAN
1:45 PM-2:15 PM
NIH Funding and Professional Development Opportunities for Diverse Researchers Michelle Jones-London PhD
2:00 PM-2:45 PM
The HSR Game Show Gregory Esper MD, MBA, FAAN, Jason Sico MD, FAAN
2:15 PM-3:00 PM
Clinical Trials and Networks – NeuroNEXT, StrokeNET, SIREN; Alzheimer’s Clinical Trials Consortium Clinton Wright MD, FAAN
3:00 PM-3:45 PM
Live Intraoperative Monitoring Constantine Moschonas MD, FAAN
Oportunidades de colaboración internacional para realizar proyectos de investigación en enfermedades neurodegenerativas (Opportunities for International Collaborations to Conduct Research on Neurodegenerative Diseases) Yakeel Quiroz PhD
AD/ADRD Opportunities Clinton Wright MD, FAAN
3:30 PM-4:00 PM
Writing and Reviewing for the Neurology® Resident & Fellow Section John Millichap MD, FAAN
3:30 PM-4:45 PM
S28 - Neuro-ophthalmology/Neuro-otology
3:30 PM-5:30 PM
C151 - Lewy Body Dementias Karen Marder MD, MPH, FAAN
C164 - Update on Medical Management of Stroke Adam De Havenon MD
C154 - Neuroimaging for the General Neurologist II: Brain Joshua Klein MD, PhD, FANA, FAAN, Shamik Bhattacharyya MD
C155 - Deep Brain Stimulation II: Advanced Management in Movement Disorders and Applications Beyond Movement Disorders Leonard Verhagen Metman MD, PhD
C156 - Hot Topics in Headaches and Related Disorders II: Migraine Pathophysiology, Brain Imaging, and Therapeutic Advances Andrew Charles MD
C159 - Mid-Level Faculty Career Development Course Deborah Hall MD, PhD, FAAN
C160 - Autoimmune Neurology II Advanced: Autoimmune Encephalitis at the Frontiers of Neuroscience Eoin Flanagan MBBCh
C161 - Child Neurology: Metabolic Marc Patterson MD, FAAN, FRACP
C152 - Clinical Epilepsy IV: Surgery Gregory Cascino MD, FAAN
C163 - Creating a Roadmap for a Diverse Workforce in Academic Neurology Nimish Mohile MD, FAAN, Roy Hamilton MD, MS, FAAN
C149 - Clinical Neurology for Advanced Practice Providers Jessica Erfan PA-C
S30 - Brain Cancer: From Epidemiology to Quality of Life
S31 - MS and CNS Inflammatory Disease: Imaging
S32 - General Neurology: Advances in Neurology: From the Clinic to the Bench
IS2 - Invited Science: Movement Disorders Deborah Hall MD, PhD, FAAN
3:45 PM-4:30 PM
HEAL Initiative - Pain Research Funding Opportunities, Clinical and Basic Michael Oshinsky PhD
4:00 PM-4:45 PM
Healthcare Disparities in Populations Jeffrey McClean MD, FAAN, Brett Kissela MD, FAAN, MS, Alejandro Vargas MD, Sharon Lewis MD
Not Dead Yet: How to Remain Relevant and Engaged in Mid to Late Career Heidi Schwarz MD, FAAN
4:30 PM-5:00 PM
Translational Research Amir Tamiz
Using the Neurology® Resident & Fellow Section John Millichap MD, FAAN
5:00 PM-5:30 PM
Trainee Experience: Navigating the AAN and Your Career
5:00 PM-5:45 PM
From Private Practice to Academics Sarah Benish MD, FAAN
5:00 PM-6:00 PM
Standing on the Shoulders of Giants Nancy Newman MD, FAAN

Wednesday, May 8, 2019
7:00 AM-7:30 AM
How to Write and Publish Research Papers, Reviews, and Other Scientific Communication Mark Hallett MD, FAAN
Trainee Experience: Navigating the AAN and Your Career
7:00 AM-7:45 AM
Simulation in Neurology Education Ariane Lewis MD, Aaron Nelson MD, Arielle Kurzweil MD
7:00 AM-9:00 AM
C165 - Current Management of Incidental and Asymptomatic Cerebrovascular Lesions Robert Brown MD, FAAN
C166 - Neuroimaging Biomarkers Across the Dementia Spectrum Liana Apostolova MD, FAAN
C168 - Parkinson's Disease Update Melissa Nirenberg MD, PhD, FAAN
C174 - Neuro-ophthalmology I: Visual Loss, Optic Neuropathies, and Papilledema Nancy Newman MD, FAAN
C170 - Video EEG: Name That Spell Amy Crepeau MD
C171 - Child Neurology: Neuromuscular/Autoimmune Neurology Anne Connolly MD, FAAN
C172 - Advances in Neurogenetics Matthew Harms MD
C173 - Skills Workshop: Practical Training in Injection Techniques in the Treatment of Headache Disorders (Registration Required) Amaal Starling MD, Rashmi Halker Singh MD
8:00 AM-8:30 AM
Recruiting Underrepresented Populations into Trials Temitayo Oyegbile MD, PhD
8:00 AM-8:45 AM
Complementary Therapies in Parkinson's Disease Veronica Santini MD
Consejos prácticos para educadores médicos (Practical Advice for Medical Educators) Yazmin Odia MD, FAAN, MS
8:30 AM-9:00 AM
Neuroscience Course Director Conversation Madhu Soni MD, FAAN
9:15 AM-11:30 AM
Frontiers in Neuroscience Plenary Session Paul George MD, PhD, MSE
11:00 AM-11:30 AM
Resident and Fellow Conversation Abhimanyu Mahajan MD
11:30 AM-6:30 PM
P4 - Poster Session 4
11:45 AM-12:30 PM
Eating Your Way to Fewer Migraines Belinda Savage-Edwards MD, FAAN, Chef Tess Connor
12:00 PM-12:45 PM
Funding Clinically Oriented/Translational Research Before R01 – Consortium and Foundation Opportunities Aasef Shaikh MD
12:00 PM-1:00 PM
Neuro-Jeopardy: Telencephalon Twisters Laurice Yang MD, MHA, Veronica Santini MD
1:00 PM-1:45 PM
Understanding the AAN's Latest Guidelines Tamara Pringsheim MD, FAAN
Headache Neuromodulation Therapy Heidi Schwarz MD, FAAN
Teaching Neurologic Competency Competently Despite the Competencies: A.B. Baker Award for Lifetime Achievement in Neurologic Education Keynote Address Steven Lewis MD, FAAN
1:00 PM-2:00 PM
Advancing Medicine: Inspiration and Innovation Featuring Patricia Churchland, PhD Patricia Churchland PhD
1:00 PM-3:00 PM
C176 - Behavioral Neurology I: Network Anatomy of Behavior and Language Maria Gorno Tempini MD, PhD
C178 - Therapy in Neurology I: Neurological Infectious Diseases and Neuro-oncology Madhu Soni MD, FAAN
C179 - Nonmotor Manifestations of Parkinson's Disease I Jennifer Goldman MD, MS, FAAN
C187 - Comprehensive Migraine Update I: Migraine Diagnosis, Pathophysiology, and Comorbidities Gretchen Tietjen MD
C188 - Neuro-ophthalmology II: Optic Neuritis, Visual Fields, and Anisocoria Nancy Newman MD, FAAN
C181 - Treatment of Pediatric Multiple Sclerosis in the Current Era Brenda Banwell MD, FAAN
C182 - Neuroimaging for the General Neurologist: Spine J. D. Bartleson MD, FAAN, Felix Diehn MD
C183 - Reading, Critiquing, and Reviewing the Neurologic Literature: An Evidence-based Approach and Case-based Presentation of Peer Reviews in Neurology Roy Strowd MD
C185 - Actualización en trastornos del movimiento (Update in Movement Disorders) Andres Deik Acosta Madiedo MD
C186 - Women Founders of Neurology and Neuroscience I Stefano Sandrone PhD
N4 - Neuroscience in the Clinic: Immunotherapies in Neurological Disease Holly Hinson MD, MCR, FAAN, John Corboy MD, FAAN
S34 - Aging and Dementia: Risk Factors, Biomarkers, and Neuropathology
S35 - Stroke Prevention Strategies
S36 - Epilepsy/Clinical Neurophysiology (EEG) II
S37 - MS Biomarkers
S38 - Headache: Clinical Trials II
1:00 PM-5:30 PM
C190 - Skills Workshop: Neurostimulation (Registration Required) David Spencer MD, FAAN
1:30 PM-2:30 PM
The Zoo Called - You Have a Consult Ann Tilton MD, FAAN
2:00 PM-2:30 PM
TALK CANCELLED: A Career in Autoimmune Neurology Pooja Raibagkar MD
3:00 PM-3:45 PM
Foundations in Success in the AAN Christine Phelps , Michael Markowski DO, FAAN, Ann Tilton MD, FAAN, Holly Hinson MD, MCR, FAAN, Jeffrey McClean MD, FAAN, Terrence Cascino MD, FAAN, Orly Avitzur MD, MBA, FAAN
How to Successfully Incorporate APPs into Your Practice James Stevens MD, FAAN
3:30 PM-5:30 PM
C193 - Behavioral Neurology II: Memory and Attention Maria Gorno Tempini MD, PhD
C194 - CANCELED Faculty
C196 - Nonmotor Manifestations of Parkinson's Disease II Jennifer Goldman MD, MS, FAAN
C203 - Comprehensive Migraine Update II: Pharmacologic and Non-Pharmacologic Therapies Gretchen Tietjen MD
C204 - Neuro-ophthalmology III: Diplopia, Ocular Motility Disorders, and Nystagmus Nancy Newman MD, FAAN
C198 - Integrating Sleep Medicine Concepts into Your Child Neurology Practice Suresh Kotagal MD, FAAN
C199 - Neuroimaging for the General Neurologist: Peripheral Nerve Kimberly Amrami MD, J. D. Bartleson MD, FAAN
C200 - Neurologic Case Studies in Pregnancy Amy Hessler DO, FAAN
C202 - Women Founders of Neurology and Neuroscience II Stefano Sandrone PhD
N5 - Neuroscience in the Clinic: Wearable Technology Eric Klawiter MD, FAAN, Deborah Hall MD, PhD, FAAN
S39 - Education Research and Research Methodology
S40 - Stroke Risk Factors and Epidemiology
S41 - Imaging in Movement Disorders
S43 - Immunotherapies and Drug Trials in Autoimmune Neurological Disorders
Presentation of the John Dystel Prize for Multiple Sclerosis Research
3:45 PM-4:15 PM
Update on the Complementary Therapies for MS: An Evidence-based Review Vijayshree Yadav MD, FAAN
4:00 PM-4:45 PM
Choosing a Career in Neurocritical Care Katharina Busl MD, MS
4:15 PM-5:00 PM
Is There a Neurologist in the Stands? Javier Cardenas MD, Glynnis Zieman MD
4:45 PM-5:30 PM
Clinical Neurophysiology Section Guided Poster Tour
5:00 PM-5:45 PM
Case Studies: When to Refer Patients for Cognitive Behavioral or Mindfulness-based Psychotherapies: Expanding the Neurologist's Toolkit Gaston Baslet MD, David Perez MD, Aneeta Saxena MD
Perspectivas profesionales para neurólogos en los Estados Unidos y América Latina (Professional Perspectives for Neurologists in the United States and Latin America) Pedro Gonzalez-Alegre MD, Ildefonso Rodriguez-Leyva MD, FAAN
5:15 PM-6:15 PM
Standing on the Shoulders of Giants Vladimir Hachinski MD, DSc, FAAN

Thursday, May 9, 2019
7:00 AM-7:30 AM
So Your Paper Didn’t Get Accepted, Now What? Roy Strowd MD
Trainee Experience: Navigating the AAN and Your Career
7:00 AM-9:00 AM
C206 - Vascular Cognitive Impairment and Dementia: Current Status and Future Larry Goldstein MD, FAAN, FAHA
C207 - Emergency Neurology: Evaluation of Coma, Meningitis, and Viral Encephalitis in the Emergency Room Jose Suarez MD
C209 - Movement Disorders for the General Neurologist I: New Concepts in the Diagnosis and Management of Parkinson's Disease Irene Litvan MD, FAAN
C210 - Low and High Pressure Headache: Clinical Presentation and Approach to Evaluation and Management Kathleen Digre MD, FAAN
C211 - Nystagmus and Saccadic Intrusions Made Simple Janet Rucker MD
C212 - Principles of Genomic Medicine: Clinical Exome Sequencing in Neurologic Disease Wayne Grody MD, PhD
C214 - Child Neurology: A Case-based Approach Elaine Wirrell MD, FAAN
8:00 AM-8:30 AM
Neuroscience of Bias Jose Posas MD
8:00 AM-8:45 AM
Creating, Evaluating, and Publishing Your Active Learning Modules Diana Barratt MD, MPH, FAAN
A Migraine in Room 3: Patient-centered Care for Residents Paul Schanfield MD
9:15 AM-11:30 AM
Controversies in Neurology Plenary Session Aleksandar Videnovic MD, MSc, FAAN, Amy Brooks-Kayal MD, FAAN
11:30 AM-6:30 PM
P5 - Poster Session 5
11:45 AM-12:30 PM
How Your Social Life Might Be Helping (or Harming) Your Brain Joel Salinas MD
12:00 PM-12:45 PM
A "How to and Why" of the Shared Medical Appointments: A Way to Meet the Needs of the Patient and Provider While Maximizing Clinical Time Nancy Isenberg MD, MPH, FAAN, Mary Rensel MD, FAAN
12:00 PM-1:00 PM
Who Wants to Be a Millionaire Jose Posas MD
1:00 PM-1:45 PM
Acupuncture Demonstration - 4 Gates Jennifer Bickel MD, FAAN
Are You My Mentor? Finding the Right Fit for Success in Research Holly Hinson MD, MCR, FAAN
1:00 PM-2:30 PM
S44 - History of Neurology
Preview Film on Robin Williams’ Journey with LBD with His Wife Susan Schneider Williams
1:00 PM-3:00 PM
C216 - Higher Cortical Visual Disorders: Case-based Review Sashank Prasad MD
C218 - Critical Care EEG Monitoring Suzette LaRoche MD, FAAN
C219 - Therapy in Neurology III: Epilepsy and Headache David Dodick MD, FAAN
C220 - Movement Disorders for the General Neurologist II: Tremor, Drug-induced Movement Disorders, RLS, and Ataxia Joohi Jimenez Shahed MD
C226 - Neuro-rheumatology: Neurological Manifestations of Systemic Inflammatory and Autoimmune Disease I Jeffrey Gelfand MD, MAS, FAAN
C221 - Functional Neurologic Disorders I: Movement, Seizures, and Multiple Sclerosis Alberto Espay MD, FAAN
C222 - Good Neurology in Challenging Conditions: Lessons from Military Neurology Michele Gatheridge MD
C223 - United We Stand: Enhancing Your Practice with APPs Jessica Erfan PA-C
C225 - Actualización científica II (Scientific Update II) Alejandro Tobon MD
S47 - Stroke Outcomes and Recurrence
S48 - Epilepsy/Clinical Neurophysiology (EEG) III
S49 - MS Epidemiology and Risk Stratification
1:00 PM-5:30 PM
C227 - Genomic Neurology: Developing Practical Knowledge of Tools and Concepts Through Case Studies Jeffery Vance MD, PhD
1:30 PM-2:30 PM
Rocky's Legacy: Historical Controversies of Boxing-related Concussions Barry Jordan MD, Anthony Alessi MD, FAAN, Tad Seifert MD
2:00 PM-2:45 PM
Innovative Ways to Decrease Wait Times in Your Practice Jason Sico MD, FAAN
3:00 PM-3:45 PM
How to Navigate the Demands of the First Years of Your Academic Career Nicholas Johnson MD, FAAN
3:00 PM-4:00 PM
Consejos prácticos para un buen examen neurológico (Neuro Exam Tips and Tricks) Jose Biller MD, FAAN, FACP, FAHA
3:30 PM-5:30 PM
C230 - Disparities in Care Charles Flippen MD, FAAN
C231 - Safe and Appropriate Opioid Prescribing in Neurology Adam Burkey MD
C232 - Women With Epilepsy (WWE): Beyond Seizure Control Anne Van Cott MD, FAAN
C233 - Therapy in Neurology IV: Movement Disorders and Stroke David Dodick MD, FAAN
C234 - Movement Disorders for the General Neurologist III: Chorea, Dystonia, Myoclonus, Stereotypies, and Tics Shyamal Mehta MD, PhD
C236 - Neuro-rheumatology: Neurological Manifestations of Systemic Inflammatory and Autoimmune Disease II Jeffrey Gelfand MD, MAS, FAAN
C235 - Functional Neurologic Disorders II: Life Experiences and Management of Functional Disorders Alberto Espay MD, FAAN
N6 - Neuroscience in the Clinic: The Brain Across the Menstrual Cycle Riley Bove MD, Temitayo Oyegbile MD, PhD
S51 - Child Neurology: Bench to Bedside: Progress in Treating Genetic Disorders
S52 - Acute Non-Interventional Stroke Care
S53 - Movement Disorders: Genetics and Clinical Features
S55 - MS Basic Science
IS3 - Invited Science: Aging and Dementia Karen Marder MD, MPH, FAAN, Heather Snyder PhD
4:00 PM-4:30 PM
Resident and Fellow Conversation Christopher Perrone MD
4:00 PM-4:45 PM
Neurohospitalist Models of Care in an Academic Department: Opportunities and Challenges S. Josephson MD, FAAN
4:30 PM-5:30 PM
Standing on the Shoulders of Giants Stanley Fahn MD, FAAN
5:00 PM-5:30 PM
Division Chief Conversation Amy Brooks-Kayal MD, FAAN
5:00 PM-5:45 PM
Influence of a Comprehensive Lifestyle Intervention on Prevention of Dementia Dean Sherzai MD, MAS, PhD, Ayesha Sherzai MD
Global Neurology: A Work in Progress Jerome Chin MD, PhD, MPH, FAAN
5:30 PM-6:00 PM
Division Chief Conversation Brenda Banwell MD, FAAN
7:00 PM-10:00 PM
C239 - Case Studies: Test Your Knowledge: A Case-based Approach to Neuroimaging Joshua Klein MD, PhD, FANA, FAAN
C240 - Case Studies: Unusual Movement Disorders Kailash Bhatia MD, FAAN
C241 - Case Studies: Challenging Headache Cases Kathleen Digre MD, FAAN
C242 - Case Studies: Dementia Gregory Day MD, MSc

Friday, May 10, 2019
7:00 AM-7:30 AM
Grant Writing 101: Getting Started Logan Schneider MD
Trainee Experience: Navigating the AAN and Your Career
7:00 AM-9:00 AM
C244 - Acute and Chronic Clinical Epilepsy Update Explained in 6 Cases Matthew Hoerth MD
C245 - Controversies in Stroke Treatment and Prevention Pierre Fayad MD, FAAN, FAHA
C246 - Hot Topics and Controversies in Parkinson's Disease Melissa Nirenberg MD, PhD, FAAN
C247 - What Do I Do Now?: Emergency and Inpatient Management of Migraine and Other Headache Disorders Stephanie Nahas MD, FAAN
C248 - Multiple Sclerosis in the Trenches: Controversy and Consensus in Clinical Decision-Making Aaron Miller MD, FAAN
C249 - Clinical Pearls: Learning from Complex Cases Simple Lessons that Apply to Everyday Problems S. Josephson MD, FAAN
8:00 AM-8:30 AM
How to Put Together Effective Research Presentations Enrique Leira MD, MS, FAAN
8:00 AM-8:45 AM
How to Give Effective Feedback Diana Barratt MD, MPH, FAAN, Adnan Subei DO, Farah Fourcand MD
9:15 AM-11:30 AM
Neurology Year in Review Plenary Session Martinson Arnan MD
11:30 AM-1:00 PM
P6 - Poster Session 6
11:45 AM-12:45 PM
Friday Grand Finale: Neuroimaging
12:00 PM-1:00 PM
The Neurology of Creativity at the Keyboard Phillip Pearl MD, FAAN
1:00 PM-1:45 PM
Growing Research in Medical Marijuana Anup Patel MD, FAAN
K is for Career Development: Tips on Successful Applications for NIH Career Development Awards Logan Schneider MD
1:00 PM-3:00 PM
C250 - Update in Epilepsy Joseph Sirven MD, FAAN
C252 - Update in Aging and Dementia Gil Rabinovici MD
C251 - Neuro-ophthalmology: Overview and Update Nancy Newman MD, FAAN
C253 - Update in Movement Disorders Alfonso Fasano MD, PhD
S56 - MS Trials and Treatment
S57 - Acute Treatment and Imaging of Ischemic Stroke
S59 - Migraine: Impact, Treatment Patterns and Resource Utilization
1:30 PM-2:15 PM
Movement Disorder Case Studies: What I Have Learned from My Patients Deborah Hall MD, PhD, FAAN, Susan Fox MD
2:00 PM-2:30 PM
Choosing a Career in Neuro-oncology Sylvia Kurz MD, PhD
2:00 PM-2:45 PM
Consensus-based Care Recommendations for Adults with Myotonic Dystrophy Type 1 Nicholas Johnson MD, FAAN
2:45 PM-3:30 PM
Neuroanatomy of the Zombie Brain: A Year in Review Brian Hanrahan MD
3:00 PM-3:45 PM
Sleep: Why You Should Spend Your Career Helping People Do It Right Logan Schneider MD
3:30 PM-4:30 PM
C254 - Education Blitz: Child Neurology: Concussion Meeryo Choe MD
C255 - Education Blitz: Normal Pressure Hydrocephalus Neill Graff-Radford MD, FAAN
C257 - Education Blitz: Evolution of Autoimmune Neurology Steven Vernino MD, PhD, FAAN
C258 - Education Blitz: Multiple Sclerosis Stephen Krieger MD, FAAN
4:30 PM-5:30 PM
NeuroZone Mark Milstein MD, FAAN, Bert Vargas MD, FAAN, Jennifer Bickel MD, FAAN, Wayne Anderson MD, FAAN

Universal Navigation

P1 - Poster Session 1

Ready to register for the 2019 AAN Annual Meeting?

Related Courses

Footer